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Abstract
Autism Spectrum Disorders (ASD) are neurodevelopmental syndromes affecting 1%-2% 
of all children. The aetiology of ASD is unknown, yet evidence supports a role for both 
genetic and non-genetic, including environmental, factors in aetiology. 
This thesis includes four related studies examining the role of maternal factors, and in 
particular maternal age, in the aetiology of ASD.   Using methods of meta-analysis, 
national Swedish health registers, as well as a multinational cohort combining national 
registers from five countries  this thesis examined: (a) the hypothesis that advancing 
maternal age is associated with ASD in the offspring ; (b) the hypothesis that maternal 
reproductive treatments are associated with ASD risk; and (c) the familial risk for ASD.
The meta-analysis provided support for the hypothesis that advancing maternal age is 
associated with risk for ASD in the offspring. Risk for ASD was 1.3 fold higher 
(95%CI:1.2-1.4) for offspring of mothers 35 years old or older compared with mothers 
25-29. The multinational cohort provided further support for the hypothesis 
demonstrating an independent effects of paternal and maternal age on risk for ASD. In 
addition, in addition to the effect of advancing age this study showed an increased risk 
with increasing differences in age between the spouses.
Fertility treatments, overall, were not associated with risk for autism [RR=1.1; 95% 0.9-
1.4]. However, in treatments for the most severe form of male infertility there was a 
strong association RR=4.6 (95%CI: 2.1-9.9). 
Our family study demonstrated that genetic factors explain half of the liability to ASD 
(h2=50%, 95% CI:). Factors related to maternal intrauterine environment do not seem 
to play a substantial role in autism aetiology. 
In conclusion, maternal age represents a moderate risk factor for autism. The 
mechanisms underlying this effect may involve both genomic and social factors, and 
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This section will describe the Autism Spectrum Disorders. Section 1.1 will describe the 
diagnostic system of autism spectrum disorders. Section 1.2 will present an overview of 
the aetiology of autism spectrum disorders and in more detail, in sub-sections, will 
present selected risk factors of particular importance for this thesis.
1.1 Autism - Diagnosis and origins
1.1.1 Autism characteristics
Autism spectrum disorders (ASD) are a group of severe disorders of brain development. 
Autism is the most severe form of these disorders. Autism is characterized by social 
deficits, verbal and non-verbal communication deficits and restricted interests and 
repetitive behaviours. Autism is evident early on, already by age 2 o -3, and there is 
considerable individual variation in expression. In addition to the three core 
components individuals affected with autism can also suffer from intellectual disability 
and physical and neurological problems. 
1.1.2 Diagnostic criteria
The diagnosis of autism is done based on symptomatology and direct observation. 
There is currently no accepted biomarker for diagnosing autism. In the current DSM IV-
R criteria (American Psychiatric Association: Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition, Text Revision) autism is part of a wider group of 5 
disorders of neurodevelopmental origin, called pervasive developmental disorders 
(PDD). These include:
1. Autistic Disorder (AD)
2. PDD not otherwise specified (= Atypical autism)
3. Asperger's disorder
4. Rett's disorder
5. Childhood dis-integrative disorder
For a diagnosis of AD the DSM IV-R specify
1. Impairment from at least 2 of 4 items describing social interaction, and,
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2. Impairment from at least 1 of 4 items describing communication, and,
3. Impairment from at least 1 of 4 items describing repetitive and stereotyped 
patterns of behaviour
With at total of at least 6 items from 1-3 above and, importantly, with onset prior to 
age 3.
The other four diagnosis in the PDD group are characterized by:
• Atypical autism: presentations that does not meet the criteria for AD because of 
late age at onset or atypical or sub-threshold symptomatology including the 
"high-functioning" ASD
• Asperger's disorder: differs from the AD category primarily in the lack of 
significant delay in language or cognitive development and with a later age of 
onset.
• Rett's disorder: Almost exclusively effecting girls with profound effect on the 
development and onset usually at 6-18 month of age. As many as 95% of the 
cases have mutations in the X-linked MECP2 gene (Buxbaum & Hof 2013, 
p.421).
• Childhood disintegrative disorder is similar to autism in expression but is 
recognized by a loss of language, social interplay or physical motor skill from an 
initially normal state. The onset is usually at the age 2-5 but in rare cases as late 
as age 10. The disorder is very rare.
The full DSM IV-R criteria is described in appendix A.
While ICD-10 criteria for Atypical autism is divided into four sub-categories, overall 
DSM and ICD diagnostic criteria are very similar (see appendix A). A bigger problem 
than the internal comparisons between ICD and DSM is probably the validity of the 
concept itself considering the lack of specific biological markers (Volkmar 1996).
The terms "autism", "infantile autism", "childhood autism" and "autistic disorder" are 
often used interchangeably to refer to the same conditions. The term "Autism 
Spectrum Disorders" (ASD) is used for the AD, Atypical autism and Asperger's Disorder 
combined.
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1.1.3 History of diagnosis
Autism was first described in 1943 by Leo Kanner (Kanner 1968) that described a group 
of 11 cases (followed up in a paper 30 years later (Kanner 1971)). Even though the 
observations made by Kanner are still valid today there have been divergent views on 
how to consider and classify autism. For a period of time autism was considered a 
subclass under schizophrenia or childhood psychosis (Hollander et al. 2010; Starling & 
Dossetor 2009) and some even wanted to consider autism a psychogenic disease 
(Hollander et al. 2010). A variety of studies over the past forty-five years have paved 
the way for the current view of autism spectrum disorders. 
The first major shift in how autism was viewed resulted from the twin studies of the 
1970s when it became clear that there are important genetic influence on autism 
(Susan Folstein & Rutter 1977; S Folstein & Rutter 1977; Bailey et al. 1995). Second, it 
was concluded that autism was not a part of schizophrenia. The substantial differences 
in age of onset between autism and schizophrenia made them incompatible as a 
common disease (Rutter 1972). Third, the difficulty to draw the exact diagnostic 
borders between different aspects of the disease made the concept of spectrum 
almost necessary (Wing & Gould 1979).
In the DSM, autism existed as a separate diagnostic entity from 1980 in DSM III and 
then as "infantile autism" only with 6 characteristics. The 1987 DSM III-R changed the 
title to “autistic disorder”. The DSM IV, published in the year 1994, extended this to 
four subtypes consisting of 16 different characteristics.
In the latest version of DSM, the DSM 5 (American Psychiatric Association et al. 2013), 
ASD was again modified to a single concept where, Asperger's disorder is not 
mentioned any longer separately, and Rett's disorder has been excluded from the 
category. A gradient of severity was added with consequences to the need for support.
The discussion on how to define and classify autism still likely continue; together with 
schizophrenia? (King & Lord 2011) associated with ADHD? (Gargaro et al. 2011) or 
together with PDD? (Tateno et al. 2011).
1.1.4 Prevalence
The prevalence of autism has increased dramatically over the past 20 years. Although 
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changes in underlying genetic or environmental causes have not been ruled out, this 
can not by itself explain the differences in prevalence between different geographical 
regions. This suggest that there may be a role for social/cultural factors such as 
awareness and ascertainment, diagnostic substitution and availability of services in 
prevalence. For instance, it has been estimated that one quarter of the increase in 
prevalence in California between 1992 and 2005, is due to changes in diagnostic 
practice(s), e.g. from earlier diagnosis of Intellectual Disability (ID) (King & Bearman 
2009). As the age of parenting has been increasing in the United States and Europe in 
recent decades (Bray et al. 2006; Martin et al. 2006) an association between maternal 
age and autism may help explain, at least in part, the increase in prevalence estimates 
of autism during the past two decades. It should also be noted that, by definition, 
prevalence is a cumulative measure with differences between populations or samples 
reflecting the differences in age distribution and as such less suited for measuring 
causal effects than the incidence and the relative risk. In our studies I, II, III and IV the 
aim has been to study aetiology and autism risk factors - not prevalence or society 
disease burden.
The US Centers for Disease Control and Prevention (CDC) estimate the prevalence of 
ASD among 8 year old children in the USA to be 1.8% for boys (1 in 54) and 0.4% for 
girls (1 in 252) (Autism and Developmental Disabilities Monitoring Network 
Surveillance Year 2008 Principal Investigators & Centers for Disease Control and 
Prevention 2012).
For the purpose of this thesis, using the data from our study III it was possible to 
estimate the prevalence among all children born in Sweden 1982-2007 and followed up 
for AD up to 2009. The data show a high heterogeneity between the different counties 
in Sweden (Figure 1 Left panel; Figure 1, Bottom right panel) and with a sharp increase 
over birth cohorts (Figure 1, Top right panel). 
The ASD prevalence among 8 year old children in Sweden born 1985-1989 was 
estimated to 0.08% (95% CI: 0.07-0.09%); born 1990-1994 0.16% (95% CI: 0.15-0.17%) 
and born 2000-2004 to 0.47% (95% CI: 0.45-0.49%). For AD the corresponding 
prevalences were 0.06% (95% CI: 0.06-0.07) for children born 1985-89 and 0.28% (95% 
CI: 0.26-0.29%) for children born 2000-2004.
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The ASD prevalence among 8 year old children over all birth cohorts 1980 to 2009 was 
0.19% (95% CI: 0.19-0.20%) and for AD 0.12% (95% CI: 0.12-0.13%).
Figure 1 ASD prevalence (%) at age 8 for children born in Sweden 1982-2007. Followed-
up for ASD until 31st December 2009
Footnote: Prevalence estimated by inverted Kaplan-Meier curves, 1-S(t), 
S(t)=Prob(Survive > t| Alive <=t)
1.2 Aetiology
Autism is a genetic disorder, i.e., genetic factors are responsible for a substantial 
proportion of individual differences in liability to the disorder, and it shares genetic 
mechanisms with the other PDD (Szatmari et al. 1998). Early twin studies showed a 
strong heritability of autism with estimate as high as 93% (Freitag 2007; Bailey et al. 
1998; Susan Folstein and Rutter 1977; Cichon et al. 2009), and very different 
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concordance rates for MZ and DZ twins (S Folstein and Rutter 1977; Bailey et al. 1995). 
For a broader ASD definition the MZ concordance rate in the twin studies was 90% 
while the concordance rate for DZ twins was below 10% (Bailey et al. 1995). 
An epidemiological study of 943,000 children of which 818 developed autism 1994-
2001 show a strong association between autism and psychiatric history in mothers 
(RR=4.0), psychiatric history in fathers (RR=1.8), and ASD in siblings (RR=27) supporting 
a strong genetic contribution in the aetiology of autism (Lauritsen, Pedersen, and 
Mortensen 2005).
Combining information from different family studies Szatmari estimated the recurrence 
rate in siblings of affected children to be 1.1-3.3% (95% confidence interval) while the 
risk for any PDD was estimated to be between 1.6-5.6% (Szatmari et al. 1998). While 
not a high number in absolute terms it is very high compared to the 5-6 per 10,000 
prevalence rate in the general population at the time, but yet much lower than risk in 
single-gene disorders.
1.2.1 Molecular genetics
The molecular genetic of autism is a fast moving field, with new results reported 
frequently. Several common variants have been associated with autism in genome-
wide association studies (Pearson & Manolio 2008), most recently a region of 
chromosome 5 (5p14.1) (Wang et al. 2009; Ma et al. 2009). In 2011 it was suggested 
that at least 103 genes and 44 genomic loci are associated with ASD or AD. These genes 
and loci have all been causally implicated in intellectual disability as well (Betancur 
2011). In addition to the common variants rare genomic alternations have also been 
linked to autism (e.g 1q21.1) (Mefford et al. 2008). Of particular interest for 
neurodevelopmental disorders are de-novo mutations. De-Novo mutations are 
alterations in a gene that are present for the first time in one family member as a result 
of a mutation in a germ cell (egg or sperm) of one of the parents or in the fertilized egg 
itself (De Rycke et al. 2002) . An association between de-novo mutations and autism 
has been reported (Neale et al. 2012) . However, despite the high heritability of autism, 
and new discoveries, the molecular basis of autism is still elusive and there is sufficient 




Advanced maternal age is one of the most frequently studied risk factors for autism 
(Durkin et al. 2008; Larsson et al. 2005; Glasson et al. 2004; Maimburg & Vaeth 2006; 
Reichenberg et al. 2006; Hultman et al. 2011; Sasanfar et al. 2010; Grether et al. 2009; 
Burstyn et al. 2010). Despite the considerable amount of research of the relation 
between maternal age and autism, including epidemiological samples, study results are 
mixed: positive associations (Grether et al. 2009) and null associations (Hultman et al. 
2011) have been reported in similar numbers, and therefore the presence of the 
associations is still strongly disputed (Reichenberg et al. 2010). Different studies have 
also used different study designs, differences in case-ascertainment (Grether et al. 
2009; Reichenberg et al. 2006; Zhang et al. 2010; Hultman et al. 2011) and differences 
in availability and adjustment for confounding, adding to the difficulty of comparing 
them. 
The goal of this thesis is to rigorously examine the association between maternal age 
and ASD; rule out potential confounding factors, and characterize the aetiological role 
of other maternal related factors. 
1.2.3 Other risk factors
The following section describes potential confounding and modifying factors for the 
association between maternal age and ASD. This thesis will consider the potential 
effects of such factors as part of the analytic approach. 
1.2.4 Paternal age
There is now strong epidemiological support for an increased risk of autism among 
offspring of older fathers (Grether et al. 2009; Hultman et al. 2011; Reichenberg et al. 
2006). These studies cover several geographic regions and health systems. Other 
psychiatric disorders such as schizophrenia (Frans et al. 2011; Malaspina et al. 2001) 
and bipolar disease (Frans et al. 2008) have also been associated with advancing 
paternal age. Where Reichenberg and colleagues (Reichenberg et al. 2006) were the 
first epidemiological study to point out de-novo mutations as the possible underlying 
mechanism for paternal age effects in autism later biological studies have verified this 
as a likely mechanism (Sanders et al. 2012; Neale et al. 2012; O’Roak et al. 2012). 
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However, there are other mechanisms that can not entirely be ruled out as 
independent risk factors. One such mechanism can be the inheritance of traits which 
are associated with a delayed fatherhood. It has been particularly difficult to separate 
paternal from maternal age effects, and to study alternative mechanisms. This thesis is 
uniquely positioned to address those challenges.
1.2.5 Sex
In the aetiology of autism gender is the strongest known predictor for autism. ASD 
prevalence in the US among 8 year old children was 4.7 times higher in boys (1 in 54) 
than in girls (1 in 252) (Sunderam et al. 2009). The ratio may however differ. It may be 
as low as 1:1 for severe cases with de-novo mutations and as high as 1:11 for Asperger 
disorder(Gillberg et al. 2006). It has also been debated if the expression is the same for 
both sexes or different (Andersson et al. 2013; Hartley & Sikora 2009; Robinson et al. 
2013) and if the aetiology is the same (Zachor et al. 2013) but with no strong support 
to favour sex differences in aetiology.
1.2.6 Pre- and perinatal factors
Several pre- and perinatal factors have been associated with autism in epidemiological 
studies , e.g. gestational age, birth weight, hypoxia (Apgar score, foetal distress, 
Caesarean section, and bleeding during pregnancy) (Hultman et al. 2002; Kolevzon et 
al. 2007; Losh et al. 2012). Obstetric conditions could be part of a causal pathway to 
autism risk and are therefore important to consider.
1.2.7 In-vitro Fertilization
The number of babies born worldwide through IVF in 2002 was estimated to range 
between 219,000 and 246,000 (de Mouzon et al. 2009). Approximately 1% of U.S. 
infants born in 2006 were conceived through IVF. Rates increase dramatically in older 
mothers (>35) (Sunderam et al. 2009). IVF have been associated with increased risk for 
post-natal intensive care (Middelburg et al. 2008; Ericson et al. 2002; Allen et al. 2008; 
Sunderam et al. 2009), congenital malformations (Olson et al. 2005), Cerebral Palsy 
(Källén et al. 2005; Lidegaard et al. 2005), and increased risk for mild delays in 
development (Bowen et al. 1998a).
Angelman's syndrome is characterized by severe intellectual disability and lack of 
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speech, as well as abnormal motor behaviours, and symptoms that have considerable 
phenotypic overlap with autism. Two studies reported higher than expected rates of 
Angelman's syndrome following IVF (Cox et al. 2002; Ørstavik et al. 2003; Gosden et al. 
2003). Higher rates of infertility problems have been reported in parents of autistic 
children (Funderburk et al. 1983). In contrast, Maimburg and Vaeth reported that 
children born following IVF had a lower risk of autism (Maimburg & Vaeth 2007). In a 
Danish study following all Danish birth 1995-2003 using the Danish IVF register (5.3% of 
all Danish births) there was no statistically significant increased risk of ASD when 
controlling for maternal age and other possible risk factors even though there were 
some indications of increased crude risk and in certain subgroups (Hvidtjørn et al. 
2011)
1.2.8 Psychiatric disorders in relatives
Several psychiatric disorders are more common among relatives of individuals with 
autism (Micali et al. 2004; Bailey et al. 1998; Wolff et al. 1988; Jokiranta et al. 2013; 
Sullivan et al. 2012). There is however no evidence for an increased risk of psychiatric 
admission after the birth of the autistic child (Bolton et al. 1998). An epidemiological 
study from 2005 reported increased risk of schizophrenia-like psychosis, RR=3.4, and 
affective disorder, RR=2.9 in parents of autistic children (including Asperger and PDD-
NOS) even when adjusting for maternal age and perinatal risk factors (Larsson et al. 
2005). Another study showed a strong association between autistic children and 
autistic disorders or broader psychiatric history in mother and in siblings (Lauritsen et 
al. 2005; Jokiranta et al. 2013).
Besides an association with advancing maternal age on the risk of psychiatric disorders 
there are also reports on an increased risk for perinatal and adverse pregnancy 
complications among schizophrenic women (Bennedsen 1998; Bennedsen et al. 1999). 
Thus, it is possible that presence of psychiatric history in mothers (particularly 
schizophrenia) will be associated with both later age of conception, and increased rates 
of pregnancy and delivery complication, thus confounding the association between 
maternal age and autism.
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1.2.9 Summary
Although the effort to find genes explaining the risk of autism has indicated more than 
100 genes, these genes only explain a very small part of the underlying aetiology 
(Betancur 2011). Instead of common genes the genetic aetiology for autism seems 
complex involving common genes, as well as several loci occurring de-novo and of 
different types (copy-number-variants, deletion, insertions) and also possibly 
epigenetic origins.
Several factors studied in epidemiological samples have been associated with the risk 
of ASD. Similar to the genetic factors, while important, and most are more important 
than any single genetic factor, on a relative scale, these variables can not explain any 
major part of the aetiology. Of the risk factors mentioned in the previous sections, this 
thesis focuses on maternal age. Although previously studied, the inconsistent results, 
and the fact that maternal age represent a modifiable risk, makes it both intriguing and 
important to study rigorously. 
2 Aims
Maternal factors have long been suggested as important for autism aetiology. Among 
such factors, maternal age is the most obvious to investigate, potentially harbouring 
multiple risk mechanisms. Therefore the aim of this thesis is to characterize potential 
pathways through which maternal age might be operating and more generally to study 
autism risk where maternal age may have an influence. It is important to study 
maternal age, together with factors potentially confounding this association, as a tool 
to suggest biological pathways. It can also have consequences for public health as the 
age of parenting has been, and keeps increasing in the Western world. This thesis 
performed the following four studies:
First, to address the heterogeneity of association between advancing maternal age and 
autism in earlier published research, I performed a meta analysis. This study meet the 
aim of this thesis by characterizing the shape and magnitude of the maternal age 
association, combined over multiple studies and by considering potential pathways for 
maternal age: offspring gender and the effect of confounding generally. Second, to 
meet the inherent limitations of a meta analysis, the independent and bivariate 
association of maternal and paternal age and ASD were analysed using a large 
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multinational population cohort, including separately for AD and ASD and for male and 
female offspring separately. This study support the aim of the thesis by directly 
evaluating and, as a result, suggesting a “new” pathway through which maternal age 
can operate: differences in age between the parents at the time of birth of the 
offspring. The study further support the study aim by characterizing (describing the 
functional form of the maternal age and of maternal age in relation to the age of the 
spouse.
The two last studies study autism risk where maternal age may have an influence by 
considering infertility problems and by considering familial risk. Thus, in study three, 
infertility problems and different in-vitro fertilization (IVF) treatments were examined 
as a second potential source underlying the maternal age-autism association and to 
suggest biological pathways to autism. In different studies intellectual disability has 
been showed to have genetic overlap (Betancur 2011) with autism and have some 
overlap in phenotypic features. The risk for autistic disorder and intellectual disability 
after IVF were studied while addressing confounding and mediating effect of parental 
age, psychiatric history and pre-term birth. Male and female offspring were be 
considered separately. This study support the aim of the thesis by characterizing 
potential pathways through which maternal age may operate: factors associated with 
fertility problems (since fertility problem is increasing with advancing maternal age) 
and IVF treatment (since maternal age could potentially confound an association 
between different IVF treatments and autism - in any direction).
Finally, in the fourth study the importance of genetic versus non-genetic, 
environmental factors in the aetiology of autism was examined by estimating the family 
clustering of ASD. The relative familial recurrence risk as well as the heritability were 
estimated using a range of familial relations from twins to cousins. The analyses include 
gender comparisons and comparisons separately for AD and ASD. This study support 
the aim of the thesis by including maternal age as one of the variables confounding the 
within-family risk. If maternal age is associated with autism risk then advancing 
maternal age for two consecutive siblings may create or inflate a sibling recurrence 
risk. Not taking maternal age into account can potentially result in risk associated with 
maternal age being mistaken for an additive genetic risk.
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2.1 Specific Hypotheses
The following a-priori hypotheses were tested: 
A Maternal age and ASD
1. Advancing maternal age is associated with increased risk of ASD in the 
offspring. 
2. Advancing maternal age and advancing paternal age are independent risk 
factors for ASD in the offspring.
B In-Vitro Fertilization (IVF) and ASD
1. IVF treatments are associated with increased risk for autism and intellectual 
disability in the offspring.
C General aetiology of ASD. The following competing hypotheses were examined:
1. Genetic factors will contribute substantially to individual differences in 
liability to ASD.
2. Shared environmental factors will contribute substantially to individual 
differences in liability to ASD.
3 Methods
It is the scope of this section to describe important methodological problems when 
considerations the studies presented and how we have addressed these problems.
3.1 Design issues, biases and confounding
Incomplete or inaccurate ascertainment of outcome and improper selection of controls 
are causes of (selection) bias in observational studies. In clinical trials this is controlled 
for by randomizing subjects to exposure (treatment group) where the bias is resolved 
into variation that is then taken care of by the statistical model. For observational 
studies randomization is not an option why other techniques must be used.
As a way to address case ascertainment, besides being of interest by its own right, in 
the studies presented here, we have included AD instead of, or together with, the ASD 
diagnosis since the stricter ICD/DSM criteria for AD should be more specific and 
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thereby less affected by misclassification compared with the wider diagnosis of ASD. 
This approach was possible given the high power in our studies.
Since we, first, have had access to entire national yearly birth cohorts and, secondly, 
the follow-up for autism is done in a publicly financed and utilized health system with 
equal access, under the assumption of no or negligible confounding, we minimize the 
risk of selection bias inherit in sampling design such as case-control, case-cohort or 
self-selection of participants. The study on IVF treatments involve a particular selection 
problem. Where most earlier studies have compared “any IVF treatment” against 
spontaneous conceived children we have chosen, primarily, another approach by 
comparing IVF treatments among children born IVF only. A comparison between 
children born after a certain IVF treatment and spontaneous born children can 
introduce bias since a specific IVF treatment can not be separated from the underlying 
fertility factors.
Bias could also be introduced through temporal trends in the ascertainment of autism. 
For this purpose we have addressed include birth year and age at diagnosis in all our 
analyses and addressed the issue of calendar effects in sensitivity analyses.
Another potential source of bias is measurement errors, differential or non-differential. 
In our studies the primary variables of exposure are maternal age, paternal age and 
family relations (siblings, cousins...) and secondary exposure variables include offspring 
year of birth and attained age. While the measurement of these variables may be 
subject to errors in retrospective studies (Lyall et al. 2012) the use of national 
prospective population register avoid these problems.
Since neurodevelopmental disorders are considered highly genetic of origin we have 
included parental psychiatric history at the birth of the offspring as a confounder in the 
analyses. Psychiatric diagnoses are not generally available in Sweden before 1973 we 
are probably missing psychiatric history for some parents. Since this is a relatively rare 
event in the general population the lack of data is a smaller problem than the 
specificity of the diagnostic codes used. For this we rely on the validation studies done 
(Ekholm et al. 2005; Kristjansson et al. 1987; Ludvigsson et al. 2011) .
In our studies of family risk and of IVF the detailed data including date of offspring 
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diagnosis has allowed us to model the probability of autism using survival analysis 
(time-to-event) techniques by fitting poisson or Cox regression. These models adjust 
properly for differences in length of follow-up between different (sets of) individuals 
which otherwise can bias the results. For the model estimating the heritability we 
adjusted for the differences in length of follow-up by including parameters for birth 
year. In study II the date of diagnosis was available only for Sweden and Denmark. In 
this study we first included parameters for birth year in a logistic regression model 
including all sites. Then, as a sensitivity analysis, we applied survival analysis (stratified 
Cox regression) using Sweden and Denmark only using attained age as time scale and 
stratifying for birth year (Korn et al. 1997).
3.2 Meta analysis versus individual level data
In study I we address the role of maternal age in the risk of autism using the approach 
of meta analysis. Meta analysis methods offer techniques to assist when combining 
results from different studies (D F Stroup et al. 2000) . The meta analysis is most 
important to do when there is heterogeneity and inconsistencies in the different 
studies. By relating the study outcome to a variable available from several studies, 
outcome = b + b*X, a meta-regression can give better understanding of study 
differences.
A drawback of the meta analysis approach is the retrospective nature since all analyses 
has been made already and adoption has to be made to this. Not all studies can be 
combined if too different categorizations have been applied or if a continuous covariate 
approach have been used in some studies and a categorical data approach in others. 
Sources that add on to the heterogeneity between studies in the meta analysis, e.g. 
different confounding factors, can instead be addressed directly. This include for 
instance using the same covariates across all sites and, using same reference group. In 
this way the study II complement and extend the results from the meta analysis. Also, 
for our particular application, several of the data sources underlying the meta analysis 
are the same as the data used in the study I.
3.3 Family clustering
Family clustering of diseases can occur between generation, parent-child, within 
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generations, between siblings or cousins. Here we are considering clustering within-
generations only. To measure the risk on an individual level due to family clustering we 
calculated the relative recurrence risk defined as a risk ratio (relative risk) for the 
probability of being diagnosed with autism conditional on an autism diagnosis in a 
family member. For autism, this has only been done reliably in one earlier study, a 
Danish study (Grønborg et al. 2013). We did this for pairs of monozygotic twins, 
dizygotic twins, full siblings, maternal half siblings, paternal half siblings and cousins. 
Where other studies calculated absolute recurrence risk conditional on autism in an 
older sibling we relaxed this model and calculated the recurrence risk using time-
varying exposure and allow younger sibling to expose and older sibling as well which 
give us higher power. A potential problem in calculating recurrence risk is the 
dependence on prevalence. For increasing prevalences a later born child will always 
have higher risk than earlier born which could bias the estimates. We adjusted for this 
in our analysis in several ways (1) Including birth year as confounder, even if increase in 
prevalence can be driven by calendar time birth year will work as a surrogate; (2) By 
not conditioning on exposure in older sibling we do not allow the design to increase 
the problem; (3) We calculated relative recurrence risk in sub-groups of birth cohorts to 
check and describe the size of the problem and (4) A monotone temporal trend could 
show up as a violation against the proportional hazards assumptions in the Cox 
regression model - we checked for this.
The family clustering can be caused by a combination of common genes and shared 
family environment. Any genetically mediated risk in siblings should be proportional to 
the genetic heritage shares (Sham 1997) . Thus, mono-zygotic twins share on the 
average 100% of their genetic risk where dizygotic twins and full-sibling only share 
50%, half-siblings share 25% and cousins share 12.8% on the average. The proportion 
of the phenotype variance explained by genetic factors is termed heritability. We 
estimated the variance components for the probability of an autism diagnosis 
expressed as a generalized mixed effect model (Rabe-Hesketh et al. 2008; Rijsdijk & 
Sham 2002).
Where the recurrence risk measure familial clustering of autism with interpretation on 
an individual level the heritability measure the simultaneous information from a wider 
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set of relatives to measure the amount of variance (differences) in the data that can be 
attributed to genetic sources and have an interpretation on the population level.
Heritability calculations have traditionally relied on twin studies which often leads to 
sample size problems due to the low rate of twinning, especially for rare diseases. We 
are extending the population of the Swedish twin register with family data to obtain 
higher power, improve the convergence of the models and allow more complete 
complex variance component models to be fitted. The standard twin model separate 
the genetic variance component into two components. The additive genetic variance 
component capture the main effect of alleles on the phenotype, transmitted from 
parent to child. The dominance genetic component is the result of interactions 
between alleles at single loci and is estimated only from relatives who share a 
genotype identical by descent (from the same parental allele), i.e. from full siblings and 
twins. Using the combined data from twins and families allow a model including all 
four variance components (the ACDE model) to be identified and estimated, var(yij) = 
σA2 + σD2 + σS2 + σE2 where the standard twin model which do not include information 
on twins reared apart only allow ACE and ADE to be identified and estimated (Rabe-
Hesketh et al. 2008).
3.4 Statistical analysis
Since different subjects are followed for different length of time they will contribute 
with different amount of information to the study. To adjust for this, in studies II, III 
and IV, we apply survival analysis to study the association between exposure and 
autism. In study IV and study II we use Cox regression and in study III we use poisson 
regression. Poisson regression is commonly used in survival analysis and gives 
approximately the same parameter estimates as the Cox regression and allow the same 
relative risk to be estimated (Whitehead 1980) but facilitate inclusion of more than one 
time scale and allow the rate and risk versus time development to be estimated 
directly.
Many epidemiological studies chose to group continuous data into categories. In study 
II and study III, for a more efficient use of the true continuous scale we are using 
splines (Hastie et al. 2009; Smith 1979) where an outcome is described by an arbitrary 
flexible form, Y = s(x), without the need to specify any shape. This allow us to predict 
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the functional form of the relation. When applied to confounding covariates, e.g. for 
paternal age when studying maternal age, this approach can generally be expected to 
adjust better for confounding than when creating categories of the data (Benedetti & 
Abrahamowicz 2004). Poisson regression using splines can be described by a 
generalized linear model.
In study II we are fitting splines to a bivariate exposure, Probability(Autism) = 
s(maternal age, paternal age). To overcome the problem with a too restricted shape 
(too flat and lack of local smoothness), that is the case when using two independent 
spline functions, Probability(Autism) = s(maternal age) + s(paternal age), we have fitted 
thin-plate splines (Wood 2003). The thin-plate spline is a smoother in two-dimensions 
where the curvature is estimated in local circular regions moving over the bivariate, i.e. 
two-dimensional, surface similar to moving averages in the one-dimensional space. As 
far as we know this technique has never been used in epidemiological research on 
autism.
When there are several members from the same family contributing there may be 
problem with correlations in the data. While not biasing the point estimates the 
variances may be biased - in any direction. For this purpose we calculated robust 
standard errors using Generalized Estimating Equations (GEE) in study IV and study III 
using family or set of siblings or cousins as cluster. Another feature of the GEE is that 
the estimation do not require the data to follow any particular parametric distribution 
such as the poisson (Fitzmaurice et al. 2004, pp.291–320; Liang & Zeger 1986).
Throughout all four studies we have made extensive use of graphical methods. The 
purpose has been to offer a visually summary of complex results. Such results can 
sometimes be difficult to derive in tables and important messages might even get lost. 
For instance, we have chosen to plot relative risk estimates and the associated 
confidence intervals on a relative scale. Using tables it is not immediately obvious that 
a confidence limit 0.00781 should be given the same interpretation of precision as 128, 
since 0.00781 = 1/128 and complex relations between different relative risk estimates 
are easily spotted (Devesa et al. 1995). Similarly we present figures of the functional 
form of probability(autism) = s(maternal age) with a potential for a complex dose-
response relation easily recorded by the eye. 
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In study II the data delivered from Israel included all autistic patients in Israel together 
with a random sample of population based controls, not the entire population as for 
the other sites. To adjust for this we applied inverse probability weights in the 
calculations with weights proportional to the sampling probability. Furthermore, as the 
usual variances in the statistical models do not correct for the variation (insecurity) of 
the sampling weights we used robust standard errors. The precision is only slightly 
decreased by this approach.
In study IV we calculated relative recurrence risk using survival analysis. In this analysis, 
by definition, only pairs of family members contribute. In the analysis a sibling (or 
cousin) pair enter the cohort when a second sibling (cousin) is born . From that date 
both members contribute with information as unexposed (X=0). If one member is being 
diagnosed with autism the exposure data this individual contribute with is then 
changed to exposed (X=1) and the follow-up continues until the other member is also 
being diagnosed with autism or end of follow-up what ever comes first. Both members 
in the pair enter the analysis exposing each other. As far as we know this approach has 
not been published earlier and will contribute with higher power compared with 
analysis only allowing an older sibling to expose a younger sibling. Yet other studies 
have used logistic regression methods using matched cohort design (Lichtenstein, 
Björk, et al. 2006; Svensson et al. 2012) with lower power and with the risk of 
introducing biases due to differences in length of follow-up.
3.5 Missing data
Missing data can be an important source for bias or reducing power in epidemiological 
studies. There are different approaches to address these problems such as Multiple 
Imputation (Rubin & Schenker 1991) or Multiple Imputation by Chained Equations 
(White et al. 2011). However, if only a relatively small proportion of the data contain 
missing values the records containing missing data can safely be deleted using only the 
complete cases in the analysis.
Moreover, in the statistical literature missing data are usually classified according to the 
underlying reason of being missing. For data missing completely at random (MCAR), 
the probability of a value being missing is independent of both the observed data and 
the unobserved data, e.g. by tossing a dice, comparisons are generally not subject to 
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bias. When, in a function Y = f(X) relating an outcome with exposure X, the probability 
of a particular value Y being missing depends only on the observed data (Y or X), then 
the missing data are said to be missing at random (MAR). If the missing data can be 
considered missing at random, the estimates obtained from the maximum likelihood 
estimation, such as poisson regression or logistic regression, are unbiased. If this 
assumption is not true, the missing data are not ignorable and the missing mechanisms 
should be modelled (Little & Rubin 1987).
In the work presented here using registers the data at hand are essentially complete. 
For instance, in the IVF study, only 0.7% had missing information on paternal age, 
maternal age or pre-term status. Similar figures apply for the other studies. These small 
numbers of missing data will not be able to bias the results or to affect the precision in 
any meaningful way. We also believe the statistical methods applied should be robust 
for data being missing due to any foreseeable reasons.
3.6 Data sources
Except for the meta analysis all studies utilized register based data for autism and 
exposure. In study 2 and 3 we used Swedish register data and in study 4 we used 
Swedish register data combined with register data from Denmark, Finland, Norway, 
Israel and Western Australia in the iCARE collaboration (Schendel et al. 2013). We 
describe the Swedish data sources and comment on the iCARE data separately.
3.6.1 The basis for register based research in the Nordic 
countries
All health care in the Nordic countries (Sweden, Denmark, Finland, Norway and 
Iceland), is publicly financiered and utilized. Especially for psychiatric diagnoses where 
no private clinics exist the population coverage is close to complete (Ludvigsson et al. 
2011). Furthermore, all Nordic countries are utilizing unique personal registration 
number in all contact with authorities (as well as private organizations and companies). 
The identifiers are automatically assigned each citizen at birth or at immigration. The 
health system, publicly financed and utilized, avoid selection biases otherwise often 
present in the creation of epidemiological cohorts (Delgado-Rodríguez & Llorca 2004) 
and the personal identifiers allow information from different services to be joined on 
an individual level. This set-up create a unique environment for epidemiological 
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research (Allebeck 2009; Olsen 2011).
There is a huge variety of registers at use for administrative and research purposes. 
Below the registers used in our studies are described in more detail. The health 
registers; the Medical birth register, the Patient register and the IVF register; are 
controlled and managed by the National Board of Health and Welfare 
("Socialstyrelsen"), a government agency in Sweden under the Ministry of Health and 
Social Affairs. 
3.6.2 Medical birth register
The Medical Birth Register (MBR) was established in 1973 (Axelsson 2003). It contains 
data on pregnancy and birth for all births in Sweden. More than 95% of the Swedish 
pregnant population attend antenatal care before the 15th gestational week and the 
register covers over 98% of births in Sweden from 1973 and onwards (Anon 2003). 
During the first visit, usually during pregnancy week 8-13, the woman is asked about 
the number of years of involuntary infertility. The information is recorded in the MBR. 
The register includes information collected prospectively, starting with the first 
antenatal visit through the time when mother and child are discharged from the 
hospital after delivery. All birth reported to the MBR are validated each year by cross-
checking the personal registration number against the Register of the Total Population. 
Antenatal care routines are standardized and the information is provided through 
antenatal, obstetrical, and neonatal records, and classified according to the 
International Classification of Diseases (ICD) version 8 until 1986, version 9 from 1987 
to 1996, and version 10 subsequently. The register include information about still birth, 
multiple birth, gestational age, birth weight, sex and Apgar score.
3.6.3 Population vital statistics
Individual vital statistics data including date of birth, date of emigration, date of 
immigration and date of death is maintained by Statistics Sweden (Total Population 
Register, Emigration and immigration register).
3.6.4 Multi-generation register
The Multi-generation register contains information about the entire Swedish 
population (Ekbom 2011; Anon n.d.). The register has been extensively used for 
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different research purposes. Children born from 1932 and alive 1961 are linked to their 
biological parents. In 1991 all records were computerized for all persons registered 30th 
June 1991 while persons deceased between 1947 and 30th June 1991 were not 
computerized. In several later waves the persons missing in the register 1991 have 
been added in. The register comprises about 10 million children (index persons, 2011) 
together with their biological parents. Importantly the register includes family 
information (e.g., identification of parents, siblings and offspring) allowing linkage to 
other population based registers, which include information on health (e.g. psychiatric 
hospitalizations), demographic variables (e.g., date of birth, death and emigration).
3.6.5 Patient register
Sweden has universal and publicly financed health insurance coverage that guarantees 
equal access to health services, regardless of employment status, socio-economic 
status or regional residency. The register has a nationwide coverage of patient 
treatment facilities and includes care in psychiatric as well as somatic hospitals. There 
are no private psychiatric hospitals in Sweden. The Swedish National Patient Register 
contains details on virtually all new psychiatric hospitalizations since 1973 (Ludvigsson 
et al. 2011). Before 1973 there is data for selected counties only. The register include 
data on admission and discharge dates and the discharge diagnosis made by the 
treating physician. Besides this diagnosis, the main diagnosis, there are also secondary 
diagnoses. Outpatient visits are included since 1999 but only from specialist care, 
thereby excluding any diagnosis by general practician. Diagnostic information is coded 
using the ICD codes. The standard procedure dictates that diagnosis will be given by a 
consultant (equivalent of an attending) psychiatrist at the time of discharge from 
hospital. The diagnostic assessment is then forwarded on a computer medium to the 
National Patient Register. These routines are standardized across Sweden. 
All infants and preschool children are regularly seen at well-child care clinics and 
undergo routine medical and developmental screening. All children aged 4 undergo 
routine general health screening, that includes mandatory developmental assessment 
(motor, language, cognitive and social development) conducted by a nurse and 
paediatrician. Children with any suspected developmental disorder (including autistic 
disorder and intellectual disability) are referred for further assessment by a specialized 
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team in a child psychiatry unit or habilitation service. During the study period 
diagnoses were made by diagnostic teams with a psychiatrist, clinical psychologist, and 
speech pathologist or occupational therapist, depending on clinical manifestations. The 
instruments include parental interviews, cognitive testing of the child, and 
observations in naturalistic settings, including the home or the unit. The Patient 
Register contains the diagnostic information. The Patient-Register has shown high 
reliability for somatic and psychiatric diagnoses (Kristjansson et al. 1987; Ludvigsson et 
al. 2011). For a diagnosis of intellectual disability the evaluation is made by a 
psychologist and according to standardized tests with high reliability.
3.6.6 IVF register
The IVF register contain frequencies of all IVF/ICSI treatments in Sweden from 1982 to 
2007. Since 2003 data on embryos transferred are registered as well. From 2007 data 
are stored in a separate Swedish "quality register" including a higher degree of details.
The 16 clinics for IVF/ICSI Sweden are required by law to report all treatments. IVF/ICSI 
treatments are offered to women in the range 25-42 years of age. There are no strict 
age restrictions for males. Eligibility requires a medically documented fertility problem. 
In Sweden, almost exclusively, IVF is used to treat female infertility while ICSI is used for 
male infertility.
3.7 The iCARE data base - A multinational data source
The International Collaboration for Autism Registry Epidemiology (iCARE) is a 
multinational collaboration across (the Nordic countries), Denmark, Norway, Finland 
and Sweden and Israel and Western Australia combining population based register date 
from all countries. As a result a database combining exposure data such as parental 
age, pre-term birth, gestational age, parity, apgar score with autism diagnosis has been 
developed. The design is a cohort consisting of all children born in the contributing 
countries between 1987 (since no diagnosis of autism earlier) and 2004 with follow-up 
until 2009. In total the combined database contain 36,736 persons with ASD 
ascertained from 6,8 million children.
The database include selected variables from the Swedish Medical birth register, 
Register for vital statistics and patient register, all described above, and the 
34 (229)
corresponding registers in the five other contributing countries. The iCARE project and 
the created autism cohort has been extensively described (Schendel et al. 2013).








Denmark 1.05  10,338 2,910
Finland 1.02 7,388 1,440
Israel 1.46 2,091 -
Norway 1.04 1,284 652
Sweden 1.82 14,501 5,386
W. Australia* 0.41 1,134 810
TOTAL 6.80 36,736 11,198
* A state based register containing both state and private register data. Follow-up to 
2004.
A special problem in the iCARE project has been the ethical and legal issues raised by 
national authorities when using national health data for research on an individual level. 
In iCARE we have solved this by setting up a federative database solution (Muilu et al. 
2007) where data physically stays on local servers in each country and anonymous data 
are transferred to the analysis server (in Australia) for each new analysis and erased 
after the execution.
3.8 Diagnostic coding system
The Swedish patient register is recording diagnoses from the International Statistical 
Classification of Diseases (ICD). Different version have been in use starting; ICD-7 1964-
68, ICD-8 1969-86, ICD-9 1987-96 and ICD-10 from 1997. Only from the ICD-9, year 
1987 is there a diagnosis available for autism. Cases of autism before 1987 were most 
likely coded as Schizophrenia with additional description of “childhood”. The National 
Board of Health and Welfare (“Socialstyrelsen”) is obtaining code translations between 
the different coding systems on their web page 
(http://www.socialstyrelsen.se/english). The ICD system is also used by the health 
registers in Denmark, Finland and Norway.
The ICD-10 and DSM IV criteria for ASD are almost identical.
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3.9 Power considerations
The power of a statistical test is the probability of rejecting the null hypothesis when 
the null hypothesis is false. The power is a concept useful for planning purposes and 
only relevant before any data have been collected (Hoenig & Heisey 2001; Levine & 
Ensom 2001). It is especially important to consider in the study of rare outcomes such 
as autism (and rare exposures).
First, for study I, we are combining all available and relevant studies in a meta-analysis. 
Meta-analysis is a tool in itself to address possible power issues in possibly under-
powered studies.
For the analysis of maternal age in the iCARE collaboration, study II, the plan was to 
have at least 6,000 cases of AD and 23,000 cases ASD - in the end we obtain twice as 
many cases. The Swedish prevalence of infantile autism for children born after 1987 is 
about 0.4% and, including a wider spectrum, for ASD about 0.9%. In the planning phase 
the power was calculated by arguments:
1. Assuming 25% and 10% of the birth having parents 25-30 yrs and >40 yrs and 
with 0.02% prevalence of AD there will be 90% power to detect an odds-ratio of 
1.2 or bigger in Sweden alone. 
2. Assuming 25% and 10% of the birth having parents 25-30 yrs and >40 yrs and 
with 0.02% prevalence of AD there will be 90% power to detect an odds-ratio of 
1.1 or bigger.
In Sweden there are about 100,000 birth each year resulting in a total of 2 million 
births between 1987-2007, with about 325,000 women >= 35. When planing the study 
III we assumed 4% IVF among these women (since more common in older mothers) 
there are about 13,000 IVF women to be compared with about 310,000 non-treated 
women. If the underlying autism prevalence among untreated is 0.4% and if the true 
(but unknown) relative risk is at least 1.5 we have a power of at least > 87% to detect 
this difference using a simple chi-2 test on the two-sided 5% level of significance. 
Please note that the calculations above must be considered conservative. Using more 
efficient statistical models for survival to adjust for actual follow-up time and including 
covariates to adjust for important confounding the power will be even higher.
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Table 2 Power calculations assuming 310,000 subjects in the control group and N 



















1.50 13.0 13.07 1.50 13.0 97.38
1.75 6.5 10.88 1.75 6.5 98.02
1.75 13.0 24.64 1.75 13.0 99.99
2.00 6.5 16.79 2.00 6.5 99.97
2.00 13.0 40.52 2.00 13.0 100
3.00 6.5 57.75 3.00 6.5 100










For study IV we estimated recurrence risk and heritability using the entire Swedish 
population - all data available.
3.10 Statistical software
We used different statistical software. As the standard work horse horse for data 
management the SAS software was used (http://www.sas.com/). The SAS software 
version 9.2 and 9.3 was used for all four studies presented here. Also, most statistical 
graphs were produced using the SAS/GRAPH software.
The glimmix procedure in the SAS/STAT software version 9.3 was used for the Poisson 
regression models in the IVF study. Except for the thin plate spline regression, the 
glimmix and genmod procedures in the SAS/STAT software version 9.3 was used for the 
statistical models in the multinational parental age study. Both glimmix and genmod 
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was used for the GEE estimation technique. The SAS/STAT power procedure was used 
for power calculations when planning the studies.
For the thin-plate regression in the multinational study on parental age the R software 
(R Core Team 2013) 2.15.2 (2012-10-26), package gamm4 version 0.1-6 (Wood & 
Scheipl 2013, p.4) was used. This statistical model was not available in the SAS 
software.
For the Cox regression, with robust standard errors, fitted to estimate the relative 
recurrence risk in the study on family risk the coxph function in the R software, package 
survival (Therneau 2013), was used on a Red-Hat linux server. This function was 
considerably faster than corresponding procedure in SAS, procedure phreg. However, 
the SAS phreg procedure was used for the calculations using the iCARE database.
The figures showing the relative risk estimates was produced using SAS/GRAPH. In the 
same study the OpenMX software (Boker et al. 2011) was used to calculate the 
heritability in autism.
For the meta-analysis of maternal age and the risk of ASD the R package metafor 
(Viechtbauer 2013) was used.
This thesis is written using the open source word processor LibreOffice 4.0 
(http://www.libreoffice.org) (LibreOffice Documentation Team 2013). The references 
were managed using the open source Zotero software (http://www.zotero.org/). 
Where not mentioned above, all software were run on the Linux Debian sid operating 
system (http://www.aptosid.com).
3.10.1 Federative database solutions in iCARE
The iCARE data base, section 3.7, include individual data. Not all countries allow such 
data to leave the border of the country for storage and pooling with other data. As a 
solution to this the federative database solution has been created (Haas et al. 2002). A 
federative database is unique in that data from different sites (countries, companies, 
database solutions, storage formats etc.) are accessed and combined without a 
common storage, or even data standard, and in a secure way ensuring the protection 
of the data at each site.
I made a considerable contribution in developing the solution for working with the 
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federative database. For the solution within ICARE open source software was used as 
far as possible. Each site administer a server where the data is stored. The server can 
be a physical computer or a virtual server residing within another server. Each site 
server store the site data in a MySQL database. To access the data the ICARE analysis 
server must be used. This is physically located in Perth, West Australia, and managed 
by the collaborators responsible for IT at the Telethon Institute for Child Health 
Research. Access to the data and the server is restricted by security protocols and 
signature of the analysis server (by IP-address). 
For analysing the ICARE data a web browser is used. Access to the analysis site 
(https://www.icareautism.org) is only possible if a security protocol with unique user id 
and password has been installed. The protocol and password is managed by the 
collaboration IT in Perth and last for one year at a time. Once connected the data can 
be analysed by uploading computer code (SAS software, STATA software or the R 
software) which is submitted in batch mode. Results are stored on the analysis server 
and can be downloaded when ready. For this purpose a web interface facilitating the 
analysis process has been developed (Figure 2).
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Figure 2 The ICARE web interface for data analysis
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4 Study I - Maternal age in autism - A meta analysis
This section contain a study published in Journal of The American Academy of Child 
and Adolescent Psychiatry. Accepted 24 February 2012. published online 06 April 2012.
Biography: Sandin S, Hultman CM, Kolevzon A, Gross R, Maccabe JH, Reichenberg A. 
Advancing maternal age is associated with increasing risk for autism: a review and 
meta-analysis. J Am Acad Child Adolesc Psychiatry. 2012 May;51(5):477–486.e1.
DOI: 10.1016/j.jaac.2012.02.018
Note: This document differ only slightly from the submitted manuscript.
1. When updating the reference list for the viva the reference to R software , 
number 36 disappeared. I replaced this with a more current reference (R Core 
Team 2013).
2. The references 31 and 41 in the published manuscript referred to the same 
manuscript. Here there is one reference only.
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4.1 Summary of the study
Objective
We conducted a meta-analysis of epidemiological studies investigating the association 
between maternal age and autism.
Method
Using recommended guidelines for performing meta-analyses, we systematically 
selected, and extracted results from, epidemiological scientific studies reported before 
January 2012. We calculated pooled risk estimates comparing categories of advancing 
maternal age with and without adjusting for possible confounding factors. We 
investigated the influence of gender ratio among cases, ratio of infantile autism to 
autism spectrum disorder (ASD), and median year of diagnosis as effect moderators in 
mixed-effect meta-regression.
Results
We found 16 epidemiological papers fulfilling the a priori search criteria. The meta-
analysis included 25,687 ASD cases and 8,655,576 control subjects. Comparing mothers 
≥35 years with mothers 25 to 29 years old, the crude relative risk (RR) for autism in the 
offspring was 1.52 (95% confidence interval [CI] = 1.12–1.92). Comparing mothers ≥35 
with mothers 25 to 29, the adjusted relative risk (RR) for autism in the offspring was 
1.31 (95% CI = 1.19-1.45). For mothers <20 compared with mothers 25 to 29 years old, 
there was a statistically significant decrease in risk (RR = 0.76; 95% confidence interval 
= 0.60–0.97). Almost all studies showed a dose-response effect of maternal age on risk 
of autism. The meta-regression suggested a stronger maternal age effect in the studies 
with more male offspring and for children diagnosed in later years.
Conclusions
The results of this meta-analysis support an association between advancing maternal 
age and risk of autism. The RR increased monotonically with increasing maternal age. 
The association persisted after the effects of paternal age and other potential 
confounders had been considered, supporting an independent relation between higher 
maternal age and autism.
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4.2 Introduction
Most plausible neurodevelopmental theories of autism focus on genetic factors (Bailey 
et al. 1995). However, there is evidence that non-heritable, pre-, or perinatal events, 
and/or environmental exposures are likely to also have a significant etiological role 
(Bristol et al. 1996).
Advanced maternal age is one of the most frequently studied risk factors for autism 
(Durkin et al. 2008; Larsson et al. 2005; Glasson et al. 2004; Maimburg & Vaeth 2006; 
Croen et al. 2007; Reichenberg et al. 2006; Daniels et al. 2008; Shelton et al. 2010; 
Grether et al. 2009; Lundström et al. 2010; Lauritsen et al. 2005; Croen et al. 2002; 
Eaton et al. 2001; Fombonne 2005; Burstyn et al. 2010; Williams et al. 2008; Windham 
et al. 2011; Leonard et al. 2011). However, the results from the individual studies are 
mixed and the presence of the associations is still disputed (Reichenberg et al. 2010).
It is important to examine the relationship between advanced maternal age and autism 
for two main reasons. First, an association between maternal age and autism may 
provide clues to the biological pathways leading to autism. Older maternal age has 
been associated with increased rates of chromosomal abnormalities (Salem Yaniv et al. 
2011). Older mothers also have increased risk of obstetric complications possibly due 
to uterine muscle dysfunction and diminished blood supply with age (Bolton et al. 
1997; Kolevzon et al. 2007). Cumulative exposure to environmental toxins may also be 
important for the association between advanced maternal age and neurological and 
psychiatric disorders (Lundström et al. 2010).
Second, age of parenting has been increasing in the United States and Europe in recent 
decades (Bray et al. 2006; Martin et al. 2006) and an association between maternal age 
and autism may help explain the increase in prevalence estimates of autism during the 
past two decades.
In order to elucidate the association between advanced maternal age and autism we 
conducted a systematic review and meta analysis of all population-based 
epidemiological studies published until June 2011 which investigated the association 
between advancing maternal age and autism. We also explored possible sources of 
heterogeneity across studies. 
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4.3 Methods
The meta-analysis was based on recommended guidelines (Donna F. Stroup et al. 2000; 
Lau et al. 1997; Stangl & Berry 2000).
Data   sources
We identified published peer-reviewed studies through search of PUBMED using the 
keywords "autism" together with "maternal" or "paternal" or "parental" or "obstetric" 
or "perinatal" together with the words "risk" or "association" or "associated". We only 
included papers published in English between 1 Jan 1990 to 31 December 2011. We 
screened the resulting abstracts and obtained full text versions of potentially relevant 
studies. We then hand-searched the reference lists of original articles to identify any 
missing papers.
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Table 1: List of studies and study characteristics identified for meta analysis
Adjustment for confounding
Studies























Durkin, US 10 states, 2008 DSM-IV 1994 1998 80.7 4.5 Case-cohort 1,251 253,347 X X X X
Larsson, DK, 2004 ICD 8/10 1973-99 1986 NK 3.2 NCC 698 17,450 X X X X X
Glasson, Australia, 2010 DSM-III / IV 1980-95 1989.5 68 5.3 CC 465 1,313 X X X
Maimburg, DK, 2006 ICD 8/10 1990-99 1994.5 100 4.1  NCC 473  4,730 X X X
Croen, US, 2007 ICD 9 1995-99 1999.5 47 5.4 Cohort 593 132,251 X X X X
Reichenberg, Israel, 2006 ICD 10 1980-85 1983 >90 5.5 Cohort 110 132,161 X X
Hultman, SWE, 2010 ICD 9/10 1983-92 1994.5 100 3.2 Cohort 860  1,034,627 X X X X X X
Sasanfar, Iran, 2010 DSM-IV 1994-2001 2005 68 3.8 Case-cohort 179 549,354 X X X
Grether, US, 2009 DSM III/IV 1989-2002 1997.5 NK 4.9 Cohort 20,701  6,506,555 X X X X X
Lundstrom, SWE, 2010 DSM-IV 1992-98 1995 NK NK Twin Cohort 164 10,884 X X X
Lundstrom, UK, 2010 DSM-IV 1994-96 2005 57 5.4 Twin Cohort 193 12,904 X
CC: Case-control, NCC: Nested case-control, AD: Infantile autism, SES: Socio economic status, NK: Not known. Note: All studies adjusted for paternal age and sex. Study 8 
additionally adjusted for smoking during pregnancy. The five right most columns for confounding represent model covariates for Birth order, Socio economic status (Paternal and/or 
maternal education, Source of payment of delivery), Prenatal (Gestational age, Weight for gestational age, Birth weight, Foetal distress, Apgar score, Congenital malformations, 
Foetal position), Psychiatric history (Maternal and/or paternal psychiatric history), Ethnicity (Maternal/Paternal race or country of origin). Study (Lundström et al. 2010) included 
two parts, one Swedish and one UK. For the UK part we received additional data from the authors. Study (Grether et al. 2009) utilizing the California Department of Development 
Services did not distinguish between autistic disorder and autism spectrum disorders since a service registry was used.
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Study   selection
We used the following inclusion criteria: (1) a population based sample of cases using 
one of two of the major clinical diagnosis systems, DSM or ICD (Table 1) ; (2) 
comparison subjects drawn from the general population with information on parental 
age obtained from the same source; (3) use of a format for presentation of data 
allowing for comparisons between studies and calculation of relative risk measures; (4) 
presentation of results for maternal age and (5) adjustment for paternal age. The 
standard of reporting associations for maternal age in the autism literature is using 
age-band categories.
Data   extraction
The following information was extracted from each study: estimates of relative risk 
(odds-ratios from case-control or cohort studies or incidence rate ratios or hazard ratios 
from cohort studies) separate from crude and multi-variable adjusted models, study 
design, number of ASD cases and non-ASD controls, confounding covariates used in 
adjusted model(s), year of diagnosis, birth cohort, diagnostic method, ratio of autistic 
disorder and autism spectrum disorder cases, male to female ratio among the autism 
cases, and how maternal and paternal age was modelled, e.g. categorically. These data 
are summarised in Table 1.
Additional data
When necessary, authors were contacted and additional information was requested.
Statistical methods
We calculated weighted relative risk (RR) estimates and associated two-sided 95% 
confidence intervals (CIs). Computations utilized the published RR and CI values 
assuming approximately normal distribution. Extensive research has demonstrated that 
age 35 is the age at which risk for a range of adverse developmental outcomes (e.g., 
Down's syndrome) increases and therefore younger ages are typically used as a 
reference points. Since best supported by the available studies the primary comparison 
contrasted maternal age group 25-29 years with maternal age group ≥35 or >40 years.
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To examine if there is an increasing risk with increasing maternal age and the potential 
risk associated with younger maternal age we also contrasted maternal age group 25-
29 years with mothers <20 years and with mothers 30-34 years. 
When modelling the log(RR) we allowed for both a within-study variance of the log 
relative risk and for a between study variance term assuming the data to follow a 
normal distribution. With yi indicating the log(RR) extracted from the publications the 
random-effects models can be defined as yi= μ + ui + ei where ui~N(0,τ2) denotes the 
normal distributed between-study variation and ei~N(0,σ2) denotes the normal 
distributed within-study variation. The statistical model accommodates crude and 
adjusted RR estimates to be included. From the published papers we extracted both 
crude models including a categorical covariate for maternal age only and adjusted 
models including and adjusting for possible confounding effects as well. Models were 
fitted separately for the crude and multivariable adjusted estimates and separately for 
the different category comparisons, e.g. ages 25-29 vs ≥35. Robustness of results was 
evaluated by (a) excluding the study with the largest effect size, and (b) excluding the 
study with the largest sample.
Potential publication bias was examined using funnel plots (Iyengar 1988) and by 
calculating Egger's test (Egger et al. 1997). The funnel plot shows the effect size of the 
different studies on the x-axis and an estimate of the sample size on the y-axis. Small 
studies should have higher variability in estimates of relative risk compared with bigger 
studies while divergence from this pattern may indicate the presence of publication 
bias.
Potential sources for study heterogeneity were examined using meta regression 
analysis. Using the above model this was done by replacing the term ui with β0 + β1xi2 + 
β2xi2 where the parameters β1 and β2 measure the size of the association of the 
moderators in a mixed-effects model. The mixed-effects models were fitted by a 
maximum likelihood technique that allows for model comparisons using the Akaike’s 
Information Criteria (AIC) (Daniels et al. 2008) for which a lower AIC value indicate 
better model fit. The proportion of males among cases and the proportion of autistic 
disorder among the cases were examined. Also, since the rate of autism has been 
increasing we included a covariate allowing for a fix change of exposure effect across 
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calendar time in a supplementary model to reduced the between study heterogeneity. 
For descriptive purposes RR estimates were calculated by levels of the moderating 
variables on RR estimates of maternal age are presented by median levels of the 
moderating variables.
Data was analyzed using R statistical software version 2.12.1 with the Metafor package 
ver 1.4.0 (Viechtbauer 2010; Anon 2005) and SAS ver 9.22 procedure GLIMMIX. 
Statistical significance level was set at two-sided 5% level corresponding to two-sided 
95% confidence intervals of the pooled relative risk estimates.
4.4 Results
4.4.1 Overview of study characteristics
Our search criteria resulted in 631 published papers. 598 studies were excluded after 
an initial review of the titles and abstracts carried by two of the authors (SS and AR). 
The remaining 34 studies were carefully reviewed and 17 were further excluded (see 
Figure S1).
Figure S1 Flow chart with numbers showing published papers selected and excluded 
from the initial search in PubMed to the publications included in the final 
pooling and meta-analysis. Note: Overlap indicates a published paper in 
which the study population overlap with another study already included in 
the meta-analysis
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Eleven studies, from the US (Durkin et al. 2008; Croen et al. 2007; Grether et al. 2009), 
Denmark (Larsson et al. 2005; Maimburg & Vaeth 2006), Australia (Glasson et al. 2004), 
Israel (Reichenberg et al. 2006), Sweden (Lundström et al. 2010; Hultman et al. 2011), 
Iran (Sasanfar et al. 2010) and the UK (Lundström et al. 2010)b fulfilled all 5 inclusion 
criteria and were included in the meta analysis (Table 1). The two Danish (Larsson et al. 
2005; Maimburg & Vaeth 2006) used nested case-control designs drawn from the 
national total populations. The study from Western Australia (Glasson et al. 2004) was 
a population based case-control design with the entire population of Western Australia 
as reference population, and the study from Iran (Sasanfar et al. 2010) a case-cohort 
design drawn from a cohort of pre-school children aged 4-11 years. The three studies 
from the US, the Israel study (Reichenberg et al. 2006) and the most recent Swedish 
study (Lundström et al. 2010) all used population based cohort designs while studies 
(Lundström et al. 2010 a; Lundström et al. 2010 b) were cohort studies on Swedish and 
UK twins.
Six other studies were excluded from the meta-analysis mainly due to overlap; Two 
studies from Sweden were excluded (Daniels et al. 2008; Hultman et al. 2002) because 
they overlap with a later study (Lundström et al. 2010), and, because of concern for 
under-ascertainment of autism cases due to changes in autism services in Sweden in 
one of the studies (Daniels et al. 2008 p. 1360). Two studies from the US (Shelton et al. 
2010; Windham et al. 2011) were not included because of substantial overlap with 
another study (Grether et al. 2009) which examined a considerably larger cohort. 
Another US study (Bilder et al. 2009) was also excluded due to overlap with the two 
earlier studies and did not meet the initial requirement of clear presentations of the 
results for the risk associated with maternal age with only crude estimates available 
and a different categorization of maternal age (<20, 20-34, >34). A study (Leonard et al. 
2011) was excluded due to substantial overlap with study (Glasson et al. 2004), use of 
case prevalence instead of case incidence, and sub-dividing the cases into children with 
and without intellectual disability. Two Danish studies (Lauritsen et al. 2005; Hvidtjørn 
et al. 2011) were not included in the formal pooling due to overlap with the other two 
Danish studies and lack of adjustment for paternal age as only crude estimates were 
available.
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Covariates used for adjustment for possible confounding in each study are specified in 
Table 1. All studies included in the meta-analysis adjusted for paternal age, birth year 
and sex. All but two studies (Glasson et al. 2004; Maimburg & Vaeth 2006) were 
adjusted for SES; all but three studies (Croen et al. 2007; Reichenberg et al. 2006; 
Sasanfar et al. 2010) for obstetric condition (e.g., apgar score, being small for 
gestational age, birth weight); all but five (Larsson et al. 2005; Glasson et al. 2004; 
Reichenberg et al. 2006; Lundström et al. 2010; Sasanfar et al. 2010) for parental 
ethnicity. Only two studies (Larsson et al. 2005; Lundström et al. 2010) adjusted for 
parental psychiatric history. 
4.4.2 Meta-analyses
The primary meta-analysis was conducted on the association between maternal age 
and ASD. The 11 studies included in the analysis had a total of 25,687 ASD cases and 
8,655,576 subjects without an ASD diagnosis.
The crude results showed statistically significant support for an increased risk of autism 
in the offspring of mothers aged 35 or older compared with mothers aged 25-29 in 8 of 
the 11 studies (Table 2). The random-effect pooled estimate of the crude risk of autism 
in mothers aged 35 or older compared with mothers aged 25-29 years was 1.52 (95% 
CI: 1.21-1.92), p-value<0.001.
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Table 2 Relative risk (RR) point estimates and two-sided 95% confidence intervals 
comparing 25-29 year old mothers with mothers ≥ 35 or ≥ 40 adjusting for 













(Durkin et al. 2008) 1.38 1.17-1.64 1.30 1.06-1.60 16 30
(Larsson et al. 2005), 
# 2.19 1.36-3.52 1.55 0.88-2.74 3 4
(Glasson et al. 2004) NA NA 1.54 1.03-2.30 5 8
(Maimburg & Vaeth 
2006) 1.60 1.28-2.00 1.30 0.99-1.70 11 18
(Croen et al. 2007), # 1.53 1.05-2.24 1.27 0.83-1.95 5 7
(Reichenberg et al. 
2006) 9.68 3.51-26.7 2.68 0.80-8.96 1 1
(Hultman et al. 2011), 
# 1.53 1.26-1.86 1.15 0.91-1.47 12 22
(Sasanfar et al. 2010) 1.17 0.69-1.99 0.85 0.42-1.69 2 3
(Grether et al. 2009), 
# 1.84 1.72-1.97 1.43 1.32-1.55 41 *
(Lundström et al. 
2010 a), Swe 1.01 0.67-1.52 0.78 0.43-1.40 3 4
(Lundström et al. 
2010 b), UK 0.78 0.51-1.20 0.91 0.50-1.65 3 4
Pooled I 1.52 1.21-1.92 1.31 1.19-1.45
Pooled II* 1.59 1.25-2.03 1.24 1.11-1.39
*) Excluding the study by Grether et al (Grether et al. 2009)
#) 25-29 year old vs. ≥ 40 (all other 25-29 year old vs. ≥ 35)
The crude associations were reduced in all studies after adjustment for potentially 
confounding covariates (Table 2). Associations nevertheless remained statistically 
significant in 3 of the studies (Durkin et al. 2008; Larsson et al. 2005; Glasson et al. 
2004). After adjustment for potential confounding covariates the random-effect pooled 
estimate of risk of autism in mothers aged 35 or older compared with mothers aged 
25-29 years was 1.31 (95% CI: 1.19-1.45) (Figure 1), p-value<0.001.
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Figure 1 Association between increasing categories of maternal age and risk for autism 
spectrum disorder (ASD). Presented are the adjusted relative risk (RR) comparing 25- to 29-
year-old mothers with younger (<20) and older (30 –34 or ≥35 years) mothers. Note: RR on the 
x-axis. Black dots and horizontal bars outline relative risk point estimates and associated two-
sided 95% confidence intervals for the relative risk of autism spectrum disorder in offspring 
comparing mothers <20, 30 to 34, and ≥35 years (bottom to top within each study) years with 
mothers 25 to 29 years. Study number to the far left. Pooled results on the upper part of the 
figure where pooled-2 do not include one study (Grether et al. 2009) in the calculations. Exact 
numbers for RR and the confidence intervals to the right. In parentheses to the right of the 
study number the study weight (value 0 –100) in the pooling procedure is shown.
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There was no evidence to support publication bias (Figure S2), and the test of 
heterogeneity between studies was not statistically significant
Figure S2 Funnel plots. Note: Standard error vs. log(relative risk (RR)) corresponding 
to RR estimates in Table 2. P values corresponding to Egger's test of 
publication bias
Because the study from California (Grether et al. 2009) which showed a statistically 
significant association between advancing maternal age and ASD contributed as much 
as 20,701 of the ASD cases to the meta analysis this study was excluded in a sensitivity 
analysis. The pooled results were similar even after this study was excluded.
When the association between maternal age and autism was examined across the 
range of categories of maternal age there was evidence for a monotonic increase in risk 
of autism with increasing maternal age categories. Of the 9 studies which included 
more than one age group comparison all but two studies (Larsson et al. 2005; 
Lundström et al. 2010 b) reported findings that were consistent with a monotone 
maternal age effect. Figure 1 shows the associations between increasing categories of 
maternal age and risk of ASD in the offspring. The effect was only minimally attenuated 
after excluding the study from California (Grether et al. 2009).
In a complementary analysis we also examined the studies reporting RR for maternal 
age ≥40(Larsson et al. 2005; Croen et al. 2007; Grether et al. 2009; Lundström et al. 
2010) and the studies only reporting on maternal age ≥35 (Durkin et al. 2008; Glasson 
et al. 2004; Maimburg & Vaeth 2006; Reichenberg et al. 2006; Lundström et al. 2010; 
Lundström et al. 2010; Sasanfar et al. 2010) separately and compared the RR for the 
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highest age category. The RR for maternal age ≥40 compared with maternal age 25-29 
was 1.37 (95% CI: 1.19-1.58) and the RR for maternal age a ≥35 compared with 
maternal age 25-29 was 1.23 (95% CI: 1.09-1.39) (p-values<0.001).
Combining studies (Durkin et al. 2008; Larsson et al. 2005; Glasson et al. 2004; Croen et 
al. 2007; Grether et al. 2009; Sasanfar et al. 2010; Lundström et al. 2010) to evaluate 
the risk associated with younger maternal age (<20) with 25-29 years old mothers 
showed a statistically significant decrease in risk (RR: 0.76; 95% CI: 0.60-0.97, p-
value=0.028). Excluding the highly influential study (Grether et al. 2009) the RR point 
estimate was slightly higher but now the confidence interval included 1.0 (RR: 0.82; 
95% CI: 0.59- 1.12).
4.4.3 Moderator analysis and meta-regression
Meta-regression was used to assess if the effect of maternal age on the risk of autism 
was modified by other study-specific covariates. Three variables were considered as 
potential moderators in the meta-regression analyses: Percent male offspring in the 
study,; study year of autism diagnosis (median of first and last diagnosis) and percent 
ASD cases diagnosed as autistic disorder. Information about study year of autism 
diagnosis was available in all 11 studies (Durkin et al. 2008; Larsson et al. 2005; Glasson 
et al. 2004; Maimburg & Vaeth 2006; Croen et al. 2007; Reichenberg et al. 2006; 
Grether et al. 2009; Lundström et al. 2010 a; Lundström et al. 2010 b; Sasanfar et al. 
2010; Hultman et al. 2011). Information on percent male offspring was available in ten, 
and information on percent with autistic disorder was available in eight studies.
For mothers ≥ 35 the covariates percent male offspring and year of autism diagnosis, 
were both statistically significant when controlling for each other jointly. Year of 
diagnosis was statistically significant among mothers 30-34 when simultaneously 
adjusting for percent male offspring or percent autistic disorder. For maternal age <20 
the percent male offspring was statistically significant when entered as a single variable 
and also when adjusting for year of diagnosis. To summarise: For all three age 
categories of maternal age a higher amount of boy offspring strengthened the effect of 
maternal age; positive for maternal ages 30-34 and ≥ 35 and negative for maternal age 
< 20 while the maternal age effect diminished with later year of diagnosis. The 
moderating effect of the percent male offspring and year of diagnosis among mothers 
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≥ 35 is summarised in figure 2.
Figure 2 Predicted relative risk of autism (RR) for maternal age ≥35 vs. maternal age 
25 to 29 years as a function of percent male offspring and year of diagnosis. 
Note: Each dot indicates the RR for each study. Solid line and 95% 
confidence limits predicting association for diagnosis in 1995. Gray solid 
and dashed lines for predictions 1985 and 2005, respectively
For ease of interpretation and to quantify the impact of the three potential moderators 
RR estimates were calculated in subgroups of these variables (table 3). The increasing 
effect with increasing maternal age remain in all sub-groups.
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Table 3 Relative risk (RR) and associated two-sided 95% confidence intervals (CI) 
comparing maternal age 25-29 years with maternal ages <20, 30-34 and ≥ 35 
years in sub-groups of the moderator variables
< 20 years 30-34 years ≥ 35 years
N RR 95% CI N RR 95% CI N RR 95% CI
Sub-groups by percent male offspring*
≤ 82% 4 0.93 0.64-1.37 3 1.12 0.98-1.28 5 1.25 1.10-1.42
> 82% 4 0.65 0.60-0.70 4 1.14 1.09-1.19 5 1.42 1.32-1.53
Sub-groups by year of diagnosis*
≤ 1995 4 0.90 0.50-1.61 4 1.24 1.05-1.46 6 1.26 1.08-1.46
> 1995 5 0.65 0.61-0.70 4 1.13 1.09-1.18 5 1.34# 1.19-1.51
Sub-groups by percent infantile autism*
< 74% 4 0.62 0.43-0.89 3 1.07 0.76-1.50 4 1.22 0.94-1.58
≥ 74% 2 0.79 0.56-1.12 2 1.09 0.93-1.29 4 1.26 1.10-1.45
N: Number of studies in each sub-group, * median across studies (82.5%, 1995 and 74%), # In 
the sub-groups of year of diagnosis for mothers ≥ 35 one study (Grether et al. 2009) had a 
substantial impact on the >1995 sub-group potentially accounting for the high RR in this group .
4.4.4 Additional analyses
Advancing maternal age has been associated with increased risk for obstetric 
complications (Lundström et al. 2010), and several obstetric conditions have been 
associated with increased risk for autism (Kolevzon et al. 2007). Six studies in the meta-
analysis also controlled for the effects of obstetric conditions (Table 1). After 
adjustment for obstetric conditions the association between advancing maternal age 
and autism remained statistically significant in three (Durkin et al. 2008; Larsson et al. 
2005; Grether et al. 2009) of the six studies (Durkin et al. 2008; Larsson et al. 2005; 
Glasson et al. 2004; Maimburg & Vaeth 2006; Lundström et al. 2010; Lundström et al. 
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2010; Grether et al. 2009) with RR for maternal age ≥35 compared with maternal age 
25-29 estimated at 1.41 (CI: 1.31-1.52) and 1.37 (CI: 1.27-1.49) respectively (p-values 
<0.001); (Table 2). Two of the studies not included in the meta analysis also reported a 
statistically significant association between autism and older age of mothers after 
adjustment for obstetric complications (Burstyn et al. 2010; Williams et al. 2008; 
Lundström et al. 2010). The RR of autism associated with a 10 year continuous linear 
increase in maternal age was available in 6 studies (Durkin et al. 2008; Croen et al. 
2007; Reichenberg et al. 2006; Grether et al. 2009; Lundström et al. 2010; Hultman et 
al. 2011) with a pooled estimate RR of 1.23 (95% CI: 1.19-1.27) and when excluding the 
study (Grether et al. 2009) RR: 1.07 (95% CI: 0.99-1.15).
4.5 Discussion
The role of advancing maternal age in the aetiology of autism has been debated (King 
et al. 2009; Baxter et al. 2007). This meta analysis supports the assertion that 
advancing maternal age at the time of birth is associated with an increasing risk for 
autism and spectrum disorders. The association between advancing maternal age and 
risk of autism in the offspring was robust to adjustment for confounding including 
paternal age, obstetric complications, birth year, birth order and markers for socio-
economic status, with offspring of mothers older than 35 having 30% increased risk for 
developing autism.
There was some support that the association between maternal age and autism varied 
as a function of the proportion of male cases and year of diagnosis. A stronger 
association between maternal age and risk of autism was observed in studies with a 
higher proportion of male offspring cases. These results are not conclusive, but are 
intriguing nevertheless. Two previous studies (Croen et al. 2007; Reichenberg et al. 
2006) observed that the effects of paternal and maternal age on risk of autism varied 
as a function of the offspring sex. The association between advancing paternal age and 
autism was stronger in female offspring, whereas the association between advancing 
maternal age and autism was stronger in male offspring. The moderator analysis 
supports this hypothesis which may point to possible sex-specific aetiology in autism.
Year of diagnosis was another potentially moderating variable suggesting that the 
effect of advancing maternal age may have been decreasing over time. Year of 
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diagnosis was also noted as diluting the effect of maternal age in an earlier study 
(Grether et al. 2009). A possible explanation includes age dependent changes in 
ascertainment of autism and autism spectrum disorders, or changes related to changes 
in the risk or ascertainment of phenotypic subtypes (Grether et al. 2009). 
Although previously reported (Croen et al. 2007), and speculated as a cause for the 
moderating effect of year of diagnosis (Grether et al. 2009), the association between 
maternal age and autism did not vary between different autism sub types in the meta-
regression.
These results, like those of any meta-analysis, should be viewed with caution. Meta-
regression is a form of observational association and therefore cannot be used to make 
causal inferences about the data (Higgins & Thompson 2004). There may be 
confounding factors that underlie the relationships reported here. In addition, given 
the differences between studies in covariates selected and availability, the meta-
regression analysis captured only some of the studies included in the meta analysis. 
Despite these potential shortcomings, our results suggest that research on maternal 
age and autism should consider the effects of potential moderating factors. Another 
potential issue for this article is the largest study included in the meta-analysis11 , 
contributing 80% of the number of cases. Inclusion of this study could be considered 
problematic also because autism cases were ascertained only if they had both a 
diagnosis of autism as well as a substantial functional impairment (Grether et al. 2009). 
However, our sensitivity analysis demonstrated that inclusion of this study did not bias 
the results of the meta analysis or the moderator analysis. Removing this study from 
the analysis did not substantially change the magnitude of the association of the meta 
analysis, and the effect of year of diagnosis and proportion of males remained 
statistically significant. A potential limitation of the study is that access to the data was 
restricted to categories of maternal age. This did not allow exploring the full underlying 
maternal age continuum. Finally, in our focus on published epidemiological studies we 
do recognize there may also be other important aspects that would have required 
inclusion of more clinically oriented papers but in the context of the meta analysis may 
be less reliable.
Potential aetiological mechanisms of maternal age
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One possible explanation for the maternal age effect is an increased occurrence of 
genomic alterations. Numerous neurological and psychiatric disorders have been 
related to genomic alterations (Reichenberg et al. 2009). Maternal age is an important 
factor in the aetiology of chromosome anomalies (Ginsburg et al. 2000; Martin 2008) 
and genomic modifications (Kaytor et al. 1997; Orr & Zoghbi 2007). Interestingly, a 
number of studies have uncovered an increased prevalence of de-novo copy-number 
variants (CNVs), and other forms of genomic alterations, in autistic children (Christian 
et al. 2008; Marshall et al. 2008; Sebat et al. 2007), supporting the notion that novel 
mutational events may be important in the pathogenesis of autism. Whether these 
events are also related to advancing maternal age remains to be determined.
An alternative explanation is that epigenetic dysfunction underlies some parental age 
effects. ‘Epigenetics’ refers to the heritable, but reversible, regulation of gene 
expression (Henikoff & Matzke 1997). Epigenetic dysfunction has been associated with 
several neuropsychiatric disorders (Mill et al. 2008), and is also implicated in single-
gene disorders, including Rett's and Fragile X syndromes, characterized by autistic-like 
features in some patients(Reichenberg et al. 2009).
It is also possible that the accumulated exposure to various environmental toxins over 
the life-course could result in genomic and/or epigenetic alterations in the germ cells of 
older parents. Toxins have been shown to induce DNA damage, germline mutations 
and global hypermethylation (Yauk et al. 2008) in germ cells, and have long term 
developmental consequences in offspring (Williams & Ross 2007). In addition, 
increasing maternal age may be related to endocrine and hormonal factors, not only by 
ageing alone but also through maternal stress, increasing infertility and assisted 
reproductive treatment (Newschaffer et al. 2007).
In conclusion, this meta analysis supports an association between advancing maternal 
age and risk of autism. The relative risk increased monotonically with increasing 
maternal age. The association persisted after the effects of paternal age and other 
potential confounders have been considered, supporting an independent relation 
between higher maternal age and autism.
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5 Study II - Parental age in a large multinational 
cohort
This section contain the manuscript as submitted for a last round with the co-authors.
5.1 Summary of the study
Background
Autism spectrum disorders (ASD) are developmental disorders affecting 1-2% of all 
children. Advancing paternal and maternal age have been suggested as risk factors for 
autism, but although there are several population-based studies, results are 
inconclusive. This study examines whether advancing paternal and advancing maternal 
age are independently associated with risk for ASD 
Methods
This study was a population based cohort study from five countries (Denmark, Israel, 
Norway, Sweden and Western Australia) including all live born singletons at different 
periods from 1985 through 2004 . Information on parental ages, demographic 
characteristics, pregnancy and ASD outcome in the offspring were obtained from 
patients, service and medical registries. The study included all live born singletons. 
Relative risk (RR) was calculated using logistic regression and splines to link the 
probability of ASD with parental age continuously. For maternal and paternal age 
separately but also as a bivariate exposure. Graphical methods were implemented as 
analytic strategy to examine qualitative aspects of the data and to enhance 
interpretation.
Results
Among 5,766,794 singleton births in the study 30,474 (0.53%) had ASD. Advancing 
paternal age and advancing maternal age were each associated with increased risk for 
ASD in the offspring (p=0.0001) after controlling for potential confounders and the 
other parent's age. Yet, bivariate models showed that highest risk for ASD is seen in 
three groups approximated by (I) Fathers older than 45 independent of maternal age; 
(II) Fathers 35-45 with mothers ≥10 years younger; and (III) Mothers 30-40 years old 
with father ≥10 years younger. These groups included 7.2% of all births. We did not find 
support for a modifying effect of the sex of the offspring and results were similar, 
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although with greater effect sizes for autistic disorder. Younger maternal age (<20) was 
also associated with increased risk for ASD (p=0.0001).
Conclusions
Advancing paternal age and advancing maternal age at the time of birth of offspring 
increases the risk of ASD. De novo germline and somatic mutations may partly explain 
these associations. The evidence for risk associated with older parental age coupled 
with large parental age differences suggests that social factors, in particular assortative 
mating, play an important role as well.
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5.2 Introduction
Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders 
characterized by difficulties in social interaction and communication accompanied by 
stereotypic, repetitive behaviour and narrow interests (Hollander et al. 2010). Once 
believed to be rare, ASD now reportedly affect 1-2% of children in developed countries. 
Twin and family studies provide compelling evidence for a substantial role for genetic 
factors in the aetiology of autism (Bailey et al. 1995; Grønborg et al. 2013). However, 
studies also emphasize that environmental influences are aetiologically important 
(Hallmayer et al. 2011).
Advancing parental age has been repeatedly investigated in relation to ASD risk. 
Associations between older age of fathers as well as older age of mothers have been 
reported (Grether et al. 2009; Hultman et al. 2011; Sandin et al. 2012; Parner et al. 
2012). Although there are several population-based studies, meta-analyses have shown 
considerable heterogenity between studies in the magnitude of associations (Hultman 
et al. 2011; Sandin et al. 2012), and it has been difficult to determine whether the 
effects of paternal and maternal age represent independent risk factors. This is 
important because the main reason to examine the relationship between parental age 
and ASD is that it provides clues to the biological pathways leading to autism, and 
different mechanisms may mediate advancing paternal or maternal age (Kolevzon et al. 
2007).
The association between advancing parental age and ASD is be unclear due to several 
methodological limitations. These include variation in, or lack of, statistical control for 
other risk factors (e.g., age of the other parent, birth order, perinatal complications); 
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high levels of missing-data; selection bias; and differences in the classification of 
parental age categories. Furthermore, even population based studies have been limited 
by sample size and could not reliably examine the risk associated with parental age in 
tails of the age distributions or to properly separate the independent and combined 
effects of paternal and maternal age. 
The goal of this study was to provide highly reliable estimates of the association 
between parental age and ASD, and determine the combined and independent effects 
of the paternal and maternal age on risk.
The study build on a unique resource: the "International Collaboration for Autism 
Registry Epidemiology (ICARE)" (Schendel et al. 2013), a multinational collaboration 
combining harmonized national cohorts across several geographic regions and health 
systems with the purpose of studying risk factors for autism.
5.3 Methods
This study uses a population-based cohort design based on data assembled by iCARE 
(Schendel et al. 2013). ICARE utilizes nation- or state-wide health and administrative 
registers from six countries, Denmark (DK), Finland, Israel (ISR), Norway (NOR), Sweden 
(SWE) and Western Australia (WAU) for the study of familial and environmental risk 
factors for autism. ICARE development, resources, data coordination, standardization 
and harmonization procedures have been described in detail (Schendel et al. 2013). 
Specific details relevant for this study are provided below. Ethical approval for the study 




The study population is comprised of all live born singletons in Denmark, Norway, 
Sweden between January 1st, 1985 and December 31st, 2004. Data from Western 
Australia were comprised of all 1985-1999 birth. Data from Israel were comprised of all 
1993-2004 births with a subsequent ASD diagnosis and a random sample of controls 
during the same birth year period. All births were derived from comprehensive 
population data reported to each site’s nation- or state wide medical birth register. 
Linkage of individual level data on all cohort members (birth, outcome, exposure and 
covariate information) was based on unique personal identification numbers available 
to each site for data preparation purposes (although no personal identification 
numbers are retained in any final ICARE harmonized dataset). Universal health care 
coverage that is publicly financed and utilized is available to all citizens of Denmark, 
Israel, Norway and Sweden and contacts with the public health care system are 
required to be reported. In Western Australia both public and private health care 
provisions are available although both public and private health care providers are 
required to report to the public health system. This means that for this study the 
cohort information from registries across all sites is not biased by differential access to 
health care and is population-based. 
5.3.2 ASD Outcome, Parental Age and Covariate information
Cohort members were followed from birth through 2009 a reported diagnosis of an 
ASD in Denmark, Israel and Sweden, through 2006 in Norway and through 2004 in 
Western Australia. Two sites (Denmark, Sweden) retrieve autism diagnosis data from 
government-maintained medical registries that record diagnoses or procedures from 
each in- or outpatient clinic or hospital contact. For the other three sites (Israel, 
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Norway, Western Australia) diagnostic information is derived from government-
maintained service/benefits registries that record contacts with individuals receiving 
services/benefits for autism. ASD diagnoses were based on ICD versions 8, 9 and 10 in 
Denmark, Norway and Sweden while the DSM-IV classification system was used in 
Israel and Western Australia. The iCARE harmonization protocol for ASD diagnostic 
codes across the different classification systems is provided in Table S2.
Parental ages, sex and year of birth of the offspring were obtained from the 
comprehensive birth or civil registration registries at all sites.
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Table S2 Harmonization of autism spectrum disorder (ASD) diagnoses across different diagnostic systems




(Psychosis; used in 




 299.1 (Disintegrative 
psychosis)
 299.8 (Other) Note: Should 
include Asperger Syndrome 
and Other PDD) 
 299.9 -unspecified Note: 
Should include PDD-NOS.
ICD-10 
 F84.0 (AD) 
 F84.1x (Atypical Autism)
 F84.5 (Asperger 
Syndrome)
 F84.8 (Other PDD) 
 F84.9 (PDD-NOS)
 F84.2 (Rett Syndrome)
DSM-IV 
 299.0 (AD) 
 299.1 (Childhood 
Disintegrative disorder 
(CDD))
  299.8 (Rett Syndrome) 




Autistic disorder (AD)) 299.00 299.0 F84.0 299.0 
Asperger Syndrome (ASP) 299.02 299.8 F84.5 299.8 
Pervasive developmental 
disorder – not otherwise 
specified (PDD-NOS) 
299.01, 299.03 299.9 F84.9
F84.1x, F84.8 
299.8 
When multiple diagnoses are available for a given individual: If ever Rett Syndrome or CDD, then classify as not ASD, regardless if also ever had an ASD diagnosis. Iif 
never Rett Syndrome or CDD, then classify as: (a) AD: Autistic disorder/childhood autism if ever received this diagnosis (i.e., disregard other ASD subtype 
diagnoses), (b) ASP: If never autistic disorder/childhood autism AND ever had Asperger syndrome (i.e., disregard other ASD subtypes), (c) PDD-NOS: if never AD and 
never ASP and ever (PDD-NOS OR ATYPICAL AUTISM OR OTHER PDD) 
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5.3.3 Statistical methods
The data were analysed by fitting logistic regression to the data relating the probability 
of autism to a linear function of the covariates. Since the data from Israel were 
obtained using a case-cohort design, with known sampling probabilities for the cases 
and controls, rather than a birth cohort design we included the sampling weights in the 
analyses (Borgan et al. 2000). Sampling weight equal to one was used for all non-Israel 
individuals. To adjust for the variation introduced by the weights robust standard errors 
were used (Barlow 1994). For the purpose of achieving a qualitative interpretation of 
the functional form of risk for ASD across all parental ages we fitted splines (Smith 
1979; Hastie et al. 2009). Also, using splines for adjustment of a continuous variable 
allow for a more detailed adjustment for confounding than using categories of the 
same variable (Benedetti & Abrahamowicz 2004). The relative risk (RR) of autism by 
categories of parental age is presented in tables to quantify the degree of association. 
All tests of statistical hypotheses were done on the two-sided 5% level of significance.
The analyses of paternal and maternal age independently were done in the following 
steps; First, in a qualitative approach, we fitted splines to continuous maternal age 
(years) and paternal age (years) separately while adjusting for site, sex and 
confounding: the age of the other parent categorically (<20, 20-24, 25-29, 30-34, 35-39 
and ≥40 for mothers and 40-44 and ≥45 for fathers) and birth year (4-year intervals). 
Second, to quantify the risk, RR was calculated by age category instead of using splines. 
To adjust for differences in the observed rate of autism all models allowed for different 
intercepts for each site and for male and female offspring separately. The relative risk 
of autism and associated two-sided 95% Wald type confidence intervals was calculated 
for each parental age.
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In an analysis unique for the high power of the current dataset we also analysed 
paternal and maternal age jointly. This was done in two ways. First using thin-plate 
splines (Wood 2003) we created a 3D figure illustrating the risk of ASD as a function of 
maternal and paternal age jointly including interaction effects and adjusting for sex and 
birth year categorically as above. The thin-plate spline is a smoother in two-dimensions 
where the curvature is estimated in local regions moving over the bivariate, i.e. two-
dimensional, surface similar to moving averages in the one-dimensional space. We 
calculated number of births and number of ASD and AD cases by categories of pairs of 
paternal-maternal ages. Second, to remove the effect of the spouse efficiently we 
analysed parental age in sub-groups of the spouse. To avoid the sub-group analysis 
being entirely driven by the number of autism cases as would be the case with hugely 
different number of autism cases in different sub-groups, we created subgroups of 
maternal age with approximately equal number of autism cases in each maternal age 
subgroup. This resulted in maternal age cut-offs ≤26, 27-31 and >31 years. For each 
subgroup independently we fitted the logistic spline models, crude and adjusted. We 
used the same approach for the analysis of maternal age in subgroups of paternal age 
(≤28, 29-34, >31). Third, to support the joint approach to the risk of autism we also 
fitted logistic regression models including separate covariates for mean age of mother 
and father and for the difference in age between mother and father. The first covariate 
capture the direct effect of ageing while the difference in age capture the effect not 
necessarily associated with ageing. To examine which of the two components is most 




We calculated RR for offspring of male and female sex separately. In addition to the 
analyses for all ASD, we repeated the same set of analyses for autistic disorder only 
(not including Israel data where information on the diagnostic categories of ASD was 
not available).
A binomial model such as logistic regression assumetion that all subjects have been 
exposed to the same amount of risk time (equal length of follow-up) or that the length 
of follow-up does not affect the risk. If the assumption is not correct biases can be 
introduced. For this purpose we included birth year as a covariate in all our models. In 
addition to this we also performed a sensitivity analysis including Denmark and 
Sweden only, which had data on date of diagnosis. For Denmark and Sweden combined 
we fitted Cox regression and compared the estimated RR and associated confidence 
intervals with the corresponding results from logistic regression. Similarly, since (in a 
family) parental age is directly associated with calendar time bias from increasing 
prevalences by calendar time can be suspected. The fitted Cox regression model 
described above will adjust for calendar effects as well (Korn et al. 1997). 
5.3.5 Statistical considerations
In studies combining data from different sources there may be an issue of site-to-site 
heterogeneity. With the big sample size at hand any unspecific test for differences in 
shape of parental age between sites is likely to be statistically significant. Instead, with 
the focus on qualitative differences rather than quantitative differences we addressed 
this by visual inspection of the graphs of the spline predictions and verifying combined 
results by additional models excluding any potentially heterogeneous site.
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5.4 Data management
All data are stored, combined and analysed using the approach of secure database 
federation (Muilu et al. 2007; Haas et al. 2002). The statistical analyses were done 
using SAS software version 9.3. The thin-plate splines were fitted using the gamm4, ver 
0.1-6 (Wood & Scheipl 2013, p.4) package running the R software version 2.15.2 (Anon 
n.d.) on a linux 64-bit server.
5.5 Results
The multinational combined ICARE cohort included a total of 5,766,794 births, 30,474 
(0.53%) children with ASD and 10,082 (0.17%) children with AD. Distributions of births, 
cases, birth year and parental age by paternal and maternal age are presented in 
Table 1.
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Table 1 Covariates distributions by parental age
Births (% Male) ASD (%)* AD (%)* Maternal Age# Paternal Age# Birth Year
Maternal Age
<20 128,017 (50) 684 (0.53) 207 (0.16) 18 (17-19) 23 (17-28) 1994 (1986-2002)
20-29 3,125,845 (51) 16,275 (0.52) 5,093 (0.16) 26 (22-29) 29 (24-35) 1994 (1987-2002)
30-39 2,374,617 (51) 13,007 (0.55) 4,485 (0.19) 33 (30-37) 35 (30-41) 1995 (1987-2003)
>=40 138,283 (50) 936 (0.68) 343 (0.25) 41 (40-43) 42 (35-49) 1996 (1988-2003)
Paternal Age
<20 27,303 (53) 174 (0.64) 54 (0.20) 19 (17-22) 18 (17-19) 1994 (1986-2002)
20-29 2,156,605 (51) 10,963 (0.51) 3,298 (0.15) 25 (21-30) 26 (23-29) 1994 (1986-2002)
30-39 2,993,093 (51) 15,842 (0.53) 5,316 (0.18) 30 (25-36) 34 (30-38) 1995 (1987-2003)
40-49 540,562 (53) 3,497 (0.65) 1,288 (0.4) 35 (28-40) 43 (40-47) 1996 (1988-2003)
>=50 49,137 ( 51) 426 (0.87) 172 (0.35) 35 (28-42) 53 (50-58) 1996 (1988-2003)
*: Cases (percent), # mean (10th percentile, 90th percentile)
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Table 2 Relative risk (RR) of autism spectrum disorder (ASD) and autistic disorder (AD) by age intervals of parental age









<20/20-29  1.22 (1.13-1.32) 1.22 (1.12-1.33) 1.19 (1.03-1.39)) 1.07 (0.92-1.25)
30-39/20-29 0.99 (0.96-1.01) 0.95 (0.92-0.98) 0.98 (0.95-1.00) 1.07 (1.04-1.10)
40-49/20-29 1.34 (1.25-1.43) 1.12 (1.04-1.21) 1.26 (1.22-1.31) 1.29 (1.23-1.36)
>=50/20-29   1.63 (1.48-1.80) 1.67 (1.50-1.85)
AD
<20/20-29 1.11 (0.96-1.27) 1.16 (1.00-1.35) 1.15 (0.88-1.51) 1.03 (0.79-1.36)
30-39/20-29 1.11 (1.07-1.16) 0.99 (0.94-1.04) 1.13 (1.08-1.18) 1.15 (1.09-1.22)
40-49/20-29 1.60 (1.43-1.78) 1.18 (1.05-1.33) 1.57 (1.47-1.67) 1.51 (1.39-1.64)
>=50/20-29   2.18 (1.87-2.54) 2.01 (1.70-2.35)
*: Relative risks relative 20-29 year old; # adjusted for site-intercept, sex, birth year, age of the spouse; ASD: Autism Spectrum Disorder; AD: Autistic Disorder.
From table 6.14 Study ADVPATMATAGE/ Sven Sandin, Prog: w_modana10_7 SAS9.3/Linux 131010 5:02
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5.5.1 Independent Effects of Paternal and Maternal age:
Figures 1 and Figure 2 present the pattern of association between advancing paternal 
and advancing maternal age and risk for ASD adjusting for sex, birth year and the age of 
the spouse.Qualitatively, there was a statistically significant linear increase in the risk of 
ASD with increasing paternal age (Figure 1), and a statistically significant monotonic 
increase in the risk of ASD with increasing maternal age (Figure 2). This is quantified in 
risk estimates in Table 2. For example, relative to the group aged 20 to 29 years fathers 
older than 50 years had 1.7 fold (95% CI: 1.5-1.8) increased risk for having an offspring 
with ASD. Relative to the group aged 20 to 29 years mothers older than 40 years had 
1.1 fold (95% CI: 1.1-1.2) increased risk of having an offspring with ASD.
There was also evidence for increased risk of ASD among younger mothers (Figure 2). 
Relative to the group aged 20 to 29 years mothers younger than 20 years had 1.3 times 
(95% CI: 1.2-1.4) increased risk of having an offspring with ASD (Table 2).
Similar risk pattern associations were evident for AD, but risk estimates were higher 
compared with ASD (figure S1 and figure S2; table 2)
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Figure 1 Development of relative risk for ASD with increasing paternal age. Dotted lines indicate 2-sided 95% confidence intervals
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Figure 2 Development of relative risk for ASD with increasing maternal age. Dotted lines indicate 2-sided 95% confidence intervals
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Figure S1 Development of relative risk for AD with increasing paternal age. Dotted lines indicate 2-sided 95% confidence intervals
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Figure S2 Development of relative risk for AD with increasing maternal age. Dotted lines indicate 2-sided 95% confidence intervals
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5.5.2 Joint effects if Paternal and maternal age
Couples consisting of mothers 20-40 years of age and fathers 20-50 of years of age 
generate 97% of all births. 2.2 of all births have a mother younger than 20 and 2.4% a 
mother older than 40. 0.9% of all births have a paternal age older than 50 (table S1).
Table S1 Number of births and percent of all births by categories of paternal and 
maternal age

























The bivariate distribution of number of births by paternal and maternal age across all 
sites is illustrated in figure S3.
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Figure S3 Parental age distributions. Number of births by paternal and maternal age
The ASD risk as a function of the joint exposure of paternal and maternal age 
(bivariate) is displayed in Figure 3. The figure present a 3D surface of the RR estimates 
for the different paternal-maternal age combinations. As reference group across the 
entire surface we used the couples where the father and mother were both equal to 
25. Colours from light and very light green towards the yellow to red colour spectra 
indicate increased risk while dark green colour indicate decreased or equal risk 
compared with the couples of 25 year old parents.
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Figure 3 Relative risk (RR) of ASD by paternal and maternal age jointly
The surface planes generated by the corresponding point-wise 95% upper and lower 
confidence limits are presented in the figure S7.
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Figure S7 Relative risk of ASD by paternal and maternal age jointly - Lower (lower 
panel) and upper (upper panel) 95% confidence limits
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The paternal-maternal age associated risk of ASD in Figure 3 show an inverse-shaped 
form compared to the age of mating distribution (Figure S3). Lowest ASD risk is 
concentrated in a central elliptic region corresponding to the ages of couples 
generating a majority of births, that is 29-39 year old fathers and 25-35 year old 
mothers. Risk of ASD increases in all directions from this region, that is with increasing 
age differences between the spouses.
Highest risk for ASD is seen in three regions approximated by (a) Fathers older than 45 
independent of maternal age; (b) Fathers 35-45 with mothers <25; and (c) Mothers 25-
40 years old with father ≥5 years younger. These three regions correspond to 3.0%, 
3.4% and 0.8% of all birth. 
The association between maternal and paternal age jointly and AD was similar to that 
of ASD (figure S8).
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Figure S8 Relative risk of AD by paternal and maternal age jointly - Lower 95% confidence limit (left), RR point estimate (middle) and upper 95% 
confidence limit (right)
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When evaluating which of the two components explain most of the variations, for ASD 
the direct ageing was more pronounced while for AD the direct ageing and difference 
in age components were equally important. However, there was strong support that 
both were important, jointly (table S3).
Table S3 Model selection. Goodness of fit comparing logistic regression models with 
and without parameters for mean parental age (mean of maternal and 
paternal age), the difference in parental age (maternal-paternal age) or both.
Model and model parameters
ASD AD
AIC Diff# AIC Diff#
f0: site + birth year + sex 363,640 0 139,226 0
f1: site + birth year + sex + mean 363,516 124 139,104 122
f2: site + birth year + sex + diff 363,509 131 139,106 120
f3: site + birth year + sex + mean + diff 363,437 203 139,036 190
#: AIC differences versus model f0
For AD the risk patterns was similar as that of ASD but with higher RR on more extreme 
ages of fertility.
5.5.3 Subgroup analyses
The risk of ASD by advancing paternal age was evident in all three sub-group of 
maternal age (<27, 27-30 and >31) (figure S5). For couples where the mother was ≤ 31 
there was a statistically significantly decreased risk for fathers less than 30 compared 
with fathers at age 30. For the sub-group of oldest mothers, >31, the effect of 
advancing paternal age was delayed compared with the sub-groups of mothers ≤ 31 
and not visible before the father was 40.
Similar, for RR associations with maternal age in sub-groups of the father: #The risk of 
ASD by advancing maternal age was evident and similarly shaped in each sub-group of 
paternal age and <29, 29-34 and >34 (figure S5). However, as seen earlier in figure 3, 
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there is a pattern of higher risk for couples with bigger age difference between the 
father and the mother.
Figure S5 RR of ASD in subgroups of the parental age. Colour bands for 
95% confidence intervals. Each sub-group contain one third of the
cases.
5.5.4 Supplementary analyses
The relative risk were similar for male and female offspring (figure S4). Fitting Cox 
regression models to the data from Denmark and Sweden produced RR similar to the 
RR from the logistic regression.
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Figure S4 RR of ASD in by parental age for male (red) and female (blue) offspring 
separately. Colour bands for 95% confidence intervals.
Note: All RR are calculated relative age 30 within each sex-subgpoup separately, males separately from 
females.
The functional form of maternal age versus RR was similar across sites, only Israel 
showed any diverging shape for the maternal age by RR of ASD association. Combining 
all sites except Israel: The functional form of the maternal age by ASD relative risk 
development looked similar to when including Israel (Figure S6) and the 3D figure of 
the joint effect of paternal and maternal age on the risk of ASD was qualitatively similar 
(Figure S9).
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Figure S6 Maternal age versus RR ASD combining all sites - With and without including 
Israel
5.6 Discussion
The results of this study provide the strongest evidence to-date supporting the 
hypothesis that older age of fathers, and older age of mothers at the time of birth of 
the offspring are both associated with risk for ASD in the offspring. Therefore 
representing independent risk factors. From the approximately age of 30, risk for ASD 
increased with increasing paternal or maternal age all the way up to the limits of male 
and female reproduction age. The magnitude of observed associations between 
parental age and risk for ASD were similar to those reported in earlier meta analyses 
(Sandin et al. 2012; Hultman et al. 2011), and were more pronounced for AD compared 
with ASD.  Although it may seem that the RR associated with paternal age is higher 
than the RR for maternal age, this is due to the difference in child-bearing potential.  
When comparing fathers and mothers on the same age scale, from the age 30 to the 
age 45, the risk increase with advancing age was similar.
Results also showed evidence for an interaction effect of paternal and maternal age: 
The bivariate model showed lowest ASD risk in couples of similar age, risk increased 
when one spouse was a several years older than the other and was most pronounced 
when both parents where old, compared to having only one older parent in the 
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parents couple. There was no support for difference in associations for male or female 
offspring. The relative risk of ASD with parental age was similar across sites, using 
clinical registers as well as (public) insurance based registers, with some quantitative 
heterogeneity but not qualitatively.
The main mechanism proposed for the paternal age effect is through genomic 
alterations. This hypothesis postulates that de-novo mutations are responsible for the 
association between paternal age and ASD with increasing frequencies of mutations 
accumulating with advancing paternal age (Kong et al. 2012; Reichenberg et al. 2006). 
Recent human (Kong et al. 2012) and animal studies (Flatscher-Bader et al. 2011) 
provide support for this hypothesis. In contrast, mechanisms mediating the effect of 
advancing maternal age on risk for ASD have not been frequently investigated. 
Maternal age has been associated with chromosomal changes (Martin 2008; Ginsburg 
et al. 2000) and genomic modifications (Kaytor et al. 1997).  
The study further provides new insights into potential aetiological factors in autism. 
Results showed that offspring of couples of moderately old fathers (aged 35-45) with 
substantially younger mothers (>10 years younger) as well as offspring of moderately 
old mothers (aged 30-40) with substantially younger fathers (>10 years younger) had 
increased risk for ASD. These results suggest that  ASD aetiology may include the 
effects if social factors. Such factors, for example, traits related to the autism 
phenotype, may be present independently in fathers or mothers leading to delayed 
parenting (Croen et al. 2002) . Traits such as shyness and aloofness which may limit 
interactions with women have been described in fathers of autistic children (Eaton et 
al. 2001; Fombonne 2005). Alternatively, social factors may act jointly in the father and 
mother, representing assortative mating where individuals with similar traits 
(phenotype) and associated genotype mate, or secondary assortative mating between 
individuals with complementary traits (Merikangas 1982). Assortative mating has been 
associated with adverse outcome in the offpsring in both human and animal studies. In 
a large study from Britain increasing husband-wife height difference was associated 
with abnormal pregnancy outcomes (Mascie-Taylor & Boldsen 1988). Female and male 
mice that mated with preferred partners had higher reproductive success and better 
progeny performance than individuals mated with non-preferred partners (Drickamer 
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et al. 2003). Evidence for assortative mating has been documented in disorders with 
phenotypic similarity to ASD (Mataix-Cols et al. 2013). This intriguing possibility should 
be studied further because it has implications to both genetic studies and early 
detection and intervention.
Study results also suggest that younger age of parents may be associated with 
increased risk of ASD. Although not observed in meta-analysis of maternal age (Sandin 
et al. 2012), a study of two twin samples from Sweden and the UK showed an 
association between younger paternal age and risk of ASD (Lundström et al. 2010). 
While most focus has been on the effect of advancing parental age and risk to the 
offspring, our observation that young parental age, in particular maternal age, also 
increases risk for ASD, agree with epidemiological observations in several other 
disorders/traits. For example, a report a U-shaped risk profile for pre-term birth and 
birth weight in relation to paternal age (Abel et al. 2002). These observations are 
interesting given the suggested links between pre- and perinatal complications and the 
risk of developing ASD (Kolevzon et al. 2007).
From a mathematical statistical perspective a bias is defined as a numerical difference 
between the underlying true value of an estimator (such as the relative risk) and its 
estimate. Thus, it is a systematic error in the estimation of an effect. While 
randomization of treatments (exposures) to study participants offer a tool, while not a 
complete solution, to address bias problems it is not feasible in observational the 
epidemiological studies presented in this thesis.
The two major sources of bias in observational studies include selection bias and 
measurement errors.
Selection bias occur when the selection of the study population is not representative 
for the target population. Selection bias can occur in any study but is of special concern 
in case-control studies since selection is done conditional on the already observed 
outcome. In cohort studies bias could be introduced as a result of self-referral of 
participants but in a cohort study including the full population such as ours there are 
other possible sources. 
One common source is non-response where exposure or outcome data are missing for 
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parts of the data. Another source of bias in the selection is the detection bias where 
exposed (or unexposed) subjects are followed or measured more intensively then the 
unexposed. With the registers collecting data in a publicly financed and utilized health 
system and with no private psychiatric health services the first source must be 
considered very unlikely since this cover the full population and the basic data 
collected is essentially complete. To what extent our results are biased by detection 
bias is harder to judge. It could for instance be argued that 'older parents' are more 
educated and experienced and as such better in getting access to health care and 
subsequent psychiatric diagnosis in their offspring than are the 'younger parents'. 
As for selection bias measurement errors of both outcome and/or exposure variables 
can lead to biases in different directions. While our approach using full national cohorts 
with prospective follow-up using national registers avoids several possible errors such 
as recall bias due to self-report of data or due to biases introduced by interviewers, 
there are other sources that could have had severe consequences on our results. While 
the determination of parental age is exact using registers the (mis-) classification of 
autism can potentially be problematic. If the measurement error is independent of the 
exposure (“non-differential' errors) the effect is always a diluting effect of the effect 
size for dichotomous exposures and for most cases on non-dichotomous exposure. If 
the measurement error is different for different levels of exposure, e.g. more 
accurately diagnosed autism among older mothers than among younger mothers, the 
bias can be in any direction. To address the possible problems with the classification of 
children with autism we have analyzed autistic disorder (as well). Autistic disorder is 
the most severe form (sub-type) in the autism spectrum and as such can be expected 
to be more accurately classified.
A yet different type of bias in the study can be due to confounding where a variable is 
effecting both the exposure and the outcome. In a prospective cohort with essentially 
complete follow-up confounding is typically a variable occurring 'naturally'. In contrast 
to the other types of bias there are ways to deal with confounding in the analysis. For 
instance, in it's simplest form, if a confounding variable is present the effect of 
confounding can be addressed by including the covariate as a main effect in the model. 
Such an approach could also start with calculating an effect estimator in different sub-
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categories of the confounding variable to ensure there is no interaction between the 
exposure and the confounding variable. Obvious confounders here is the birth year and 
calendar time, since both parental age and the rate of autism have increased 
dramatically over the last 20 years, and similarly did the age of partners. We adjusted 
for both these variables. It has been suggested to adjust for socio-economic status but 
we did not have that variable information available. Also, as I discuss above, it is not 
entirely clear if this should be done or not. Other suggestions have been to adjust for 
variables such as gestational age, birth weight or perinatal complications. However, all 
these variables can be considered to be on the causal path from exposure (parental 
age) to autism in the offspring and should therefore be approached with care. We 
decided not to include any such variable.
The epidemiological approach to dealing with the biases, including confounding, 
mentioned above is diverse and include among others (a) selecting the appropriate 
study population, (b) careful selection and execution (ideally prospective) of  
measurements, (b) try to achieve complete follow-up, (c) be careful not to design 
studies with high and uncontrolled drop-outs or missing values, (d) include important 
covariates (confounders or modifying effect) and (e) the choice of appropriate 
statistical methods.
To summarize, the study comes with several strengths such as the big sample size, 
prospective follow-up in national cohorts, consistent results across nations, geographic 
regions and different health and case-ascertainment systems while applying the unified 
and up-to-date statistical methods. Validation studies of the reported ASD diagnosis 
have been, or are being, performed in five sites with concordance of over 90% 
between the recorded and validation study diagnoses at the two sites that have 
concluded their studies (Schendel et al. 2013).
The study have some limitations. We lack several potentially confounding variables 
such as socio-economic status and parental psychiatric history. However, in earlier 
studies (Frans et al. 2013; Larsson et al. 2005) these confounders have not been shown 
to confound the relation between advancing paternal age and autism. In a recent 
Swedish study, partly overlapping with the Swedish data in the current study, the 
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increased risk among mothers < 20 was reduced in size and no longer statistically 
significant when adjusting for education and county of birth while the risk associated 
with advancing maternal age was increased (Frans et al. 2013). Availability of reliable 
and exact data for the date of diagnosis would have allowed a more detailed statistical 
adjustment for risk time and length of individual follow-up but the assumptions about 
the data distribution used here follow the main approach used by most earlier studies 
(Grether et al. 2009; Hultman et al. 2011; Reichenberg et al. 2006; Sasanfar et al. 2010) 
. Each parent will include on average 2-3 children but the lack of family data did not 
allow us to adjust for this in the analyses, again in agreement with practice in earlier 
studies.
5.7 Conclusion
Using population data from five nations and multiple geographic regions this study 
provides strong consistent evidence for a role for both advancing paternal and 
advancing maternal age in the etiology of autism.  Advancing paternal age and 
advancing maternal age at the time of birth of offspring increases the risk of ASD. 
Younger maternal age may also be associated with increased ASD risk. De novo 
germline mutations, and toxic exposure may partly explain the observed associations. 
Since substantial differences in the ages of the parents are also associated with risk of 
ASD, this study suggests that social factors, in particular assortative mating may also 
play an important role 
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6.1 Summary of the study
Importance
Between 1978 and 2010 approximately 5 million infants were born after in-vitro 
fertilization (IVF) treatments. Yet, there is limited information on neurodevelopment 
after IVF, especially after the first year of life.
Objective
To examine the association between use of any IVF and different IVF procedures and 
the risk of autistic disorder and mental retardation in the offspring.
Design, Setting and Participants
A population-based, prospective cohort study using Swedish national health registers. 
Children born between 1982 and 2007 were followed-up for a clinical diagnosis of 
autistic disorder or mental retardation until December 31st 2009. The exposure of 
interest was the IVF procedure, categorized according to whether intra cytoplasmic 
sperm injection (ICSI) (for male infertility) was used and whether embryos were fresh 
or frozen. For ICSI, whether sperm were ejaculated or surgically extracted sperm was 
also considered.
Main Outcome Measures(s)
Relative risks (RRs) for autistic disorder and mental retardation and rates per 100,000 
person-years, comparing spontaneously conceived children with those born after an 
IVF procedure. Among those born after an IVF procedure, 5 procedures used in Sweden 
were compared with the most common treatment, IVF without ICSI with fresh embryo 
transfer. We also analyzed the sub-group restricted to singletons. We adjusted for sex, 
birth year, age of diagnosis, and parental age and psychiatric history.
Results
In Sweden, more than 2,5 million children were born between 1982 and 2007; 30,959 
(1.2%) were born after an IVF procedure and followed for a mean of 10 (SD=6) years. 
Overall, there were 6,959 children with autistic disorder (103 [1.5%] born following IVF) 
and 15,830 with mental retardation (180 [1.2%] born following IVF). The RR for autistic 
disorder after any procedure compared with spontaneous conception was 1.14 ([95% 
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CI: 0.94-1.39], rates 19.0 vs 15.6 per 100,000 person-years) and for mental retardation, 
1.18 ([95% CI:1.01-1.36, rates 46.3 vs 39.8). Overall, there were 6,737 singleton 
children with autistic disorder (54 [0.8%] born following IVF) and 15,279 with mental 
retardation (101 [0.7%] born following IVF). For both outcomes, there was no 
statistically significant association when restricting to singletons.
Compared with IVF without ICSI with fresh embryo transfer, there were statistically 
significantly increased risks for autistic disorder following ICSI using surgically extracted 
sperm and fresh embryos RR, 4.60 ([95% CI: 2.14-9.88], rates 135.7 vs 29.3 per 100,000 
person-years); for mental retardation following ICSI using surgically extracted sperm 
and fresh embryos RR, 2.35 ([95% CI: 1.01-5.45], rates 144.1 vs 60.8); and following ICSI 
using ejaculated sperm and fresh embryos RR, 1.47 ([95% CI: 1.03-2.09], rates 90.6 vs 
60.8). When restricting the analysis to singletons, the risks for autistic disorder 
associated with ICSI using surgically extracted sperm were not statistically significant, 
but the risks associated with ICSI using ejaculated sperm were significant for mental 
retardation (with frozen embryos, RR, 2.36 ([95% CI: 1.04-5.36], rates 118.4 vs 50.6); 
with fresh embryos, RR, 1.60 ([95% CI: 1.00-2.57], rates 80.0 vs 50.6)). 
Conclusion and Relevance
In Sweden, compared with spontaneous conception, any IVF treatment was not 
associated with autistic disorder but was associated with a small but statistically 
significantly increased risk of mental retardation. Regarding specific procedures, the 
use of IVF with ICSI for paternal infertility was associated with a small increase in the 
relative risk for autistic disorder and mental retardation compared with IVF without 
ICSI. The prevalence of these disorders was low, and the increase in absolute risk 




Between 1978 and 2012, approximately 5 million infants worldwide were born 
following in-vitro fertilization (IVF). The original IVF procedure, allowing an egg to be 
fertilized by sperm in-vitro, is usually used in the absence of male-factor infertility. This 
procedure is used in Sweden in about half of all treatments. Embryos can be 
transferred immediately after fertilization (fresh) or frozen for later use. The 
introduction of the intra cytoplasmic sperm injection (ICSI) in 1992 (Palermo et al. 
1992) , where a sperm is injected into an egg, allows treatment for male-factor 
infertility. For ICSI, sperm can be collected by ejaculation or surgical extraction.
Studies have demonstrated that IVF with or without ICSI is generally safe (Joint RCOG 
Document 2012) but can be associated with an increased risk for perinatal 
complications, including pre-term birth (Sazonova et al. 2011). Concern has been raised 
about ICSI in particular,(Anon 2004) which bypasses the natural selection of sperm, 
may physically damage the egg, and may contaminate the cytoplasm of the egg cell 
with culture media when the sperm is inserted. IVF procedures have also been 
associated with several neurological disorders, including cerebral palsy (Strömberg et 
al. 2002), Russell-Silver (Eroglu & Layman 2012), Beckwith-Wiedemann and Angelman 
syndromes (Eroglu & Layman 2012; Allen & Reardon 2005). No study has investigated 
the association between different IVF procedures and neurodevelopment, and few 
studies have investigated whether IVF treatments are associated with 
neurodevelopment after the first year of life (Hvidtjørn et al. 2009). Few studies have 
looked at autistic disorder and mental retardation, 2 of the most severe chronic 
developmental disorders, affecting 1% to 3% of all children in developed countries 
(Mash & Barkley 2002 pp362–389).
This prospective cohort study was designed to analyze the hypotheses that the use of 
any IVF procedure as well as specific procedures are associated with increased risk of 
autistic disorder and mental retardation in the offspring. 
6.3 Methods
6.3.1 Study Population
A birth-cohort of all children born alive in Sweden from January 1, 1982 to December 
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31, 2007 was established using data from Swedish national registers, including the 
Medical Birth Register(Axelsson 2003), Multi-generation Register (Ekbom 2011) Patient 
Register (Ludvigsson et al. 2011; Sellgren et al. 2011; Ekholm et al. 2005) and the IVF 
Register (Appendix B, eTable 1). Children were followed up until December 31, 2009. 
The study was approved by the Swedish National Board of Health and Welfare, and the 
ethics committee at the Karolinska Institutet (Stockholm, Sweden).
6.3.2 Exposure
Information about IVF treatments (Appendix B, eTable 1) was obtained from the 
National Board of Health and Welfare. IVF without ICSI is used almost exclusively to 
treat female infertility, while IVF with ICSI is used for male infertility.
We classified mode of conception as spontaneous or IVF. IVF was further classified as 
using ICSI; and if ICSI was used, by the source of sperm, ejaculated or surgically 
extracted. Treatment with surgically extracted sperm was introduced 1996. Embryos 
can either be cultured in-vitro for 2-3 days (cleavage-stage) or for 5-6 days (blastocyst). 
During treatment, several embryos are often produced. The embryos not immediately 
used can be frozen. IVF procedures were also classified by whether the embryo was 
fresh or frozen. Thus, 6 procedures currently used in Sweden were considered: (1) IVF 
without ICSI with fresh embryo transfer; (2) IVF without ICSI with frozen embryo 
transfer; (3) ICSI using ejaculated sperm with fresh embryos; (4) ICSI with ejaculated 
sperm and frozen embryos; (5) ICSI with surgically extracted sperm and fresh embryos, 
and (6) ICSI with surgically extracted sperm and frozen embryos. 
6.3.3 Outcome
Autistic disorder is characterized by deficits in social interaction, communication, and 
restricted, stereotypical or repetitive behavior. Mental retardation is defined as an IQ 
below 70 and limitations in adaptive behavior. In Sweden, all infants and preschool 
children are regularly seen at well-child care clinics and undergo routine medical and 
developmental screening. At age 4 years, a mandatory developmental assessment 
(motor, language, cognitive and social development) is conducted. Children with a 
suspected developmental disorder are referred for further assessment by a specialized 
team. Diagnostic information is reported to the Patient Register.
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The International Classification of Diseases, 9th and 10th revisions were used. We 
focused on mental retardation and on the narrow diagnosis of infantile/childhood 
autism (diagnostic codes ICD-9 299A or ICD-10 F84.0), and do not include other forms 
of autism spectrum disorders. 
6.3.4 Covariates
We considered several factors that might confound or modify the association between 
IVF treatments and autistic disorder or mental retardation in the child. Parental 
psychiatric history (Larsson et al. 2005) was classified as present/not-present for each 
parent separately using any diagnosis at any time before the birth of the child (for ICD-
codes see Appendix B, eTable 2). We also obtained information on parental age 
(Hultman et al. 2011; Grether et al. 2009; Sandin et al. 2012), birth year, multiple 
births, and preterm birth (Sazonova et al. 2011) (<week 37). Multiple births and 
preterm birth may lay on a causal pathway to adverse developmental outcome, and 
were therefore examined as effect modifiers.
6.3.5 Statistical methods
First we examined the association between any IVF procedure and autistic disorder and 
mental retardation compared with spontaneous conception. This is the most important 
comparison from a public health perspective. Second, as there may be different risks 
associated with different procedures or parental factors underlying the choice of 
procedure, we analyzed the association between 5 of the different IVF categories and 
autistic disorder and mental retardation compared with the most commonly used and 
least complicated procedure, IVF without ICSI with fresh embryo transfer. As couples 
undergoing fertility treatment may share common risk factors the relevant comparison 
group consists of other couples undergoing IVF treatment (Carson et al. 2010) which 
controls for reasons for infertility. We also provide the results using spontaneous 
conception as the reference.
We also combined data to investigate procedures with similar underlying parental 
factors and to increase power: all ICSI procedures, regardless of sperm source and type 
of embryo;, frozen embryos, regardless of type of IVF procedure; and surgical 
extraction of sperm, regardless of embryo type. In an exploratory analysis, we also 
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examined whether the embryo was transferred at the cleavage or blastocyst stage; 
blastocyst transfer data was available from 2002.
For descriptive purposes, we calculated the rate and the percentage of children with 
autistic disorder and mental retardation and exact 95% confidence intervals (CIs) 
(Clopper, C J & Pearson, E S 1934).
Using Poisson regression (SAS GLIMMIX version 9.3), we estimated RRs and 2-sided 
95% Wald CIs. We fitted regression models by splitting the follow-up-time (child 
attained age between cohort entry and cohort exit) into 1-year intervals. Poisson 
regression gives approximately the same parameter estimates and likelihood ratios as 
Cox proportional hazards regression when the length of follow-up is split into finer 
intervals but allows for greater flexibility in the modeling (Whitehead 1980) . For each 
child and outcome, we only considered the first event. Each child was followed from 
age 1.5 years up to death, emigration from Sweden, onset of disease, the age of 28 
years, or December 31, 2009, whichever came first. We first fitted crude models 
including covariates for exposure together with sex, birth year and attained age, then 
adjusted models including the potential confounding covariates parental age (paternal: 
<30, 30-39, 40-49 and ≥50; maternal: <25, 25-29, 30-34, ≥35) and paternal and 
maternal psychiatric history at offspring birth (yes/no). This set of models was fitted for 
the comparisons of any IVF procedure vs spontaneous conception as well as for the 
comparison of specific procedures.
To allow the most efficient adjustment of the time variables, attained age and birth 
year, we fitted natural cubic splines (Hastie et al. 2009; Benedetti & Abrahamowicz 
2004) allowing for adjustment without assuming a specific functional form such as 
linear or stepwise.
All statistical tests were done on the 2-sided 5% level of significance. All RR are 
presented together with absolute rates per 100,000 person years adjusted for birth 
year, sex and age.
6.3.6 Supplementary analyses
To check for confounding potentially present in an observational study such as this and 
to allow a better understanding of the observed associations, we performed a-priori 
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specified analyses.
To confirm associations were not due to temporal trends, crude models were adjusted 
for calendar time using splines. To allow the treatment comparisons to be summarized 
with a single RR, we examined IVF procedure-by-age-interactions, allowing for different 
RRs at different ages. We calculated RR separately for male and female offspring.
At the first prenatal visit, mothers are asked about length of involuntary infertility. 
Additional models included this variable as a linear continuous confounder. Women are 
also asked about hormone treatment as the only fertility treatment; we compared 
children of these women vs spontaneous conception fitting crude and adjusted 
models.
We fitted a separate set of models also adjusting for certain genetic diseases and 
disorders (Appendix B, eTable 2) with known phenotypic and genetic overlap with 
autistic disorder and mental retardation (Hollander et al. 2010) .
Finally, we repeated all analyzes described above restricted to singletons.
For model checking purposes we fitted supplementary models (Fitzmaurice et al. 2004) 
assuming independence between families and a common correlation within and not 
requiring the data to follow a particular parametric distribution. We added several 
analyzes post hoc: To complement the analyzes of IVF procedures we calculated RR 
using spontaneous conceived children as control group. We analyzed the last 9 birth 
cohorts as a subgroup. To facilitate interpretation of the mechanism of the 
associations, we fitted the models separately to the subgroups of pre-term and term 
children. In yet separate analyzes we calculated and compared RR for multiple births 
after IVF and for multiple births after spontaneous conception.
6.4 Results
Characteristics of the children are presented in Table 1. A total of 2,541,125 children 
were alive at 1.5 years of age and had complete data on all the covariates; 30,959 
(1.2%) were born following an IVF procedure. 18,288 children (0.7%) had missing 
information on parental age or term/pre-term status and were not included (65 with 
autistic disorder and 204 with mental retardation, including 1 and 2 cases among those 
born after an IVF procedure. After 1998 44% of infertility treatments have used ICSI for 
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male reproduction problems and frozen embryos increased from 9% before 1998 to 
26% after 2005 (Table 1).
Autistic disorder was diagnosed in 6,959 children and mental retardation in 15,830; 
103 (1.5%) and 180 (1.1%), respectively, were born after an IVF procedure. Cases had a 
mean follow-up time of 10 years (SD=6) , median 14 years (range, 0.1 to 26.5 years). 
The rates (per 100,000 person-years) of autistic disorder and mental retardation among 
spontaneous conceived children were 20.2 and 46.1, respectively. The highest rates of 
autistic disorder (215.0) and mental retardation (161.2) were in children born following 
ICSI using surgically extracted sperm with fresh embryos (Table 2).
102 (229)
Table 1 All children. Distribution of confounders and children characteristics for spontaneous conceived, across IVF procedures and for women with hormone 
treatment as the only fertility treatment.
Variable Spontaneously Conceived



















Number of Children (%boys) 2,510,166 (51.4) 16,668 (52.9) 2,777 (51.1) 9,241 (49.7) 1,477 (49.6) 628 (49.3) 168 (55.4)
Father Psych. History, N (%) 36,405 ( 1.5) 183 ( 1.1) 39 ( 1.4) 136 ( 1.5) 12 ( 0.8) 9 ( 1.4) 8 ( 4.8)
Mother Psych. History, N (%) 46,366 ( 1.8) 363 ( 2.2) 51 ( 1.8) 157 ( 1.7) 30 ( 2.0) 12 ( 1.9) 2 ( 1.2)
Pre-term, N (%) 143,688 ( 5.7) 3,631 (21.8) 435 (15.6) 1,562 (16.9) 190 (12.9) 107 (17.1) 17 (10.1)
Multiple Birth, N (%) 54,673 (2.18) 5,285 (31.7) 606 (21.8) 2,379 (25.7) 258 (17.5) 164 (26.1) 39 (23.2)













IVF: In Vitro Fertilization, ICSI: Intra Cytoplasmic Sperm Injection, N: Number of children; pre-term: before week 37
(continued on next page)
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(continued from previous, Table 1)
Variable Spontaneously Conceived






























































































































Years of involuntary infertility, 
Median (10th-90th percentiles)
0 (0-0) 3 (0-8) 2 (0-7) 3 (0-7) 2 (0-6) 2 (0-7) 2 (0-6)
IVF: In Vitro Fertilization, ICSI: Intra Cytoplasmic Sperm Injection, N: Number of children; pre-term: before week 37
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Table 2 All children. Autistic Disorder and Mental Retardation. Number of cases, Person year of follow-up, Percent of children diagnosed with each disease, Rate 
(unadjusted) and Rate adjusting for age, sex and birth year.




















































NA: Not application since no cases, CI: Two-sided confidence interval, IVF: In Vitro Fertilization, ICSI: Intra Cytoplasmic Sperm Injection, Person Years: Year each live born child is 
contributing with in the analysis; Percent of children calculated as number of children observed with a disease diagnosis divided with the number of children born and reaching the 
age 1.5, #: Unadjusted rates, ##: Age, Birth year and sex adjusted rates; ###: Exact confidence intervals calculated on crude proportion autistic disorder and mental retardation 
without adjusting for possible confounding.
(continued on next page)
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(continued from previous, Table 2)



























Children born after specific IVF procedures
IVF without ICSI, 













IVF without ICSI, 



































ICSI, fresh embryo, 
surgically extracted 
sperm











ICSI frozen, embryo, 
surgically extracted 
sperm
0    787 0(0-2.17) NA NA 0 787 0 (0-2.17) NA NA
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Below only adjusted RRs are presented. Crude RRs are presented in Figures 1, 2 and 3. 
All results, including supplementary analyzes, are presented in the online tables 
(indicating supplementary results using italic font).
Compared with children born following spontaneous conception, those born after any 
IVF procedure had a statistically significantly increased risk of mental retardation RR, 
1.18 ([95% CI: 1.01-1.36], rates 46.3 vs 39.8). The RR for autistic disorder was 1.14 
([95% CI: 0.94-1.39], rates 19.0 vs 15.6). For both mental retardation and autistic 
disorder, the risk estimates were slightly lower in singletons and not statistically 
significant RR, 1.01 ([95% CI: 0.83-1.24], rates 38.8 vs 38.5) and RR, 0.89 ([95% CI: 0.68-
1.17], rates 14.4 vs 15.0) respectively (Appendix B, eTable 3 and eTable 4).
There was a statistically significantly increased risk for autistic disorder after ICSI using 
surgically extracted sperm with fresh embryos RR, 4.60 ([95% CI: 2.14-9.88], rates 
135.7 vs 29.3) compared with children born after IVF without ICSI with fresh embryos. 
In children born preterm, the RR was 9.54 ([95% CI: 3.43-26.57], rates 364.5 vs 38.4). 
The increase in risk was not evident in singletons RR, 0.95 [95% CI: 0.13- 7.09], rates 
21.9 vs 23.9) (Appendix B, eTable 5).
There was increased risk of mental retardation in children born after ICSI using 
surgically extracted sperm with fresh embryos compared with children born after IVF 
without ICSI with fresh embryos RR, 2.35 ([95% CI:1.01- 5.45], rates 144.1 vs 60.8). In 
children born preterm, the RR was 4.38 ([95% CI:1.53-12.48], rates 413.9 vs 92.2). The 
increase in risk was not evident in singletons RR, 0.70 ([95% CI: 0.10- 5.16], rates 36.1 
vs 50.6). 
There was increased risk of mental retardation in children born after ICSI using 
ejaculated sperm with fresh embryos RR, 1.47 ([95% CI: 1.03- 2.09], rates 90.6 vs 60.8) 
but not frozen. This risk increase was present also in singletons RR, 1.60 ([95% CI: 1.00- 
2.57], rates 80.0 vs 50.6). Risk for mental retardation was also statistically significant in 
singletons after ICSI using ejaculated sperm with frozen embryos RR, 2.36 [95% CI: 
1.04-5.36], rates 118.4 vs 50.6)) but not among all children. For other procedures, the 
RR was not statistically significant (Appendix B, eTable 6).
To further elucidate the effect of specific techniques, we analyzed combined 
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procedures. For autistic disorder, comparing the 2 procedures involving surgically 
extracted sperm with the 4 procedures involving ejaculated sperm, there was an 
increase in risk associated with the surgical extraction RR, 3.29 ([95% CI:1.58- 6.87], 
rates 110.1 vs 30.9). The risk was even higher among preterm births RR, 8.06 ([95% CI: 
2.97-21.85], rates 319.8 vs 42.3) but was reduced in magnitude and was no longer 
statistically significant when restricted to singletons RR, 0.73 ([95% CI: 0.10- 5.30], rates 
18.3 vs 24.3) (Appendix B, eTable 7).
For mental retardation, comparing the 4 different ICSI procedures with the 2 
procedures without ICSI, there was an increased risk RR, 1.51 ([95% CI: 1.10- 2.09], 
rates 93.5 vs 61.8). The risk increase was similar in singletons RR, 1.50 ([95 CI: 0.98-
2.29], rates 80.2 vs 54.8) and among preterm births RR, 1.73 ([95% CI: 1.05-2.86], rates 
166.7 vs 96.0). The risk increase comparing procedures using surgical extraction vs 
ejaculated sperm was present only for mental retardation among preterm births RR, 
3.31 ([95% CI: 1.18-9.31], rates 356.7 vs 109.4) (Appendix B, eTable 8).
Comparing IVF procedures using blastocyst transfer with those using cleavage-stage 
transfer and comparing procedures using frozen embryos with those using fresh 
embryos, the risks for autistic disorder and mental retardation were not statistically 
significant.
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Figure 1 Comparing children born after any IVF vs Spontaneously conceived. Relative risk of Autistic Disorder (left graph) and Mental Retardation 
(right graph) with spontaneously conceived as reference group. Dot for relative risk. Line bars for the two-sided 95% confidence intervals. 
All models except “Crude” are adjusted for confounding. Term and pre-term are subgroups of the data. Number of cases and number of 
children (N) in any IVF and reference group indicated within parenthesis under each line bar.
 
(xx vs xx, N=nn vs mm) indicate number of cases and number of children in the studied group vs reference group respectively. Crude: Adjusted for sex, attained age and birth year, 
Adj: Adjusted for sex, attained age, birth year, paternal age categorically, maternal age categorically, maternal psychiatric history at offspring birth (Y/N), paternal psychiatric history 
at offspring birth (Y/N)
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Figure 2 All children. Relative risk of Autistic Disorder (left graph) and Mental Retardation (right graph) with IVF without ICSI, fresh embryo 
ejaculated sperm as reference. Dot for relative risk. Line bars for the two-sided 95% confidence intervals. All models except “Crude” are 
adjusted for confounding. Term and pre-term are subgroups of the data. Number of cases and number of children (N) in studied group and 
reference group indicated within parenthesis under each line bar. Groups in the figures without line bars do not have sufficient data to 
allow an estimation of the confidence intervals. For the same reason ICSI, frozen embryo, surgically extracted sperm is not shown.
 
(xx vs xx, N=nn vs mm) indicate number of cases and number of children in the studied group vs reference group respectively. Crude: Adjusted for sex, 
attained age and birth year, Adj: Adjusted for sex, attained age, birth year, paternal age categorically, maternal age categorically, maternal psychiatric 
history at offspring birth (Y/N), paternal psychiatric history at offspring birth (Y/N)
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Figure 3 Singletons. Relative risk of Autistic Disorder (left graph) and Mental Retardation (right graph) with IVF without ICSI, fresh embryo ejaculated 
sperm as reference. Dot for relative risk. Line bars for the two-sided 95% confidence intervals. All models except “Crude” are adjusted for 
confounding. Term and pre-term are subgroups of the data. Number of cases and number of children (N) in studied group and reference 
group indicated within parenthesis under each line bar. Groups in the figures without line bars do not have sufficient data to allow an 
estimation of the confidence intervals. For the same reason ICSI, frozen embryo, surgically extracted sperm is not shown
 
(xx vs xx, N=nn vs mm) indicate number of cases and number of children in the studied group vs reference group respectively. Crude: Adjusted for sex, attained age and birth year, 
Adj: Adjusted for sex, attained age, birth year, paternal age categorically, maternal age categorically, maternal psychiatric history at offspring birth (Y/N), paternal psychiatric history 
at offspring birth (Y/N)
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6.5 Supplementary analyses 
The RR for specific IVF procedures using spontaneously conceived children as reference 
group were almost identical to the RR using IVF without ICSI fresh embryo as reference 
(Appendix B, eTable 10). The RRs did not change when adjusting for calendar year. 
When restricting to birth cohorts after 1998, the overall adjusted results remained 
stable and statistical significance remained except the risk for mental retardation 
following ICSI using surgically extracted sperm with fresh embryos, which dropped in 
precision RR, 2.08 ([95% CI: 0.74-5.89], rates 119.3 vs 61.2).
There were no major differences in risk of autistic disorder and mental retardation by 
age. The estimated RRs were similar in male and female offspring.
There was no increase in risk associated with years of infertility. Adjustment for this 
variable did not change the estimated associations with IVF/ICSI. The RR comparing 
hormone stimulation as the only treatment vs. spontaneous conception was not 
statistically significant different.
There were a total of 366 cases with known genetic diseases in the cohort, only 3 born 
following IVF (all following IVF with fresh embryos). Adjusting for presence of such 
conditions did not change the RR estimates or CIs.
For spontaneously conceived children multiple births contributed 2% of the person-
years compared with 38% for IVF without ICSI with fresh embryos and 18-31% for 
other procedures. Among children with a diagnosis of autistic disorder or mental 
retardation, 3% were multiple births compared with 2% among children with no 
diagnosis at end of follow-up.
Among spontaneously conceived children, risk of autistic disorder in multiple births 
compared with singletons was RR, 1.15 ([0.95% CI: 0.99-1.34], rate 15.9 vs 13.8). 
Among children born after any IVF procedure RR, 1.88 ([95% CI:1.28-2.77], rates 46.0 vs 
24.9) which was statistically significantly higher than among spontaneous conceived 
children (p=0.021) (Appendix B, eTable 11).
For mental retardation the comparable RR was RR 1.49 ([95% CI:1.11-2.00], rates 91.4 
vs 60.0) among multiple births following IVF treatment and 1.42 ([95% CI:1.29-1.56], 
rates 51.1 vs 36.4) among spontaneously conceived multiples (Appendix B, eTable 11).
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6.6 Discussion
Studies on long term neurodevelopment of children born following IVF treatment, 
especially after the first year of life, are limited. Studies on the association between IVF 
and autism (Maimburg & Vaeth 2006; Hvidtjørn et al. 2011; Lyall et al. 2012) or mental 
retardation (Strömberg et al. 2002; Carson et al. 2010; Leunens et al. 2008; Middelburg 
et al. 2008; Leslie et al. 2003; Bonduelle et al. 1998; Pinborg et al. 2004) show mixed 
results. A case-control study showed IVF to be a risk factor for autistic disorder (Zachor 
& Ben Itzchak 2011) while 2 other studies did not (Maimburg & Vaeth 2006; Hvidtjørn 
et al. 2011). Increased risk for developmental delay was reported in twins born 
following IVF (Strömberg et al. 2002), and in singletons following ICSI (Knoester et al. 
2008), while a similar study did not find any difference (Ponjaert-Kristoffersen et al. 
2005).
To the best of our knowledge this is the largest study examining the relationship 
between specific IVF procedures and autistic disorder and mental retardation, 
examining the full range of IVF procedures. While the data did not show an association 
between any IVF procedure and autistic disorder, compared with spontaneous 
conception, there was a small, statistically significant increase in the risk for mental 
retardation. When restricted to singletons, the risk for mental retardation was no 
longer statistically significant. However, the results demonstrated an association 
between autistic disorder and mental retardation and specific IVF procedures with ICSI 
related to paternal origin of infertility compared with IVF without ICSI.
The absolute differences in rates were small, below 7 per 100,000 person-years for 
mental retardation comparing any IVF procedure with spontaneous conception. While 
not a common treatment, the highest rate difference occurred with ICSI using surgically 
extracted sperm and fresh embryo transfer, compared with IVF without ICSI with fresh 
embryos (178.2 per 100,000 person-years for autistic disorder).
Our investigation of specific procedures was done in the subset of the population who 
all shared some degree of fertility problems. While this is the correct comparison for 
evaluating the effect of IVF beyond the general effects of sub-fertility, the question of 
how generalizable the data are can be raised (Carson et al. 2010). For this reason, we 
also presented these results using children born following spontaneous conception as 
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the comparison group (Appendix B, le 10). 
Mental retardation was associated with ICSI with fresh embryos. This association was 
robust and not due to multiple births, premature birth, or parental characteristics. 
Mental retardation was also associated with ICSI with frozen embryos among children 
born prematurely (multiples or singletons), and with IVF without ICSI with frozen 
embryos among preterm singleton infants.
Autistic disorder and mental retardation were also associated with ICSI using surgically 
extracted sperm. The increase in risk was present in the analysis including all children 
and was stronger in preterm births. While the complete resolution of the risk in 
singletons can be explained by the reduction in statistical power it also suggest that the 
risk was, at least in part, mediated through multiple embryo transfer or preterm birth. 
In this context, the formal statistical analysis comparing multiples and singletons 
showed a higher rate of autistic disorder among multiples, although multiple birth may 
not be a risk factor for autistic disorder generally. An indirect cause for this might be 
the use of multiple embryo transfer in more severe cases of infertility or a direct effect 
of parental infertility factors.
We examined several alternative explanations for the results. First, hormone 
stimulation is part of IVF treatment. It has been suggested that use of hormones, not 
IVF treatment, is associated with increased risk of autistic disorder (Funderburk et al. 
1983). We compared the risk of autistic disorder and mental retardation in children 
born to mothers reporting hormone treatment who had no IVF procedure. The risk for 
autistic disorder and mental retardation were not increased compared with the control 
population with RR point estimates below one.
Second, any risk associated with an IVF procedure could be due to advancing parental 
age or other parental characteristics. Adjusting for paternal and maternal age and for 
parental psychiatric history did not attenuate the risk associated with the IVF 
procedures.
Third, since 1981 the single-embryo transfers have increased from 10% to 70% of all 
treatments while the rate of premature births dropped from 40% to 10%. However, our 
results were not restricted to the earlier years of treatment and we adjusted for birth 
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year. Also, the RR remained unchanged in the sensitivity analyzes restricted to birth 
after 1998.
While we did not have information on the number of treatment cycles, there was no 
association with years of infertility. This association may however be complicated with 
different causes acting differently, e.g. if couples with paternal infertility tend to apply 
for IVF earlier.
A possible mechanism linking IVF and neurodevelopmental disorders is epigenetic 
modifications (Schanen 2006; Dada et al. 2012). Epigenetic processes have been 
associated with Rett's (Robertson & Wolffe 2000) and Angelman's syndroms (Mann & 
Bartolomei 1999), disorders characterized by autistic-like features in some patients. 
Experiments in mice have suggested that some of the steps involved in IVF might be 
related to epigenetic defects (Paoloni-Giacobino & Chaillet 2004; De Rycke et al. 2002). 
Mammal embryo cultured in-vitro is also susceptible to imprinting control (De Rycke et 
al. 2002). The risk of epigenetic changes may be modified the longer an embryo spends 
in culture. While blastocyst transfer is rare and also involves sperm selection, it offers 
an indirect test of this hypothesis. We did not find any change in risk with blastocyst 
transfer.
The strengths of this study include the large, prospective, population-based sample and 
a health system with equal access. We included more detailed IVF treatment 
information with longer follow-up and control for confounding than previously done. 
Closest in comparison is a cohort study of autistic spectrum disorder from 2011 
(Hvidtjørn et al. 2011) that also included detailed control for confounding but only 9 
years of follow-up, a sample size one fourth of ours, and no results on specific 
procedures. The detailed information allowed direct comparison of specific IVF 
procedures with IVF with fresh embryo transfer, allowing adjustment for shared 
confounding by causes of infertility and treatment.
The study have several limitations. We could not examine if multiple birth was 
associated with zygosity. We only had information on live births and cannot rule out 
confounding by miscarriage. 
We did not have information on parental education or socioeconomic status. In 
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Sweden IVF treatment is free of charge for childless women for up to 3 treatment 
cycles. Additional cycles are not expensive compared with many other countries, but 
there are still many couples even in Sweden that cannot afford treatment beyond the 3 
free-of-charge attempts. Any potential bias is likely to be small. 
Information about the number of embryos transferred was only available from 2003. 
Therefore, this effect could not be reliably examined. The overall study objective of 
testing for an association between IVF/ICSI and autism or mental retardation is built 
from a composite hypothesis involving 10 statistical tests, of which 4 had unadjusted p-
values below the 0.05 limit. After adjusting for multiplicity using Holm's procedure 
(Holm 1979), only 1 was statistically significant. Finally, some outcomes were based on 
small numbers, some estimates have wide confidence intervals and many others have 
lower confidence limits close to one. Future studies in different populations are needed 
to further examine these issues.
6.7 Conclusions
In Sweden, compared with spontaneous conception, any IVF treatment was not 
associated with autistic disorder but was associated with a small but statistically 
significantly increased risk of mental retardation. Regarding specific procedures, the 
use of IVF with ICSI for paternal infertility was associated with a small increase in the 
relative risk for autistic disorder and mental retardation compared with IVF without 
ICSI. The prevalence of these disorders was low, and the increase in absolute risk 
associated with IVF was small. These associations should be assessed in other 
populations.
Our results should be applicable to most countries where IVF and ICSI are used. There 
are no major differences in equipment or laboratory work across countries but there 
may be some differences in choice of procedure. For instance, in several countries (like 
the United States), ICSI is often used when the sperm sample is normal because of a 
presumed (but unproven) higher efficiency. Blastocyst transfer is infrequently used in 
Sweden but is more common in the United States.
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7 Study IV - Familial risk of autism
This section contain the manuscript with the title "Familial risk of autism" as submitted 
to peer-review journals October 10, 2013.
7.1 Summary of the study
Importance
Autism Spectrum Disorders (ASD) is one of the most severe chronic development 
disorders. Studies have found that ASD aggregates in families, but to what extent this is 
caused by genetic factors, or shared or non-shared environment remains unresolved.
Objective
To provide estimates of familial aggregation and heritability of ASD.
Design, Setting and Participants
A prospective population based cohort of all children born in Sweden 1982-2007. Using 
national registers we identified all pairs of monozygote and dizygote twins, full siblings, 
maternal and paternal half siblings and cousin pairs. We included all clinical diagnosis 
of ASD to 31st December 2009.
Main Outcome Measures(s)
Familial aggregation of ASD and AD was evaluated by calculating relative recurrence 
risk for different family relations. Extended twin-models estimate how much of the 
probability of developing ASD can be attributed to genetic (additive and dominance) 
and environmental (shared and non-shared) factors.
Results
The ASD relative recurrence risk was estimated to 148.7 (95% Confidence Intervals (CI) 
57.5 - 384.9) for monozygotic twins, 8.4 (95%CI 3.9-18.3) for dizygotic twins, 10.4 
(95%CI 9.5-11.4) for full-siblings, 3.3 (95%CI 2.6-4.2) for maternal half siblings, 2.9 
(95%CI 2.2-3.7) for paternal half siblings, and 2.0 (95%CI 1.8-2.2) for cousins. We found 
no statistically significant differences in recurrence risk according to sex. The 
recurrence risk pattern was similar for AD but of higher magnitude.
Extended twin-models supported a disease etiology including only additive genetic and 
117 (229)
non-shared environmental effects components for both ASD and AD. The ASD 
heritability was estimated to 50% (95%CI 0.44-0.55) and the AD heritability was 
estimated to 0.54 (95%CI 0.44-0.64).
Conclusion and Relevance
In Sweden, genetic and environmental risk factors are equally important in ASD 
etiology. These results challenge the current dominant etiological model of ASD. The 




Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders 
affecting almost 1% of the population, and defined by impairments in social interaction 
and communication and the presence of restricted interests and repetitive behaviors. 
Autistic disorder (AD) is most profound form of ASD (Hollander et al. 2010) .
Family studies have consistently found that ASD aggregates in families, suggesting a 
genetic component to the etiology. Early twin studies estimated the heritability of ASD, 
or the proportion of the phenotype variance due to genetic factors, to be about 90% 
(Bailey et al. 1995; Susan Folstein & Rutter 1977; Steffenburg et al. 1989; Lichtenstein 
et al. 2010; Ronald et al. 2006), making it the most heritable of all developmental 
disorders. As a consequence, etiological models and associated research in ASD, focus 
predominantly on genetic factors (Hallmayer et al. 2011). While recent twin studies 
support high heritability(Lichtenstein et al. 2010; Ronald et al. 2006) a large twin study 
(Hallmayer et al. 2011) indicated substantial role for shared environmental influences 
on risk for autism. Results of family studies also challenge the substantial role of 
genetic factors (Constantino et al. 2013). The mixed, sometime conflicting results, have 
brought considerable uncertainty regarding the etiology of ASD.
Furthermore, although previous studies were carefully conducted they have critical 
limitations. Concerns have been raised about twin studies often having only small 
samples limiting the reliability when estimating heritability of rare diseases such as 
ASD. None of the previous studies represent a prospective population based random 
sample which raises concerns for potential biases introduced by population selection. 
Restricted follow up time, , and possible differences in etiology for different ASD 
subtypes may also limit reliability. Furthermore, while heritability estimates provide a 
valuable metric for the effects of genetic factors in the population, they do not provide 
any information on individual risk. Detailed etiological models will require accounting 
for risk on a population level, as well as providing quantitative information in a given 
individual, thus allowing for individualized disease prevention and treatment(Manolio 
et al. 2009) .
Consequently, there is a need to obtain reliable estimates of heritability for ASD, as well 
119 (229)
as combine these population-based estimates with individual-level risk estimates 
providing a more precise and complete picture of the etiology of ASD.
To that goal we conducted a prospective longitudinal cohort study of all births in 
Sweden between 1982 and 2007. Using all pairs of monozygote (MZ) and dizygote (DZ) 
twins, full siblings, half siblings and cousin pairs in the population we determined the 
family clustering of ASD by estimating relative recurrence risk within families, and 
assessed the importance of genetic vs. environmental factors in the etiology of ASD.
7.3 Methods
7.3.1 Study Population
A birth-cohort of all children born alive in Sweden January 1, 1982 to December 31, 
2006 was established using data from Swedish national registers including the Medical 
Birth Register(Axelsson 2003) , Multi Generation Register(Ekbom 2011) , Patient 
Register(Ludvigsson et al. 2011; Sellgren et al. 2011; Ekholm et al. 2005) , Twin 
register(Lichtenstein, Sullivan, et al. 2006) and Statistics Sweden registers for vital 
statistics. All Swedish live-born children are assigned a unique personal identification 
number. The number is used in all contacts with authorities and ensuring accurate and 
complete individual-level linkage between registries. We defined the recurrence risk as 
the risk of autism following an autism diagnosis in a sibling (see Statistical methods), 
therefore single-child families were excluded from the cohort. Twin zygosity 
information was available from the Twin Registry. The study was approved by the ethics 
committee at the Karolinska Institutet, Stockholm, Sweden.
7.3.2 Ascertainment of autism and psychiatric diagnosis
In Sweden all infants and preschool children are regularly seen at well-child care clinics 
and undergo routine medical and developmental screening. At age 4 a mandatory 
developmental assessment (motor, language, cognitive and social development) is 
conducted. Children with suspected developmental disorders are referred for further 
assessment by a specialized team in a child psychiatry unit or habilitation service. 
Diagnostic information is reported to the Patient Register. The register has nearly 
complete national coverage (Ludvigsson et al. 2011) and include psychiatric in-patient 
diagnoses since 1973 and out-patient diagnoses from the year 2000. With prospective 
120 (229)
follow-up until 31st December, 2009. Autistic disorder (AD) was defined by ICD-9 
299.A/B/X and ICD-10 F84.0 while ASD also included ICD-10 F84.1 (Atypical autism), 
F84.5 (Asperger’s syndrome), F84.8 (Other pervasive developmental disorders) and 
F849 (Pervasive developmental disorder, unspecified).
7.3.3 Covariates
We considered several factors that might confound or modify the familial associations. 
Parental psychiatric history was classified as present/not-present for each parent 
separately using any psychiatric diagnosis at any time before the birth of the oldest 
child in a siblings or cousins pair using ICD 7th-10th revisions. We also obtained 
information on parental age, birth year and sex.
7.3.4 Statistical methods
The relative recurrence risk (RR) for siblings is the risk of autism diagnosis in a sibling of 
an autistic child compared with a sibling to a non-autistic child. We calculated 
recurrence risk in families of different genetic relatedness; full-siblings, maternal and 
paternal half-siblings and cousins. Cousin-pairs were defined as cohort members 
having the same grandparents, but no parents in common. To allow a direct 
comparison between cousin recurrence risk and sibling recurrence risk we did not 
consider cousins between single-child-families.
We estimated the RR for ASD by the hazard ratios obtained from Cox proportional 
hazards regression using the sibling attained age as underlying time scale(Korn et al. 
1997). When the exposure is not an affected family member the recurrence calculated 
here is commonly labeled as Relative Risk (RR). Each individual in a sibling or cousin 
pair was entered into the cohort and followed for a diagnosis of autism starting from 
the age of one or from 1st of January 1987, which ever came first. Each sibling/cousin 
was then followed to his first autism diagnosis, death, emigration or death or 
emigration of his non-autistic sibling or 31 December 2009, whichever came first. The 
exposure (autistic or non-autistic sibling) was treated as a time-varying covariate in the 
models. As each sibling in a sibling pair can contribute to the calculations twice (both 
as an exposed sibling and as a proband) we used robust standard errors(Liang & Zeger 
1986).
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For descriptive purposes we calculated the cumulative probability of ASD up to the age 
of 20 using the Cox regression. For the calculation of relative recurrence risk the Cox 
regression makes an implicit assumption of hazards ratios constant across time (age of 
the sibling). We verified the validity of this assumption by plotting the Schoenfeld 
residuals(Grambsch & Therneau 1994) .
A change in RR for later birth cohorts may be due to truncation of follow-up time or 
due to changes in incidence. The children born 1982 are followed for 28 years while 
the children born 2006 are only followed for three years. In the Cox model this could 
show up as a violation of the proportional hazards assumption which we tested for. To 
address this further we calculated the RR by birth cohorts using all available follow-up 
time.
We excluded multiple births from the sibling analyzes. We calculated the RR separately 
for monozygotic and dizygotic twins, full siblings, maternal and paternal half siblings as 
well as for cousins. We considered several factors that might confound the recurrence 
risk including parental psychiatric history, parental age, birth year and sex of the 
exposing sibling. As parental psychiatric history and parental age may be on a causal 
path between familial risk and adverse developmental outcome we fitted models 
adjusting for confounding with and without these covariates. We treated the covariates 
categorically as sex of the exposed sibling, birth cohort (1982-86, 1987-91, 1992-96, 
1997-2001, 2002-06), maternal age (≤35, >35), paternal age (≤40, >40), and paternal 
and maternal psychiatric history (yes/no) at birth of the oldest sibling.
We used an extended sibling design (MZ twins, DZ twins, full siblings, maternal half 
siblings, paternal half siblings) to decompose the variance in liability into additive 
genetic factors (A) reflecting additive effects of different alleles, non-additive genetic 
factors (dominance, D) reflecting interaction effects between alleles at the same gene 
locus, shared environmental factors (C) reflecting non-genetic influences that 
contribute to similarity within pairs of siblings and non-shared environmental factors 
(E) reflecting experiences that make sibling pairs dissimilar. MZ twins are assumed to 
share 100% of their A in a pair and DZ twins are assumed to share 50% of their A; full 
siblings, assumed to share 50%, maternal half siblings, assumed to share 25%, and 
paternal half siblings, who are assumed to share 25% of A in a pair. Furthermore we 
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assume that all sibling types included share the C-parameter in pairs, except paternal 
half siblings since children tend to be living with their mother while growing 
up(Moeller 1994). We also included dominant genetic effects (D), 100% shared 
between MZ twins, 25% between DZ twins, 25% between full siblings, and not shared 
between half siblings. We first calculated tetrachoric correlations. Contrasting the 
tetrachoric correlations for different family relations allowed for an initial examination 
of the relative contribution of genetic and environmental influences. We then 
estimated the relative contribution of genetic (i.e., A and D) and environmental (i.e., C 
and E) using the liability-threshold model where an underlying normal distribution is 
assumed for the liability of having the disease (Neale & Cardon 1992, pp.43–77 pp43-
77). Including the five different types of siblings made the model identifiable. We 
allowed for different prevalence of the outcome in the different sibling types, and 
adjusted the prevalence for gender and birth cohort.
First we compared the ACE, ADE and DCE models with the full ADCE model. Next, using 
likelihood ratio tests, submodels where the genetic parameter, shared environmental 
parameter, and both these parameters are dropped (AE, DE,CE, and E models), were 
tested to explain the observed data and pattern of variance using as few parameters as 
possible. For comparison purposes we calculated heritability among twins only using 
the tetrachoric correlations as well.
All calculations were done for ASD and AD separately. All tests of statistical hypothesis 
were done on the two-sided 5% level of significance. We used SAS software version 9.3 
and the R software version 2.15.2 Linux 64-bit (survival package for Cox regression with 
robust standard errors). For heritability analyses we used R software version 2.15.2 
Windows 32-bit (OpenMx package version 1.3.1-2179)(Boker et al. 2011) .
7.4 Results
Cohort characteristics are presented in Table 1. The cohort included 2,711,265 full 
sibling pairs, 442,408 maternal half sibling pairs, 455,219 paternal half sibling pairs and 
37,805 twins and 11,643,186 cousin pairs. We found 14,524 cases of ASD of which 
5,687 (39%) had a diagnosis of AD.
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Siblings Cousins DZ Twins MZ Twins
Subject pairs 2,711,265 442,408 455,219 11,643,186 29,424 8,381
Subjects 1,819,174 292,739 290,748 1,241,226 29,032 8,338
Boys (%) 51.4% 51.2% 51.1% 51.5% 51.0% 47.2%
ASD cases (%) 12,276 (0.67%) 2,981 (1.02%) 2,578 (0.89%) 8,073 (0.65%) 215 (0.74%) 41 (0.49%)
AD cases (%) 4,891 (0.27%) 1,037 (0.35%) 925 (0.32%) 3,021 (0.24%) 97 (0.33%) 21 (0.25%)
Maternal Psych. History (%)# 40,221 (2.21%) 18,724 (6.40%) 14,690 (5.05%) 25,180 (2.03%) 908 (3.13%) 196 (2.35%)
Paternal Psych. History (%)# 39,262 (2.16%) 15,909 (5.44%) 16,373 (5.63%) 23,778 (1.92%) 792 (2.73%) 200 (2.40%)
Birth Year,
Median (p5-p95) 1993 (1984-2005) 1993 (1983-2005) 1993 (1983-2005) 1993 (1984-2004) 1996 (1983-2005) 1994 (1982-2002)
Age at ASD diagnosis,
Median (p5-p95) 12 ( 4-22) 13 ( 4-22) 13 ( 4-23) 13 ( 4-22) 11 ( 4-21) 10 ( 4-25)
Person Years, 
Median (p5-p95) 14 ( 4-24) 11 ( 3-21) 10 ( 3-21) 15 ( 4-24) 13 ( 3-25) 14 ( 7-26)
ASD: Autism Spectrum Disorder; AD: Autistic Disorder (infantile autism); p5: 5th percentile, p95: 95th percentile. #: At birth of the child
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eTable 4 Number of births, ASD and AD cases and prevalences by year of birth
Birth Year Number of Births ASD Cases ASD Prevalence (%) AD Cases AD Prevalence (%)
82-86 321,206 1,961 0.61 448 0.14
87-91 503,960 4,377 0.87 1321 0.26
92-96 489,652 4,506 0.92 1790 0.37
97-01 389,999 2,606 0.67 1388 0.36
02-06 348,650 1,074 0.31 740 0.21
ASD: Autism Spectrum Disorder; AD: Autistic Disorder (infantile autism); p5: 5th percentile, p95: 95th percentile
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The ASD observed crude prevalence varied between 0.31% to 0.92% during the 5-year-
band birth cohorts 1982-2006 (eTable 4). For individuals with a sibling with ASD the 
cumulative probability of an ASD diagnosis at age 20 was estimated to 13% compared 
with 1.2% for individuals without an ASD sibling (figure 1).
Figure 1 Age-cumulative probabilities for ASD diagnosis in sibling with and without a 
sibling with an earlier ASD diagnosis. 95% two-sided point wise confidence 
bands for exposed siblings.
 
Dashed line: Cumulative probability of an autism diagnosis up to this age for siblings with a sibling 
proband with an autism diagnosis. Solid line: Cumulative probability of an autism diagnosis up to this age 
for siblings with a sibling proband free from an autism diagnosis.
7.4.1 Relative recurrence risk
Figure 2 presents relative recurrence risks for ASD and associated two-sided 95% 
confidence intervals for the different degrees of genetic distance between family 
relatives. The RR remained stable after adjustment for sex, parental psychiatric history 
and parental age. There was some support for confounding attributable to birth 
cohorts (figure 2, bottom panel).
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Figure 2 ASD recurrence risks for full and maternal (MH) and paternal (PH) half 
siblings, cousins and DZ twins. Point estimates and two-sided 95% confidence 
intervals. MZ twins not shown.
Footnote: Male-Female indicate risk in female exposed to a male relative. The MZ adjusted RR was 148.7 
(95% CI 57.5 - 384.9), outside the range of the figure. Adjusted: Models adjusting for birth cohort and 
sibling and proband sex and paternal and maternal psychiatric history at birth of the child and older 
maternal age (≤ 35, > 35) and older paternal age (≤ 40, > 40); MH: Maternal half siblings, PH: Paternal 
half siblings; Old Pa: Paternal age > 40; Yng Pa: Paternal age ≤ 40; Old Ma: Maternal age > 35; Yng Ma: 
Maternal age ≤ 35; Fa Psych; With a paternal psychiatric history; Fa Psych: With a paternal psychiatric 
history; With a maternal psychiatric history; Ma Psych: With a maternal psychiatric history.
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When adjusting for 5-year birth cohorts, sex of child and proband and parental and 
maternal psychiatric history the RR was 148.7 (95%CI 57.5 - 384.9) for monozygotic 
twins, 8.4 (95%CI 3.9 - 18.3) for dizygotic twins, 10.4 (95%CI9.5 - 11.4) for full siblings, 
3.3 (95%CI 2.6 - 4.2) for maternal half siblings,2.9 (95%CI 2.2 - 3.7) for paternal half 
siblings and 2.0 (95%CI 1.8 - 2.2) for cousins. For crude RR see eTable 3.
eTable 3 Crude (no adjustment for confounding) recurrence risk (RR) and two-
sided 95% confidence intervals
Family relation ASD AD
Pairs RR (95% CI) Pairs RR (95% CI)
MZ Twins 41 217.06 (85.22 - 552.86) 21 301.76 (57.87 - 1573.38)
DZ Twins 217 12.38 (5.65 - 27.12) 99 28.78 (8.75 - 94.64)
Full Siblings 17,961 14.35 (13.10 - 15.72) 7,273 24.18 (20.66 - 28.30)
Paternal Half Siblings 3,999 4.24 (3.26 - 5.51) 1,462 4.32 (2.17 - 8.63)
Maternal Half Siblings 4,446 4.98 (3.91 - 6.35) 1,573 7.60 (4.43 - 13.06)
Cousins 72,436 2.723 ( 2.45 - 3.025 ) 27,352 3.35 (2.65 - 4.24)
MZ: Monozygotic; DZ: Dizygotic; ASD: Autism Spectrum Disorder; AD: Autistic Disorder
RR for AD are presented in figure 3. The RR for AD had a generally higher magnitude 
compared with ASD but with lower prevalence. Adjusting for 5-year birth cohorts, sex 
of child and proband and parental and maternal psychiatric history the RR was 116.8 
(95%CI 16.7 - 814.2) for monozygotic twins, 17.0 (95%CI 5.2-55.4) for dizygotic twins, 
15.0 (95%CI 12.8-17.5) for full sibling 4.4 (95%CI 2.5-7.6) for maternal half siblings,2.9 
(95%CI 1.5-5.9) for paternal half siblings and2.3 (95%CI 1.8-2.9) for cousins.
While graphical inspection of the RR point estimates suggest a trend for higher RR in 
female-female sibling pairs there were no statistically significant differences in RR 
between males and females or by sex of the proband (figure 2, figure 3). The model 
goodness-of-fit supported the assumption of hazards being proportional over the time 
of follow-up.
128 (229)
Figure 3 AD recurrence risks for full and maternal (MH) and paternal (PH) half 
siblings, cousins and DZ twins. Point estimates and two-sided 95% 
confidence intervals. MZ twins not shown.
Footnote: Male-Female indicate risk in female exposed to a male relative. The MZ adjusted RR was 116.8 
(95% CI 16.7 - 814.2), outside the range of the figure. Adjusted: Models adjusting for birth cohort and 
sibling and proband sex and paternal and maternal psychiatric history at birth of the child and older 
maternal age (≤ 35, > 35) and older paternal age (≤ 40, > 40); MH: Maternal half siblings, PH: Paternal 
half siblings; Old Pa: Paternal age > 40; Yng Pa: Paternal age ≤ 40; Old Ma: Maternal age > 35; Yng Ma: 
Maternal age ≤ 35; Fa Psych; With a paternal psychiatric history; Fa Psych: With a paternal psychiatric 
history; With a maternal psychiatric history; Ma Psych: With a maternal psychiatric history
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7.4.2 Heritability
The unadjusted ASD tetrachoric correlation was estimated to 0.54 (SD=0.203) for MZ 
twins; 0.25 (SD=0.127) for DZ twins; 0.25 (SD=0.015) for full siblings; 0.11 (SD=0.039) 
for maternal half siblings and to 0.07 (SD=0.049) for paternal half siblings; (eTable1). 
For AD the tetrachoric correlation for full siblings was estimated to 0.27 (SD=0.025); for 
maternal half siblings to 0.13 (SD=0.079) and for paternal half siblings 0.14 (SD=0.078) 
while MZ and DZ twins did not allow estimation due to sample size (eTable2). The 
tetrachoric correlations adjusted for sex and birth cohort were almost identical 
(eTable1, eTable 2).
eTable 1 ASD. Tetrachoric correlations (SD)
Sibling
Relation




































































MZ: Monozygotic twins; DZ: Dizygotic twins; x: Not estimable (missing observation where both siblings 
are cases)
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eTable 2 AD. Tetrachoric correlations (SD)
Sibling
Relation














MZ x x x Not applicable
Not 
applicable x


























(0.142) 0.21 (0.148) 0.14 (0.080)
MZ: Monozygotic twins; DZ: Dizygotic twins; x: Not estimable (missing observation where both 
siblings are cases)
Since the full ACE and ADE models gave similar fits the ACE model was chosen as the 
full model under which nested sub-models were tested. Using likelihood ratio tests 
where models with fewer parameters were compared with the full ACE model the best 
fitting model was the AE model, that is, a model with only a genetic (heritability) and a 
non-shared environment component (Table 2). On the basis of the AE model the ASD 
heritability was estimated to h2 = 0.50 (95%CI 0.46-0.56) and the non-shared 
environmental influence was 0.50 (95%CI 0.44-0.55).
In the full ACE model, also including the shared environment, the variance associated 
with the shared environment was estimated to 0.04 (95%CI 0-0.15), non-shared 
environment to 0.54 (95%CI 0.44-0.66) and heritability to 0.42 (95%CI 0.19-0.55). Using 
twins only the heritability was estimated to 0.52.
For AD the AE model was the best fitting model as well (Table 2) and the AD heritability 
was estimated to h2 = 0.54 (95%CI 0.44-0.64).
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Table 2 ASD and AD Heritability. Model goodness of fit and variance component estimates.
Model #p -2 LL Diff -2 LL p-value
Variance components (95% Confidence Intervals)
a2 + d2
a2 (heritability) d2 c2 e2
ASD - Autism Spectrum Disorder
ADCE 14 143,909.8 NA NA 0.33 (0.00-0.55) 0.16 (0.00-0.59) 0.05 (0.00-0.17) 0.46 (0.24-0.65) 0.49 (0.21-0.75)
ACE 13 143,910.4 0.7 0.415 0.42 (0.19-0.55) x 0.04 (0.00-0.15) 0.54 (0.45-0.66) 0.42 (0.19-0.55)
ADE 13 143,910.53 0.8 0.382 0.44 (0.24-0.55) 0.13 (0.00-0.51) x 0.43 (0.23-0.55) 0.57 (0.45-0.77)
DCE 13 143,912.8 3.0 0.082 x 0.45 (0.18-0.71) 0.14 (0.07-0.20) 0.41 (0.21-0.62) 0.45 (0.18-0.71)
AE 12 143,911.0 1.2 0.550 0.50 (0.45-0.56) x x 0.50 (0.44-0.55) 0.50 (0.45-0.56)
DE 12 143,933.6 23.8 0.000 x 1.00 (1.00-1.00) x 0.00 (0.00-0.00) 1.00 (1.00-1.00)
CE 12 143,923.1 13.3 0.001 x x 0.24 (0.21-0.26) 0.76 (0.73-0.79) x
E 11 144,178.5 268.8 0.000 x x x 1.00 (1.00-1.00) x
AD - Autistic Disorder
ADCE 14 64,586.2 x x 0.49 (0.00-0.64) 0.00 (0.00-0.61) 0.02 (0.00-0.24) 0.48 (0.18-0.72) 0.49 (0.04-0.82)
ACE 13 64,586.2 0.0 0.992 0.49 (0.04-0.64) x 0.03 (0.00-0.24) 0.48 (0.36-0.72) 0.49 (0.04-0.64)
ADE 13 64,586.3 0.1 0.807 0.54 (0.25-0.64) 0.00 (0.00-0.54) x 0.46 (0.17-0.56) 0.54 (0.44-0.83)
DCE 13 64,590.7 4.5 0.034 x 0.65 (0.00-0.84) 0.11 (0.04-0.30) 0.23 (0.10-0.79) 0.65 (0.00-0.84)
AE 12 64,586.3 0.1 0.971 0.54 (0.44-0.64) x x 0.46 (0.36-0.55) 0.54 (0.44-0.64)
DE 12 64,645.6 59.4 0.000 x 1.00 (1.00-1.00) x 0.00 (0.00-0.00) 1.00 (1.00-1.00)
CE 12 64,590.9 4.7 0.096 x x 0.26 (0.21-0.31) 0.74 (0.69-0.79) x
E 11 64,682.9 96.8 0.000 x x x 1.00 (1.00-1.00) x
#p: Number of parameters in the model; -2 LL: -2 * log-likelihood; Diff df: Number of degrees of freedom for the -2 LL (difference in number of parameters between the model and the ADCE model); 
Diff -2 LL: 2 * difference in log-likelihood between the model and the ADCE model; p-value: p-value for the testing the hypothesis the parameters not in the model but in the ADCE model are all equal 
to zero; a2: Additive genetic; d2: Dominant genetic; c2: Shared environment; d2: Non-shared environment; a2 + d2: "Broad-sense heritability" including both the additive and the dominant genetic 
components. x: Not applicable. Note: All models adjusted for gender and birth cohort.
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7.5 Discussion
To the best of our knowledge this is the largest population based longitudinal study 
evaluating familial risk and heritability of ASD. Studying more than 2 million Swedish 
families documented the familial aggregation of ASD across the range of genetic 
relations to a proband showing increased relative risk with increasing genetic 
relatedness. Using the family data we found evidence for similar importance for genetic 
and environmental influences on liability for ASD. The results were similar for ASD and 
AD.
Heritability of ASD was estimated to 50%, suggesting that genetic factors explain half of 
the liability for autism. 50% of the liability for ASD was related to unique environmental 
factors. i.e. to experiences that are different between members of the same family. 
These results should be replicated in other populations, yet they provide strong 
evidence for an equal role for environmental and genetic factors in the etiology of ASD.
This estimate of heritability is considerably lower than the 90% in earlier twin studies 
(Bailey et al. 1995; Susan Folstein & Rutter 1977; Steffenburg et al. 1989) and closer to 
that of a recent California twin study which estimated that the heritability of ASD was 
38%(Hallmayer et al. 2011) . The heritability estimate can also be compared with a 
Swedish twin cohort (Ronald et al. 2011) of more than 12,000 children where 
heritability of between 49% and 72% was reported for autistic-like traits (social 
impairment, communication impairment and restricted and repetitive behavior and 
interests). 
Earlier twin studies documented only minimal non-shared environmental contribution 
to liability to ASD. The California twin study, in contrast, suggested substantial shared 
environmental influences, i.e. to experiences that are common between members of 
the same family. The large family data in our study indicated that such influences have 
only a negligible effect on ASD etiology. Dizygotic twins and full siblings (both having 
50% genetic similarity, but dizygotic twins assumed to have more shared maternal 
prenatal environment), and maternal half siblings and paternal half siblings (both 
having 25% genetic similarity, but maternal half siblings assumed to have more shared 
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maternal prenatal environment) had comparable risks for ASD. In the presence of a 
familial confounding, factors effecting all members of a family, the RR is expected to be 
lower for the dizygotic twin compared with full siblings and for the maternal half-
siblings compared with the paternal half-siblings. The RR can also be compared with 
the RR for schizophrenia, a neurodevelopmental disorder with earlier overlap in 
diagnosis and with shared clinical an etiological features (Stone & Iguchi 2011). In a 
sample overlapping with the parents and grandparents of our study the RR was 
estimated to 8.5 for full siblings, 2.5 for half siblings and 2.3 for cousins (Lichtenstein, 
Björk, et al. 2006).
The differences in results between the present study and earlier research may in part 
be attributed to differences in sampling, case ascertainment and analytic approach. 
The present study used a true population based sample, continuously following up 
participants since birth and previously validated clinical diagnosis of ASD done by 
expert clinicians. Previous twin studies relied on considerably less robust 
methodologies for case ascertainment, including self-referral, service registers, and 
parental reports on diagnosis. Even when detailed diagnostic assessment was done the 
participation rates were low and it could not be ruled out that participation was 
associated with presence of an autistic child in the family (Bailey et al. 1995), limiting 
generalizability. We adjusted for birth cohorts, trying to address potential biases due to 
differences in length of follow-up with study subjects in different birth years (Lindström 
et al. 2006). It is unclear how this was addressed and effected previous studies. We 
believe the effect of such a bias could inflate the shared environment component.
Factors potentially effecting the variance for non-shared environment includes a 
misclassification of cases. This could further be supported with possible, but unknown, 
differences in etiology across the different forms and symptoms of ASD symptoms. Our 
data do not support this though as our results for the liability of ASD and AD were 
essentially the same.
The relative recurrence risk between different pairs of family members reflects the 
genetic influences on the trait and offers a quantitative and practical measure of 
familial risk. Thus, the relative recurrence risk has an important application which 
distinguishes it from the more theoretical measures of heritability. For example while 
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genetic factors account for 50% of individual differences in liability to ASD, a sibling of a 
proband with ASD who shares 50% of the genes has a 10-fold increase in risk. This can 
potentially be applied at an individual level for family counseling.
Only few earlier studies have had the possibility to calculate the relative recurrence risk 
(Grønborg et al. 2013; Ritvo et al. 1989; Constantino et al. 2013). Two studies are 
presenting self-selected samples (Constantino et al. 2013; Ritvo et al. 1989) and with 
limited family data. A recent Danish study provide reliable estimates using an excellent 
epidemiological sample similar to ours. They show lower RR, RR=7.5 for full siblings but 
with similar relative relation between full siblings and maternal and paternal half-
siblings. Our sample include twice as many cases of ASD and more detailed family data 
including monozygotic and dizygotic twins and cousins. Our bigger sample also allowed 
us to investigate sex of offspring in some more detail. Several earlier studies have 
reported absolute sibling recurrence risk (Ritvo et al. 1989; Szatmari et al. 1998; Bolton 
et al. 1994; Chudley et al. 1998; Sumi et al. 2006; Constantino et al. 2010; Ozonoff et al. 
2011) but absolute risk is a cumulative measure which depends on the length of follow 
up (higher at age 15 than at age 5) and will differ between populations. As elsewhere in 
epidemiology, where the relative risk is a preferred measure of disease risk, the relative 
recurrence risk circumvent these limitations.
This study has multiple strengths including the large, prospective, full-nation 
population-based sample and a health system with equal access. In addition to sibling 
pairs we were also able to include cousins and twins including zygosity information and 
to adjust for parental psychiatric history. To estimate the RR we used time-to-event 
methods to avoid introduction of bias due to differences in follow-up time for different 
subjects. The methods of analyzing risk between siblings will also adjust for potential 
bias due to changes in prevalence of autism in later years where later born siblings may 
be expected to have a higher risk of being diagnosed.
The same underlying population was used to estimate the recurrence risk and 
heritability. We are using a prospective cohort approach for the sampling and following 
all subjects from birth and onwards using clinical registers. By utilizing this approach we 
are avoiding potential and unpredictable selection-biases due to disease status or 
factors such as parental education. Using the registers we are also avoiding problems 
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associated with self-reports and retrospective collection of data. We included birth 
year in the statistical models estimating heritability to avoid biases due to differences in 
length of follow-up and due to confounding by temporal trend.
The study has some limitations. We did not have information on parental education or 
socioeconomic status. In Sweden there is equal access to health services and they are 
free of charge. Any potential bias is therefore likely to be small. We also did not have 
information on level of intellectual disability in ASD. This may be studied separately in 
future studies. There is a well documented gender bias in autism (Fombonne 2005), 
and it has been suggested that females may require greater familial etiologic load to 
manifest the autistic phenotype (Robinson et al. 2013). We did not find strong support 
for any sex specific differences in the relative recurrence risk. This effect might be 
small, and therefore require even greater samples to be reliably documented. The most 
important confounder was birth year. The RR was slightly increased over the last few 
birth cohorts (figure 2, figure 3). This could probably be explained by the increase in 
prevalence in the later years. Relatives born closer in time have a more similar base 
probability for ASD than relatives born distal in time. Due to power limitations the 
adjustment for birth year was only possible by assuming a strict linear relation for the 
MZ twins while these estimates may be slightly more biased.
7.6 Conclusion 
The results of this study show equal importance for genetic and environmental 
influences on the risk of ASD. These results challenge current etiological models of ASD, 
which weights towards greater influence of genetic factors. This study can also have 
clinical implications: The risk information for twins, siblings and cousins should be 
considered when counseling families with affected children.
Future efforts to identify environmental risk factors should be considered at least as 
important, if not more important than, finding candidate genes for ASD because 
environmental factors represent potential modifiable risks more amenable to 
prevention or intervention strategies at the population and individual levels.
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8 General discussion
This section will summarize and integrated the finding from the studies presented in 
sections 4-7.
8.1 Summary of results
The aetiology of autism remains largely unknown. There is consistent support for 
substantial genetic contribution to the aetiology, but there is also evidence that non-
heritable factors play a significant role. Evidence that support the role of environmental 
factors in the aetiology of autism is, however, not consistent, and has been 
passionately debated.
As one important environmental risk factor, this thesis examined the role of maternal 
age at birth of the offspring by characterizing potential pathways through which the 
risk may be operating.
A meta-analysis examined the hypothesis that older maternal age is a risk factor for 
autism and demonstrated that maternal age >35 years is associated with a small to 
moderate increase in risk for autism. There was evidence for a dose-response 
relationship with older maternal age associated with increasing risk.
I also examined the hypothesis that maternal age affect the risk of autism using data 
from the International Collaboration for Autism Registry Epidemiology (iCARE). The 
association between maternal age, paternal age and autism was examined in detail 
using advanced statistical and visualization methods. iCARE combines population-based 
data from 5 countries: Australia, Denmark, Finland, Israel, Norway and Sweden, 
allowing highly powered studies of perinatal risk factors for autism.
More than 5 million births and 30,000 ASD cases were examined. The marginal effect 
of paternal and maternal age were similarly associated with ASD and with the more 
severe form AD. The marginal paternal age risk was more pronounced for AD. The 
association was verified across several heterogeneous countries and health systems. 
There was also evidence for a risk pattern consistent with possible assortative mating. 
Couples with higher differences between paternal and maternal age; 'old dad – young 
mom' as well as 'old mom – young dad' had higher risk for ASD in the offspring. 
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In the earlier meta-analysis we did not find any support for an increased risk with 
younger maternal age. If anything, the data supported a lower relative risk with 
younger maternal age. Of the studies contributing with relative risk estimates for 
mothers < 20 only 2 showed point estimates higher than one, none of them statistically 
significant. 8 studies showed point estimates of relative risk less than one of which 
three were statistically significant. A potential explanation is differences in the 
adjustment for confounding. Most of the studies selected for the meta-analysis adjust 
'better' for potential confounding than we had the ability to do. Examples of such 
confounders include socio-economic status, ethnicity and prenatal characteristics. As a 
comment, without further information it is however not clear if it is a good idea to 
include a covariate such as socio-economic economic status in the regression models. 
For instance, if socio-economic status is caused by maternal age and caused by 
diagnosis of disease or if socio-economic status is the cause of maternal age and, at the 
same time, there is an (unmeasured) variable confounding disease risk and socio-
economic status then including a covariate for socio-economic status may instead 
introduce bias.
Another potential explanation for the difference between the meta-analysis and the 
full cohort approach in study II is the differences in categorization of the maternal age 
data. In the ICARE analysis we used maternal age 20-29 years as the reference. In the 
meta-analysis the analyzes were performed using ages 25-29 as reference category 
which may end up in a slightly lower relative risk. Another possible bias arises from 
using categories of age when the actual age distribution is different than the median in 
different age intervals. We do not know if the median age in the category < 20 is almost 
20 or closer to 16 which may change the estimate slightly
Next I examined a potential source underlying the maternal age-autism association. 
Using national Swedish registers containing all births and containing information on in-
vitro fertilization (IVF) I examined the possibility that the maternal age effect in autism 
is due to in-vitro fertilization (IVF). Overall there was no association between IVF and 
autism. When, in the first study ever, the range of different IVF treatments were 
examined, there was evidence for an association between treatments related to male 
infertility and intellectual disability and, for the treatment associated with the most 
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profound form of male infertility, with risk for autism.
Our study show that in terms of attributable risk IVF treatment can not explain the rise 
in autism and neurodevelopmental diseases among children and adolescents in the last 
10 to 20 years. It does however show increased risk for mental retardation generally 
and for autism for the rare treatment used for the most profound condition of male 
infertility.
Lastly, while maternal age can be seen as an environmental risk factor, it can also be 
viewed as a factor mediating or carrying genetic risk. To better understand the balance 
between environmental and genetic factors I examined the importance of genetic 
versus environmental factors in the aetiology of ASD more generally. Using a multi-
generational cohort of more than 2 million individuals born in Sweden I studied familial 
clustering of autism. Relative recurrence risk was estimated in twins (mono- and di-
zygotic), siblings, half siblings and cousins. Heritability was then modelled using the 
extended family-based information.
All classes of biological relatives of probands with ASD had increased risk for ASD. 
Estimated heritability for ASD was 50%. Thus, although genetic factors play an 
important role in the aetiology of ASD, they are of substantially lower magnitude than 
previously estimated. 50% of the liability for ASD was related to unique environmental 
factors. i.e., to experiences that are different between members of the same family. 
Therefore, this study provides the most convincing evidence to-date for an important 
role environmental factors in the aetiology of ASD.
Different cases of autism may reflect differences in the underlying (genetic) aetiology 
and these could be of importance. First, families with only one effected family member 
(simplex families) versus families with several members effected by autism or autism-
like conditions (multiplex families) can hint at differences in the underlying genetic 
mechanism. It has been shown that cases from simplex families on the average have a 
higher load of mutations occurring de-novo (single rare mutations or copy-number-
variants) while members in multiplex families may share directly inherited genetic 
variants. In the conduct of study IV we included a potentially confounding covariate 
indicating presence or absence of a psychiatric history at the time of birth. Including 
this covariate did not change the estimates of relative risk, which suggests that the 
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genes causing psychiatric outcomes in the parents are different than the genes in the 
offspring.
Secondly, when genetically tested cases of autism can sometimes be shown to overlap 
with other diseases of a known genetic cause and with an overlap in phenotypic 
expression. A few examples among many of such diseases or conditions include 
Angelman syndrome and Prader-Willy syndrome, Fragile X syndrome , Rett's syndrome 
and Tuberous sclerosis. These are frequently labelled as "non-syndromic" cases, 
compared with cases where autism is the primary diagnosis. While technically and 
economically challenging only a few years ago genetic testing of such diseases are 
becoming practically feasible. These cases can also have a different aetiology. In the 
study III, while most likely severely under diagnosed, we searched the registers also for 
ICD codes associated with such diseases and found 366 of the 2,5 million children 
included in the study, 48 of these among the 6,959 children with autistic disorder. 
These proportions are not likely to have introduced any substantial bias in our results.
8.2 Strength and limitations
8.2.1 Strength
The research presented in this thesis has many strengths. We have utilized 
epidemiological samples with multiple advantageous properties. First, perhaps most 
obvious, our studies all have unparalleled sample size, in terms of number of children 
as well as years of follow-up. The sample size allowed us to perform statistical 
comparisons with high precision compared with previous studies; in particular for small 
sub-groups such as high maternal and paternal age combinations or male and female 
offspring.
However, the sample size alone is not sufficient if the sampling mechanism and 
underlying sampling frame do not represent a valid dataset, but this is also among our 
strengths. The individuals examined include complete national birth cohorts. We 
included all children born across multiple birth years avoid potential selection bias. 
Third, when following the children for clinical diagnosis of autism and other health 
outcomes we have used national registers containing detailed clinical diagnostic 
information on all individuals in the population, children as well as parents and other 
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relatives. Where most of the previous studies have not been able to address the full 
spectrum of autism diagnosis we have analysed the narrow diagnosis, AD, as well as 
the diagnosis containing the wider spectrum, ASD, separately. The countries 
contributing data to our analyses have publicly financed, publicly available, and equally 
accessed health systems. In the Nordic countries there is no private psychiatric care. 
These qualities has made it possible to follow individuals longitudinally and 
prospectively and with minimum of selection biases, possibly present in other studies.
Fourth, the national registers contain detailed information on individual characteristics 
important in our analyses. The data is usually collected for reasons independent of 
both the exposure variables (maternal age) and the outcome variables (diagnosis of a 
neurodevelopmental disorder). The information includes confounders such as birth 
year, attained age of the spouse, maternal and paternal psychiatric history at the 
offspring birth, pre- and perinatal birth characteristics and administrative data on 
family relations or vital statistics. This has allowed us to perform our analyses with 
detailed adjustment for possible confounders.
Fifth, the longitudinal nature of the data also allowed us to adjust for temporal trends 
and other changes over time. For instance, we have utilized data on emigration and 
death (of parent or child) to censor individuals which otherwise would falsely 
contribute with risk time to the analyses and introduce biases.
Access to the Swedish Multi Generation Register has also allowed us to perform 
calculation of family clustering of ASD using a bigger sample than any earlier study and 
with a more detailed family data than previously used.
We have utilized appropriate modern statistical methods. These include the use of 
survival analysis to utilize the differences in length of follow-up, splines to examine the 
functional form of continuous variables, robust errors to address correlations in the 
data, alternative estimation techniques to relax assumptions of data from certain 
parametric distributions and graphical techniques. Statistical methods are however not 
an independent component in epidemiological research but a bidirectional process: 
good data supports the use of advanced statistical methods, and knowledge of 
statistical methods is key when deciding what data to use.
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For example, the properties described above, allowed us to address sex differences 
across all our comparisons; calculated heritability and relative recurrence risk using the 
most complex family structures including full siblings, maternal- and paternal half 
siblings and cousins defined from the same siblings; the relative recurrence risk has 
been described for a boy exposing boy or girl and also in the opposite direction. For the 
study of assisted reproduction treatment as a risk factor for autism we produced the 
most detailed study, up to this date, in terms of fertility treatments; longest in follow-
up, most flexible in allowing and exploring the functional form and the use of 
informative comparison groups.
We have relied on Swedish data for two of our studies, the IVF study and the study on 
family risk. As a contrast to the national Swedish data, the ICARE data allowed 
comparison of results across a wide range of different health systems increasing the 
generalizability of the results.
Meta-analysis is most advantageous when there is heterogeneity across studies. It is 
however not always possible to utilize this feature. Here we managed to first identify 
confounding covariates measured on a study level and then to utilize this information 
in a meta regression where some of the variation between studies could be attributed 
to differences in the confounding covariates.
A common problem in any statistical analysis is the presence of missing data and drop-
outs. However, our data are primarily register based and contain very little missing 
data. Where there has been drop-outs we have met this potential problem in the 
choice of statistical methods by censoring individuals from follow-up.
8.2.2 Limitations
The presented studies do have some limitations. The data sources we used included 
information on clinical ICD-10 diagnosis but were lacking the complete underlying 
clinical picture. We did not have any clinical assessments of traits or clinical symptoms 
of ASD. One such example is heritability calculations. We can not rule out 
measurement error problems with possible lack of specificity for the underlying liability 
which may bias the heritability downwards. However, this would most likely affect 
other studies similarly. Any diagnostic system, such as ICD, has limitations. For example, 
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while there are codes for autism and codes for intellectual disability there is no code 
that separate autism with and without intellectual disability.
We did not have access to socio-economic data which can be a possible source for 
confounding. Even though the register data we used come from health systems with 
equal access, one can not entirely rule out that there are differences in ascertainment 
by level of education, income and geographic areas.
A third set of limitations are the restrictions that come with non-experimental data. 
Where humans prefer partners and mating with partners of roughly the same age, an 
optimal design for the study of parental age would select partners for mating 
randomly. We tried to address this analytically by sub-dividing data to break 
dependencies and by considering the maternal and paternal age as a bivariate process.
8.3 Integration of findings and earlier research
The results and conclusions of this thesis add on to earlier research in several 
important ways.
Maternal age - iCARE study and meta-analysis
There has been considerable attention to the potential role of maternal age as a risk 
factor for ASD, but with conflicting results. We summarized and integrated this 
information in a systematic way. First, in a meta-analysis we combined already 
published studies and showed an overall statistically significantly increased risk by 
advancing maternal age; RR=1.3 (95% CI: 1.2-1.4) for mothers >=35 compared with 
mothers 25-29. While less strong and outside the primary focus of our investigations, 
the meta-analysis also indicated a reduced risk among younger women, RR=0.8 (95% 
CI: 0.6-1.0). In addition to providing strong support for a general role of maternal age in 
the risk of autism the study also suggested a factor possibly modifying the risk; 
offspring sex. Studies with higher proportion boy offspring showed slightly elevated risk 
by advancing maternal age. When addressing this question in the detailed analyses 
using the multinational ICARE cohort the modifying effect of offspring sex was nullified.
In the multinational cohort based study we verified the overall message from earlier 
studies. Compared with some individual studies, as often the case when combining 
several data sources, our analysis included less detailed data for confounding 
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compared with other studies (Hultman et al. 2011; Grether et al. 2009; Larsson et al. 
2005). We did however manage to address issues not resolved elsewhere.
First, using splines, the detailed functional form of maternal age vs autism risk showed 
increased risk for all contributing sites, less pronounced in Norway and Australia, both 
using service registers.
Secondly, in any study looking at human parental age the maternal and paternal age 
will be closely related. The high power of the ICARE cohort allowed us to separate 
these two factors better than previously done by analysing parental age in subgroups 
of the spouse. This again verified the risk associated with advancing maternal age.
Analysing maternal and paternal age jointly has been done earlier by considering 
parental age categorically (Parner et al. 2012) There, having two parents of advanced 
age did not increase the risk beyond having only one parent of advanced age. For this 
reason they concluded that spontaneous genomic alternation is not the main 
mechanism through which parental age impacts ASD. We examined maternal and 
paternal age continuously and jointly using thin-plate splines in an approach never 
used before for this question. We showed that the risk of autistic offspring increases 
both with increasing age, highest when having both an old father and an old mother, 
and with increasing differences in age, in all directions, between the mother and father 
(Study II, figure 3).
Our results agree with what is expected following assortative mating (Merikangas 
1982) where individuals with a similar trait (phenotype) and associated genotype mate 
to a higher degree than expected, or, following secondary assortative mating between 
the trait and another, opposite trait. In the review from 1982 Merikangas described 
and reviewed several studies involving effects of assortative mating on psychological 
traits and psychiatric illness (Merikangas 1982).
A few other examples are worth mentioning. Assortative mating has previously been 
shown for schizophrenia where offspring to schizophrenic parents have an increased 
risk of developing schizophrenia themselves (Parnas 1985) .
A recent paper, including twins, their siblings and their parents, examined the 
correlation between height and IQ and if the observed correlation is due to genetic 
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correlations from genes that affect both traits, pleiotropy, or if it can be explained by 
assortative mating. It concluded that both pleiotropy and assortative mating contribute 
significantly and about equally to the genetic correlation (Keller et al. 2013).
In a large British study increasing husband-wife height difference was associated with 
abnormal pregnancy outcomes (Mascie-Taylor & Boldsen 1988). This phenomena has 
also been observed in animal models testing the effects of mutual mate preferences on 
reproductive success. Female and male house mice who tested individually and mated 
with preferred partners had higher reproductive success and better progeny 
performance than individuals mated with non-preferred partners (Drickamer et al. 
2003). Assortative mating have also been documented among parents of extremely 
obese children and adolescents (Hebebrand et al. 2000).
The observed pattern of increasing risk for autism in offspring with a higher degree of 
dissimilarity in parental age may also be influenced by socio-economic factors. In a US 
twin sample the negative correlation between paternal age and different tests scoring 
for IQ in children turned the effect of paternal age statistically insignificant for most 
developmental measures once family characteristics in general and mother's education 
in particular were controlled for (Edwards & Roff 2010) .
IVF treatment
Treatments of In-vitro fertilization (IVF) have increased rapidly since first introduced in 
1978. IVF is associated with increasing parental age in both the mother and father. In 
parallel with the increase of IVF the age of parenting has increased as well (Bray et al. 
2006; Kirmeyer & Hamilton 2011). Since both these factors have been associated with 
autism it was important to study the role of IVF in autism. While the risk associated 
with IVF is not limited to neurodevelopmental disorders these are usually presented at 
an earlier age than for instance cancer and cardiovascular diseases.
As a complement to the original IVF treatment for female fertility problems, the intra-
cytoplasmic sperm injection (ICSI) was introduced in 1992 for treatment of male 
infertility problems. The techniques have since evolved further. A standard procedures 
involve freezing of embryo as an addition to the transfer of fresh embryos.
While the focus of our research has been on autism in this study we also included 
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intellectual disability (ID). With the overlap in phenotype and genotype between these 
two conditions (Betancur 2011) including ID boosted the power of the study which is 
especially important here. It also helps when addressing different aspects of 
neurodevelopment by contrasting the more social aspects associated with autism with 
the intellectual dimension of ID.
A possible mechanism linking IVF and neurodevelopmental disorders is epigenetic 
modifications (Schanen 2006; Dada et al. 2012). Epigenetic processes have been 
associated with Rett's (Robertson & Wolffe 2000) and Angelman's syndromes (Mann & 
Bartolomei 1999) , disorders characterized by autistic-like features in some cases. 
Experiments in mice have suggested that some of the steps involved in IVF might be 
related to epigenetic defects (Paoloni-Giacobino & Chaillet 2004; De Rycke et al. 2002). 
Mammal embryos cultured in-vitro are also susceptible to imprinting control (De Rycke 
et al. 2002). The risk of epigenetic changes may be modified the longer an embryo 
spends in culture. Although blastocyst transfer is rare and also involves sperm 
selection, it offers an indirect test of this hypothesis.
It is well established that that IVF treatment increases the risk for pre-term birth and 
congenital malformations (Källén et al. 2010) and several studies examined the role of 
IVF in autism and intellectual disability.
Already in 1998 the first study on ICSI and mental development was published (Bowen 
et al. 1998b). The study only included 89 ICSI, 84 IVF, and 80 spontaneously conceived 
children and followed them only up to the age of one. Using IQ scales they presented 
statistically significantly increased risk for delayed mental development before age one. 
Essentially the same study was repeated a few years later following-up the same 
cohort. Now, concluding no increased risk for delayed mental development, following 
the children up to the age of 5 (Leslie et al. 2003). A study of children born 1982-1995 
in Swedish IVF clinics that used retrospective outcome data from habitation clinics 
following the children up to 14 years of age showed increased risk of developmental 
delay among all children, but not when restricting to singletons. Pinborg studied the 
risk for AD and ID in 3,393 twins and 5,130 singletons following IVF/ICSI treatment and 
20,239 spontaneous twins born in Denmark 1995-2000 with age at follow-up 2-7 years. 
They did not detect any risk for ID or AD (Pinborg et al. 2004).
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There are several limitations to studies done prior to the one included in this thesis. 
Instead of using solid epidemiological samples most studies are under-powered, using 
small clinically ascertained samples with a short follow-up and lack of adjustment for 
possible confounding factors. Instead of analysing specific treatments for infertility they 
are evaluating IVF generally versus spontaneously conceived children. While this is an 
appropriate approach from a public health perspective this is not necessarily the 
"correct" comparison for evaluating the risk associated with IVF. This was pointed out 
in study involving a random sample of children born in Great Britain 2000 to 2002, 
singletons and twins. This study found effect of IVF/ICSI on cognitive development 
compared with the general population, but not when comparing with a control group 
resembling the group found in infertility clinics (Carson et al. 2010).
My study examining the association between IVF treatments and AD and ID aimed to 
overcome the shortcomings in these earlier studies. We included the biggest sample of 
children following IVF treatment and controls. We used prospective data and longer 
follow-up than done in previous studies. We included a detailed adjustment for 
confounding, and, adjusted properly for differences in length of follow-up for different 
children. Finally, and perhaps most important, where most earlier studies compared 
children born following IVF and spontaneously conceived children we included detailed 
treatment information sub-dividing and comparing the treatments in six different 
groups; Standard IVF (the original IVF treatment from 1978) using fresh or frozen 
embryo, ICSI using fresh and frozen embryo and ICSI using fresh and frozen embryo but 
following surgery to extract sperms.
We found only one earlier study that compared with the one in the thesis: a cohort 
study of autistic spectrum disorder from 2011 that also included detailed control for 
confounding but only 9 years of follow-up, a sample size one-fourth of ours, and no 
information on specific procedures (Hvidtjørn et al. 2011).
Familial risk and heritability
First, we showed that genetic and non-genetic, environmental risk factors are equally 
important in ASD aetiology. We also showed that the environmental component is 
exclusively of non-shared origin. This is in some contrast to previous research. Autism is 
considered one of the most heritable of all psychiatric disorders. There is however 
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considerable variation among the studies investigating this. Earlier twin studies (Bailey 
et al. 1995; S Folstein & Rutter 1977; Steffenburg et al. 1989; Lichtenstein et al. 2010; 
Ronald et al. 2006), have estimated the heritability, measuring how much of the 
liability for autism is attributed to underlying genetic factors, to more than 90%. These 
first studies were based on twins only, were conspicuously small, and based on 
clinically based samples. The high heritability of autistic traits, close to 80%, was again 
shown in a population based UK twin sample of 3,500 twins (Ronald et al. 2006) . A 
major Swedish twin-study with more than 10,000 twins (Lichtenstein et al. 2010) 
reported 80% with no shared environment. In contrast, a California twin-study of 
showed different results with only 38% heritability and a support for considerable 
influences of shared environment (Hallmayer et al. 2011).
Our study on autism familial risk overcame several of the problems in these earlier 
studies by including more detailed family relations, bigger sample size and longer time 
for follow-up. The more detailed family structures utilized here allowed us to use a 
statistical model capable of better separating the different genetic and environmental 
components. Other influences on the estimates are more difficult to overcome. For 
instance, it can not be ruled out that twins are being diagnosed in pairs instead of 
independently of each other which may inflate the genetic contribution by imposing a 
false correlation between the twins. A factor acting in the other direction is the 
influence of measurement errors. A trait measured with high variation will inflate the 
environmental component.
For families with autistic children as well as for the purpose of family counselling there 
is need for more individualized measures applicable to specific family circumstances in 
terms of understanding familial risk. For this purpose we calculated relative risks 
associated with different family-member exposures. This included one relative risk 
having a full sibling with autism, and another relative risk having a maternal full sibling 
with autism. Earlier studies have mostly calculated the absolute risk for offspring 
autism conditioned on autism among other family members (Ritvo et al. 1989; 
Szatmari et al. 1998; Bolton et al. 1994; Chudley et al. 1998; Sumi et al. 2006; 
Constantino et al. 2010; Ozonoff et al. 2011) but this is a very complicated procedure 
that involves several potential obstacles. The absolute risk, i.e. the prevalence, for 
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autism depends on the age and birth year of the child and varies between different 
geographical areas which makes different recurrence risk estimates difficult to 
compare. The relative recurrence risk of autism was proportional to the average 
amount of shared genes of the family members which also supports the genetic 
aetiology of autism. Besides our study we only found one similar study that calculated 
relative recurrence risk, a study from Denmark published August 2013 (Grønborg et al. 
2013) . The Danish study is using a similar data sample as in our study but a smaller 
sample size and less detailed family relations. The study from Denmark report RR 
slightly lower than we do, RRfull-sib=7.5 compared with our RRfull-sib=10.4 and RRmaternal-half-
sib=2.4 compared with our RRmaternal-half-sib=3.3 and RRpaternal-half-sib=1.5 compared with our 
RRpaternal-half-sib=2.9. As maternal half-siblings share mother-specific exposure during 
pregnancy the higher risk for maternal half-siblings compared with paternal half-
siblings indicates that environment exposure specific for maternal pregnancy may be of 
some importance.
The adjustment due to confounding were mainly explained by birth cohort effects. 
Additional adjustment only effected our estimates slightly. The Danish study was close 
to identical with and without adjustment for confounding.
How can a condition be “genetic” but not always run in the family? Psychiatric history 
in the family has previously been associated with an increased risk of autism (Sullivan 
et al. 2012; Jokiranta et al. 2013). As parental age and/or parental psychiatric history 
can be argued to be on a familial path related to the underlying causes of autism we 
fitted models both with and without these covariates included. When adjusting for 
parental psychiatric history the relative recurrence risk remained essentially 
unchanged. This suggest low penetrance or different genetic causes underlying the 
parental (family) psychiatric history than underlying the risk of autism in the children 
that control the recurrence risk under study. Yet another explanation is that many 
cases are caused by new mutations, mutations that arise in the germ-line of the 
parents; de-novo.
Our results can also be compared with the RR for schizophrenia, a neurodevelopmental 
disorder with earlier overlap in diagnosis and with some shared clinical and aetiological 
features(Stone & Iguchi 2011). In a sample overlapping with the parents and 
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grandparents of our study the full sibling schizophrenia RR was estimated to 
8.5(Lichtenstein, Björk, et al. 2006) , 2.5 between half siblings and 2.3 between cousins. 
Estimates slightly lower than ours but still higher than the estimates from the Danish 
study.
The study of family clustering can also be approached from the perspective of the 
change in prevalence over time. The fast increase in autism prevalence for children 
born during the 1990s is not accompanied by a similar increase in relative recurrence 
risk. Only for children born after the year 2002 the relative recurrence risk show any 
increase compared with other birth cohorts (Study IV, figure 1 & figure 2). In other 
words, irrespective if the cause is genetic or comes from the environment the risk 
factors behind the familial risk between siblings have not changed over time. 
Alternatively, the changes act multiplicatively and are therefore not influencing the 
relative recurrence risk. This pattern was similar in the Danish study.
Potential biological mechanisms for the association between advancing maternal  
age and autism
One possible explanation for the maternal age effect is an increased occurrence of 
genomic alterations. Numerous neurological and psychiatric disorders have been 
related to genomic alterations (Reichenberg et al. 2009). Maternal age is an important 
factor in the aetiology of chromosome anomalies (Ginsburg et al. 2000; Martin 2008) 
and genomic modifications (Kaytor et al. 1997; Orr & Zoghbi 2007). Interestingly, a 
number of studies have uncovered an increased prevalence of de-novo copy-number 
variants (CNVs), and other forms of genomic alterations, in autistic children (Christian 
et al. 2008; Marshall et al. 2008; Sebat et al. 2007), supporting the notion that novel 
mutational events may be important in the pathogenesis of autism. Mutation can 
happen in the germline or somatic cells. Whether these events are also related to 
advancing maternal age remains to be determined.
An alternative explanation is that epigenetic dysfunction underlies some parental age 
effects. ‘Epigenetics’ refers to the heritable, but reversible, regulation of gene 
expression (Henikoff & Matzke 1997). Epigenetic dysfunction has been associated with 
several neuropsychiatric disorders (Mill et al. 2008), and is also implicated in single-
gene disorders, including Rett's and Fragile X syndromes, characterized by autistic-like 
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features in some patients(Reichenberg et al. 2009).
It is possible that the accumulated exposure to various environmental toxins over the 
life-course could result in genomic and/or epigenetic alterations in the cells of older 
parents. Toxins have been shown to induce DNA damage, germline mutations and 
global hypermethylation (Yauk et al. 2008) in germ cells, and have long term 
developmental consequences in offspring (Williams & Ross 2007). In addition, 
increasing maternal age may be related to endocrine and hormonal factors and 
immunological changes, not only by ageing alone but also through maternal stress 
(Newschaffer et al. 2007). There is also an increase in exposure from confounding 
factors such as pre-term birth and pre-eclampsia with advancing maternal age (King et 
al. 2009; Baxter et al. 2007).
The associations between advancing maternal age and autism as well as the familial 
risk were consistent for AD and ASD even though some studies reported differences for 
the different sub-categories of the PDD classification in DSM IV (Lampi et al. 2013). It is 
possible that the different traits underlying the different ASD have different aetiology 
and different effects with maternal age. We did find differences between AD and ID 
following IVF treatment where we did not detect any increase in risk for AD when 
restricting to singleton births, but risk remained following ICSI treatments, mainly used 
for male-factor infertility in Sweden. This may be due to differences in power. 
Alternatively one can speculate, although this information does not exist as a diagnosis 
in the ICD-10 diagnostic system, weather the risks differ for autism with intellectual 
disability and autism without intellectual disability. In a Swedish study obstetric sub-
optimality (prematurity, low Apgar scores, growth restriction) was positively associated 
with autism but not with Asperger's syndrome (Haglund & Källén 2011).
8.4 Future directions
In 2013 the DSM 5 was released. Importantly for autism the Asperger's Disorder, 
Atypical autism and PDD are now incorporated in the same category. When the earlier 
DSM IV was released it was not yet known that Rett's syndrome is caused by mutations 
in the MeCP2 gene. In DSM V Rett's syndrome is no longer included. There is some 
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support to the idea that the new DSM V will be more specific but with slightly lower 
sensitivity compared with the DSM IV-TR (Frazier et al. 2012; McPartland et al. 2012) 
The consequence is of a shift to diagnosis closer to the autistic disorder and children 
with early onset of the symptoms. The diagnostic change in autism thus continuous 
with the changes with DSM V. It is also not clear how the changes in DSM V will affect 
the next version of the ICD. For these reasons confounding for temporal trends will be 
important to consider in future studies.
There is now very strong support for the role of paternal and maternal age on ASD and 
neurodevelopmental disorders generally. However, improved control for family 
confounding and extension to three generations is needed. The three generation 
approach can give useful results for better understanding the role of de-novo and 
possible epigenetic influences. The genetic data showing overlapping genetic 
mechanism over a wider set of neurodevelopmental disorders and conditions such as 
epilepsy, intellectual disability and genetic diseases should be challenged from an 
epidemiological perspective and incorporated in future studies. Differences in 
aetiological risk factors can feed useful results back to the genetic results.
There will be a need for epidemiological studies of even higher power and complexity. 
However, the different countries with national registers useful for research have 
concerns regarding allowing possibly sensitive personal data to leave the country. Also, 
combining data from several sources and with complex information on family structure 
and diagnosis results in big data(sets). Data sharing, technical as well as multinational 
collaboration, will become key for achieving this.
Environmental pollutions have been suggested as triggers for ASD (Becerra et al. 2013), 
perhaps as a consequence of a genetic predisposition or together with epigenetic 
processes. This needs to be addressed but measurements are extremely difficult since 
data currently available is not usually on an individual exposure level but connected to 
roads or geographic areas. In addition, such measurements can also show big 
variations following yearly variations in temperature and economic activity. Exposures 
are most likely confounded by socio-economic status and the dose-response or 
concentration-response is unknown. It may be necessary to create dedicated cohorts 
building up exposure databases of detailed subject-specific data. This can be done 
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using modern techniques where measurement devices are attached to individuals and 
followed over time.
Another topic to explore is the geographic heterogeneity in aetiology. Even on a local 
or national level there may be important differences both in genetic material and in 
exposures. Such an approach can follow the geographic map as well as follow different 
economic maps where different local regions, possibly separated by long distances, can 
have similarities in terms of exposure, such as different exposures to immigration, 
pollutions and temperatures.
In our research we have relied on the use of national registers which helped us to get 
around several problems present in clinically based samples. While we can follow the 
actual diagnosis of ASD in a real population there is a lack of data connecting these 
observations to the underlying biology. For this reason initiatives to enrich the register 
data with biological data would be valuable. In some places such data is available, 
again, on a national level, using individual medical records and available to patients and 
treating doctors. Another approach is to use clever statistical designs where data can 
be collected in sub-cohorts. For this approach to be successful it will be important to 
have exact and reliable information on the underlying population from which sub-
cohorts are created.
The results showing support for assortative mating of sociological influences need to 
be tested in new or extended populations with better control for confounding.
It has been debated how much of the increase in prevalence since the early 1990s is 
due to increases in exposures, if any, and how much is due to changes in the general 
awareness and availability of health care. This has not yet been addressed properly. For 
this to be addressed successfully, reliable data on socio-economic variables and income 
needs to be included. Such an approach could also be useful for further exploring the 
role of assortative mating since factors associated with mating can also be associated, 
or confounded, with these variables.
Follow up on the study III showing convincing evidence for an association between AD 
and ID with certain IVF treatments is needed. It is not entirely clear if the association is 
due to the treatments or due to the underlying infertility factors. Replication in another 
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population and health system is needed to verify the results. Furthermore, since the 
risk to a great extent seems to be associated with multiple births an interesting 
approach would be to analyse the "vanishing twins". Using ultra sound, twins can be 
detected early, but sometimes at birth there is only one child live born due to 
spontaneous abortion. The risk, ID or AD, following IVF treatment can be associated 
with vanished twins (Anand et al. 2007). Also, the highest risk was associated with IVF 
treatment using sperms being surgically extracted. This procedure is used for two 
different infertility factors, one where the tube is blocked and the sperm can not be 
ejaculated and the other where the sperms are of poor quality and sperms have to be 
retrieved from the testis directly. Separating the two procedures could be informative 
for understanding the mechanism underlying risk.
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9 Conclusions
In conclusion, our studies have shown:
• The strongest support to this date for increasing risk of AD and ASD with 
advancing maternal age. 
• The first large documented support for social interaction effects or assortative 
mating in the risk of AD and ASD.
• No support to the hypothesis that the risk of autism due to parental age is 
different in male or female offspring
• No support for the hypothesis that the maternal age association with risk for AD 
is due to IVF treatment in older women. While the original IVF treatment is 
safe, there is an increased risk of AD following the most severe form of male 
infertility using surgical extraction of the sperm. This risk is potentially 
modifiable by the use of single embryo transfer.
• Support for the importance of genetic factors in the aetiology of autism. The 
relative recurrence risk of autism is proportional to the average amount of 
shared genes between family members
• Strong evidence that he genetic and non-genetic factors contribute equally to 
the population risk of AD and ASD
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11 Appendix A - Autism diagnostic criteria
The DSM IV-TR criteria for autism include five different disorders of which each is 
described below.
11.1 Autistic Disorder
The DSM IV-TR criteria require:
A) Six or more items from (1), (2), and (3), with at least two from (1), and one each 
from (2) and (3):
1) qualitative impairment in social interaction, as manifested by at least two of the 
following:
a) marked impairment in the use of multiple non-verbal behaviours such as 
eye-to-eye gaze, facial expression, body postures, and gestures to regulate 
social interaction
b) failure to develop peer relationships appropriate to developmental level
c) a lack of spontaneous seeking to share enjoyment, interests, or 
achievements with other people (e.g., by a lack of showing, bringing, or 
pointing out objects of interest)
d) lack of social or emotional reciprocity
2) qualitative impairments in communication as manifested by at least one of the 
following
a) delay in, or total lack of, the development of spoken language (not 
accompanied by an attempt to compensate through alternative modes of 
communication such as gesture or mime)
b) in individuals with adequate speech, marked impairment in the ability to 
initiate or sustain a conversation with others
c) stereotyped and repetitive use of language or idiosyncratic language
d) lack of varied, spontaneous make-believe play or social imitative play 
appropriate to developmental level
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3) restricted repetitive and stereotyped patterns of behaviour, interests, and 
activities, as manifested by at least one of the following
a) encompassing preoccupation with one or more stereotyped and restricted 
patterns of interest that is abnormal either in intensity or focus
b) apparently inflexible adherence to specific, non-functional routines or 
rituals
c) stereotyped and repetitive motor manners (e.g., hand or finger flapping or 
twisting, or complex whole-body movements)
d) persistent preoccupation with parts of objects
B) Delays or abnormal functioning in at least one of the following areas, with onset 
prior to age 3 years: (1) social interaction, (2) language as used in social 
communication, or (3) symbolic or imaginative play
C) The disturbance is not better accounted for by Rett’s Disorder or Childhood 
Disintegrative Disorder
11.2 Asperger's Disorder
A) qualitative impairment in social interaction, as manifested by at least two of the 
following:
1) marked impairment in the use of multiple non-verbal behaviours such as eye-to 
eye gaze, facial expression, body postures, and gestures to regulate social 
interaction
2) failure to develop peer relationships appropriate to developmental level
3) a lack of spontaneous seeking to share enjoyment, interests, or achievements 
with other people (e.g., by a lack of showing, bringing, or pointing out objects 
of interest to other people)
4) lack of social or emotional reciprocity
B) Restricted repetitive and stereotyped patterns of behaviour, interests and activities, 
as manifested by at least one of the following:
1) encompassing preoccupation with one or more stereotyped and restricted 
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patterns of interest that is abnormal either in intensity of focus
2) apparently inflexible adherence to specific, non-functional routines or rituals
3) stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or 
twisting, or complex whole-body movements)
4) persistent preoccupation with parts of objects
C) The disturbance causes clinically significant impairment in social, occupational, or 
other important areas of functioning.
D) There is no clinically significant general delay in language (e.g., single words used by 
age 2 years, communicative phrases used by age 3 years).
E) There is no clinically significant delay in cognitive development or in the 
development of age-appropriate self-help skills, adaptive behaviour (other than in 
social interaction), and curiosity about the environment in childhood.
F) Criteria are not met for another specific Pervasive Developmental Disorder or 
Schizophrenia
11.3 Pervasive Developmental Disorder Not Otherwise 
Specified
This category should be used when there is a severe and pervasive impairment in the 
development of reciprocal social interaction associated with impairment in either 
verbal or non-verbal communication skills or with the presence of stereotyped 
behaviour, interests, and activities, but the criteria are not met for a specific Pervasive 
Developmental Disorder, Schizophrenia, Schizotypal Personality Disorder, or Avoidant 
Personality Disorder. For example, this category includes "atypical autism" - 
presentations that do not meet the criteria for Autistic Disorder because of late age at 
onset, atypical symptomatology, or sub-threshold symptomatology, or all of these.
11.4 Rett's Disorder
A) All of the following:
1) apparently normal prenatal and perinatal development
2) apparently normal psycho motor development through the first 5 months after 
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birth
3) normal head circumference at birth
B) Onset of all of the following after the period of normal development:
1) deceleration of head growth between ages 5 and 48 months
2) loss of previously acquired purposeful hand skills between 5 and 30 months 
with the subsequent development of stereotyped hand movements (e.g., hand-
wringing or hand washing)
3) loss of social engagement early in the course (although often social interaction 
develops later)
4) appearance of poorly coordinated gait or trunk movements
5) severely impaired expressive and receptive language development with severe 
psycho motor retardation
11.5 Childhood Disintegrative Disorder
A) Apparently normal development for at least the first 2 years after birth as 
manifested by the presence of age-appropriate verbal and non-verbal 
communication, social relationships, play, and adaptive behaviour
B) Clinically significant loss of previously acquired skills (before age 10 years) in at 
least two of the following areas:
1) expressive or receptive language
2) social skills or adaptive behaviour
3) bowel or bladder control
4) play
5) motor skills
C) Abnormalities of functioning in at least two of the following areas:
1) qualitative impairment in social interaction (e.g., impairment in non-verbal 
behaviours, failure to develop peer relationships, lack of social or emotional 
reciprocity)
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2) qualitative impairments in communication (e.g., delay or lack of spoken 
language, inability to initiate or sustain a conversation, stereotyped and 
repetitive use of language, lack of varied make-believe play)
3) restricted, repetitive, and stereotyped patterns of behaviour, interest, and 
activities, including motor stereotypes and mannerisms
D) The disturbance is not better accounted for by another specific Pervasive 
Developmental Disorder or by Schizophrenia\
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12 Appendix B - Study III Online Supplementary 
Material
The tables presented here were published as supplementary online tables in the JAMA 
manuscript.
eTable 1 Description of Swedish population based registers
eTable 2 ICD codes for autistic disorder, mental retardation, genetic diseases and 
parental psychiatric history
eTable 3 Autistic Disorder. Comparing Any IVF vs Spontaneously conceived children. 
Relative risk (RR) and two-sided 95% confidence intervals (CI). RR presented 
for crude models (adjusting for age, sex and birth year only) and adjusted 
models (additionally adjusting for confounding). RR presented also for the 
supplementary analyses adjusting for calendar time (AdjC), adjusting for 
years of infertility (Adj I) and for subgroups of male and female children; 
subgroups of pre-term and term born children; subgroup of children born 
after 1998. All calculations presented for multiple birth and singletons 
separately. Supplementary results in italic.
eTable 4 Mental Retardation. Comparing Any IVF vs Spontaneously conceived 
children. Relative risk (RR) and two-sided 95% confidence intervals (CI). RR 
presented for crude models (adjusting for age, sex and birth year only) and 
adjusted models (additionally adjusting for confounding). RR presented also 
for the supplementary analyses adjusting for calendar time (AdjC), 
adjusting for years of infertility (Adj I) and for subgroups of male and female 
children; subgroups of pre-term and term born children; subgroup of 
children born after 1998. All calculations presented for multiple birth and 
singletons separately. Supplementary results in italic.
eTable 5 Autistic disorder. Comparing specific IVF procedures vs IVF without ICSI, 
fresh embryo. Relative risk (RR) and two-sided 95% confidence intervals 
(CI). RR presented for crude models (adjusting for age, sex and birth year 
only) and adjusted models (additionally adjusting for confounding). RR 
presented also for the supplementary analyses adjusting for calendar time 
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(AdjC), adjusting for years of infertility (Adj I) and adjusting for diagnosis of 
genetic disease (Adj G) and for subgroups of male and female children; 
subgroups of pre-term and term born children; subgroup of children born 
after 1998. All calculations presented for multiple birth and singletons 
separately. Supplementary results in italic.
eTable 6 Mental Retardation. Comparing specific IVF procedures vs IVF without ICSI, 
fresh embryo. Relative risk (RR) and two-sided 95% confidence intervals 
(CI). RR presented for crude models (adjusting for age, sex and birth year 
only) and adjusted models (additionally adjusting for confounding). RR 
presented also for the supplementary analyses adjusting for calendar time 
(AdjC), adjusting for years of infertility (Adj I) and adjusting for diagnosis of 
genetic disease (Adj G) and for subgroups of male and female children; 
subgroups of pre-term and term born children; subgroup of children born 
after 1998. All calculations presented for multiple birth and singletons 
separately. Supplementary results in italic.
eTable 7 Autistic disorder. Comparing IVF techniques. Each "technique" defined by 
combining specific IVF procedures sharing the same technique. Relative risk 
(RR) and two-sided 95% confidence intervals (CI). RR presented for crude 
models (adjusting for age, sex and birth year only) and adjusted models 
(additionally adjusting for confounding). RR presented also for the 
supplementary analyses adjusting for calendar time (AdjC), adjusting for 
years of infertility (Adj I) and adjusting for diagnosis of genetic disease (Adj 
G) and for subgroups of male and female children; subgroups of preterm 
and term born children; subgroup of children born after 1998. All 
calculations presented for multiple birth and singletons separately. 
Supplementary results in italic.
eTable 8 Mental Retardation. Comparing IVF techniques. Each "technique" defined 
by combining specific IVF procedures sharing the same technique. Relative 
risk (RR) and two-sided 95% confidence intervals (CI). RR presented for 
crude models (adjusting for age, sex and birth year only) and adjusted 
models (additionally adjusting for confounding). RR presented also for the 
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supplementary analyses adjusting for calendar time (AdjC), adjusting for 
years of infertility (Adj I) and adjusting for diagnosis of genetic disease (Adj 
G) and for subgroups of male and female children; subgroups of pre-term 
and term born children; subgroup of children born after 1998. All 
calculations presented for multiple birth and singletons separately. 
Supplementary results in italic.
eTable 9 Hormones. Comparing children born following hormone treatment as only 
fertility treatment vs children spontaneous conceived without use of 
hormones. Relative risk (RR) and two-sided 95% confidence intervals (CI) 
for autistic disorder and for mental retardation for. For All children and for 
singletons. All RR from adjusted models.
eTable 10 Comparisons of children born following specific IVF procedures vs children 
born after spontaneous conception. Relative risk (RR) and two-sided 95% 
confidence intervals (CI) for autistic disorder and for mental retardation for. 
For All children and for singletons. All RR from adjusted models.
eTable 11 Comparing the risk for autistic disorder and mental retardation in multiples 
vs singletons. Results are presented separately for children following any 
IVF treatment and spontaneous conception. Multiples include any birth 
with > 1 live born child. Singletons include birth with one live born child.
eTable 12 All children. Distribution of confounders and children characteristics for 
spontaneous conceived with and without hormone treatment. Hormone 
treatment being the only treatment for fertility.
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The Medical Birth Register was established in 1973. It contains data on 
pregnancy and birth for all births in Sweden. More than 95% of the 
Swedish pregnant population attend antenatal care before the 15th 
gestational week and the register covers over 99% of all births. This 
register includes information collected prospectively, starting with the 
first antenatal visit through the time when mother and child are 
discharged from the hospital after delivery. Antenatal care routines are 
standardized and the information is provided through antenatal, 
obstetrical, and neonatal records, and classified according to the 
International Classification of Diseases (ICD) version 8 until 1986, 
version 9 from 1987 to 1996, and version 10 subsequently.
Virtually all pregnant women attend an antenatal clinic. During the first 
visit, usually during pregnancy week 8-13, the woman is asked about 
the number of years of involuntary infertility. The information is 




Frequencies of all IVF/ICSI treatment in Sweden from 1982 to 2007. 
From 2007 data are stored in a separate Swedish "quality register". 
Since 2003 data on embryos transferred are registered as well.
The 16 clinics for IVF/ICSI Sweden are required by law to report all 
treatments. IVF/ICSI treatments are offered to women in the range 25-
42 years of age. There are no strict age restrictions for males. Eligibility 
requires a medically documented fertility problem. In Sweden, almost 
exclusively, IVF is used to treat female infertility while ICSI is used for 
male infertility.
For IVF without ICSI, sperm is introduced to the egg in a dish or in a 
test-tube where fertilization takes place, in vitro, usually within 24 
hours. The fertilized egg develops into an embryo, which is further 
cultivated for a total of 2-3 days, to the “cleavage stage”, or for 5-6 days 
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to a ”blastocyst”. One or, occasionally, two (in previous years even 
more than two) embryos are then transferred to the uterus in a “fresh 
embryo transfer”. Excess embryos can be frozen and later thawed for a 
second, now frozen-and-thawed, embryo transfer. When ICSI 
treatments are applied, one single sperm is injected directly into the 
cytoplasm of the egg where fertilization later takes place. For more 
serious cases of male infertility when no, or very few, sperm are found 
in the ejaculate they can be surgically extracted from either the testis 




The Multi Generation Register contains information about the entire 
Swedish population. Children born from 1932 and alive 1961 are linked 
to their biological parents. The register comprises 9 million children 
(index persons), and 11 million unique individuals. Importantly the 
register includes family information (e.g., identification of parents, 
siblings and offspring)allowing linkage to other population based 
registers, which include information on health (e.g. psychiatric 





Sweden has universal and publicly financed health insurance coverage 
that guarantees equal access to health services, regardless of 
employment status, socio-economic status or regional residency. The 
register has a nationwide coverage of patient treatment facilities and 
includes care in psychiatric as well as somatic hospitals. There are no 
private psychiatric hospitals in Sweden. The Swedish National Patient 
Register contains details on virtually all psychiatric hospitalizations 
since 1973. Before 1973 there is data for selected counties only. The 
register include data on admission and discharge dates and the 
discharge diagnosis made by the treating physician. Outpatient visits 
are included since 1999. Diagnostic information is coded using the ICD 
codes. The standard procedure dictates that diagnosis will be given by 
a consultant (equivalent of an attending) psychiatrist at the time of 
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discharge from hospital. The diagnostic assessment is then forwarded 
on a computer medium to the National Patient Register. These routines 
are standardized across Sweden. 
All infants and preschool children are regularly seen at well-child care 
clinics and undergo routine medical and developmental screening. All 
children aged 4 undergo routine general health screening, that 
includes mandatory developmental assessment (motor, language, 
cognitive and social development) conducted by a nurse and 
paediatrician. Children with any suspected developmental disorder 
(including autistic disorder and mental retardation) are referred for 
further assessment by a specialized team in a child psychiatry unit or 
habilitation service. During the study period diagnoses were made by 
diagnostic teams with a psychiatrist, clinical psychologist, and speech 
pathologist or occupational therapist, depending on clinical 
manifestations. The instruments include parental interviews, cognitive 
testing of the child, and observations in naturalistic settings, including 
the home or the unit. The Patient Register contains the diagnostic 
information. The Patient-Register has shown high reliability for somatic 
and psychiatric diagnoses. Also, for 130 cases of autistic disorder, we 
earlier compared registry diagnosis to diagnosis according to the 
Diagnostic and Statistical Manual 4th Edition (DSM-IV) confirming 
reliability (methods and results are available from the authors on 
request). For a diagnosis of mental retardation the evaluation is made 






Individual vital statistics data including date of birth, emigration, 
immigration and death is maintained by Statistics Sweden (Total 
Population Register, Emigration and immigration register).
#: Register owned and monitored by the Swedish National Board of Health and Welfare. More detailed 
documentations at www.socialstyrelsen.se/en/
Note: Data from all registers are joined by the register owner(s)by the unique Swedish personal 
identification number.
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eTable 2. ICD codes for autistic disorder, mental retardation, genetic diseases and 
parental psychiatric history










ICD-9: 317, 318 or 319 including all sub-codes or 318A, 318B or 
318C








ICD-7: 301 and 302
ICD-8: 296, 298 and 3004.1
ICD-9: 296, 311, 298A, 298B, 300E
ICD-10: F30-F34, F38, F39
Non affective 
psychosis
ICD-7: 300 or 309
ICD-8: 295, 297, 299, 298.2, 298.3, 298.9
ICD-9: 295, 297, 298, 298C, 298E, 298W, 298X
ICD-10: F20-F25, F28, F29, F230-F233, F238, F239
Genetic 
disease##
Fragile-X ICD-9 759,83 or ICD19 Q992, Angelman ICD-9 759,89 
or ICD-10 Q935, Prader-Willi ICD-9 759,81 or ICD-10 Q871, 
Zellweger ICD-9 277,86 or ICD-10 Q878, William ICD-9 758,9 or 
ICD-10 Q938, Tuberous Sclerosis ICD-9 259,5 or ICD-10 Q851, 
Tourette ICD-9 307,23 or ICD-10 F952, Neuofibromatosis ICD-9 
237,7 or ICD-10 Q850, Duchennes muscular dystrophy ICD-9 
359,1 or ICD-10 QG710, Cornelia de Lange ICD-9 759,89 or ICD-
10 Q871, DeGeorge ICD-9 279,11 or 758,32 or ICD-10 Q821, 
Smith-Lemli-Opitz ICD-9 759.84 or ICD-10 Q871, Klinfelter ICD-
9 758,7 or ICD-10 Q980, Q981, Q982, Q983 or Q984. There is 
an overlap where ICD-10 Q871 can be both de Lange and 
Smith-Lemli-Opitz.
#: Codes used from 1987, ##: Source: Hollander E, Kolevzon A, Coyle JT. Textbook of 
Autism Spectrum Disorders. American Psychiatric Pub; 2010.
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100,000 Model RR (95% CI) p-value
All Children Spontaneous 6,856 33,994,678 15.6 reference group
All Children Any IVF 103 231,118 19.0 Crude 1.22 (1.01-1.49) 0.04
All Children Adj 1.14 (0.94-1.39) 0.18
All Children AdjC 1.22 (1.01-1.49) 0.04
All Children AdjI 1.15 (0.93-1.43) 0.19
All Children >1998 Spontaneous 2,123 4,708,440 36.0 reference group
All Children >1998 Any IVF 68 112,209 48.4 Adj 1.25 (0.98-1.60) 0.07
All Children Boys Spontaneous 5,067 17,453,631 25.3 reference group
All Children Boys Any IVF 76 119,364 29.7 Adj 1.14 (0.91-1.43) 0.26
All Children Girls Spontaneous 1,789 16,541,047 9.6 reference group
All Children Girls Any IVF 27 111,754 13.1 Adj 1.16 (0.79-1.69) 0.45
All Children Pre-
Term
Spontaneous 665 1,959,075 25.6 reference group
All Children Pre-
Term
Any IVF 35 53,629 29.4 Adj 1.10 (0.78-1.54) 0.59
All Children Term Spontaneous 6,191 32,035,603 15.1 reference group
All Children Term Any IVF 68 177,489 16.2 Adj 1.00 (0.79-1.28) 0.97














Model RR (95% CI) p-
value
Singletons Spontaneous 6,683 33,285,383 15.0 reference group
Singletons Any IVF 54 149,932 14.4 Crude 0.96 (0.74-1.26) 0.78
Singletons Adj 0.89 (0.68-1.17) 0.41
Singletons AdjC 0.96 (0.73-1.26) 0.77
Singletons AdjI 0.89 (0.67-1.18) 0.42
Singletons >1998 Spontaneous 2,068 4,599,526 36.0 reference group
Singletons >1998 Any IVF 36 79,704 36.1 Adj 0.92 (0.66-1.29) 0.64
Singletons Boys Spontaneous 4,939 17,095,982 24.3 reference group
Singletons Boys Any IVF 42 77,261 23.7 Adj 0.94 (0.69-1.27) 0.68
Singletons Girls Spontaneous 1,744 16,189,401 9.1 reference group
Singletons Girls Any IVF 12 72,671 8.4 Adj 0.77 (0.43-1.35) 0.36
Singletons Pre-Term Spontaneous 596 1,663,935 25.0 reference group
Singletons Pre-Term Any IVF 7 14,139 19.0 Adj 0.71 (0.34-1.50) 0.37
Singletons Term Spontaneous 6,087 31,621,448 14.7 reference group
Singletons Term Any IVF 47 135,793 14.1 Adj 0.89 (0.67-1.19) 0.45
Crude model denotes model adjusting for birth year, age and sex only; Adj model denotes adjusting for birth year, age and sex and additionally adjusting for 
paternal psychiatric history, maternal psychiatric history and paternal and maternal age; AdjC model denotes adjusting for birth year, age and sex, and additionally 
for calendar time; AdjI model denotes adjusting for birth year, age and sex, paternal psychiatric history, maternal psychiatric history and paternal and maternal age, 
and additionally for years of infertility. Note: x indicate cells not estimable since too few cases.
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Model RR (95% CI) p-value
All Children Spontaneous 15,647 33,947,960 39.8 reference group
All Children Any IVF 180 230,710 46.3 Crude 1.16 (1.00-1.35) 0.04
All Children Adj 1.18 (1.01-1.36) 0.03
All Children AdjC 1.16 (1.00-1.35) 0.05
All Children AdjI 1.13 (0.96-1.32) 0.14
All Children >1998 Spontaneous 3,408 4,703,484 70.3 reference group
All Children >1998 Any IVF 98 112,101 85.5 Adj 1.20 (0.98-1.47) 0.08
All Children Boys Spontaneous 9,429 17,430,939 47.5 reference group
All Children Boys Any IVF 123 119,121 60.8 Adj 1.33 (1.11-1.59) <.01
All Children Girls Spontaneous 6,218 16,517,022 33.3 reference group
All Children Girls Any IVF 57 111,589 32.4 Adj 0.94 (0.73-1.22) 0.66
All Children Pre-Term Spontaneous 2,127 1,950,931 96.7 reference group
All Children Pre-Term Any IVF 70 53,427 79.2 Adj 0.87 (0.69-1.11) 0.27
All Children Term Spontaneous 13,520 31,997,029 36.4 reference group
All Children Term Any IVF 110 177,283 36.9 Adj 1.01 (0.84-1.22) 0.90














Model RR (95% CI) p-value
Singletons Spontaneous 15,178 33,240,234 38.5 reference group
Singletons Any IVF 101 149,677 38.8 Crude 1.01 (0.83-1.23) 0.93
Singletons Adj 1.01 (0.83-1.24) 0.89
Singletons AdjC 1.01 (0.83-1.23) 0.94
Singletons AdjI 0.95 (0.78-1.17) 0.64
Singletons >1998 Spontaneous 3,306 4,594,778 69.8 reference group
Singletons >1998 Any IVF 60 79,605 74.0 Adj 1.03 (0.80-1.33) 0.81
Singletons Boys Spontaneous 9,136 17,074,246 45.8 reference group
Singletons Boys Any IVF 68 77,117 50.1 Adj 1.13 (0.89-1.44) 0.31
Singletons Girls Spontaneous 6,042 16,165,988 32.3 reference group
Singletons Girls Any IVF 33 72,561 28.1 Adj 0.84 (0.59-1.18) 0.31
Singletons Pre-Term Spontaneous 1,875 1,656,758 95.8 reference group
Singletons Pre-Term Any IVF 17 14,068 66.2 Adj 0.74 (0.46-1.20) 0.22
Singletons Term Spontaneous 13,303 31,583,476 35.8 reference group
Singletons Term Any IVF 84 135,610 36.2 Adj 1.01 (0.81-1.25) 0.94
Crude model denotes model adjusting for birth year, age and sex only; Adj model denotes adjusting for birth year, age and sex and additionally adjusting for paternal psychiatric 
history, maternal psychiatric history and paternal and maternal age; AdjC model denotes adjusting for birth year, age and sex, and additionally for calendar time;  AdjI model 
denotes adjusting for birth year, age and sex, paternal psychiatric history, maternal psychiatric history and paternal and maternal age, and additionally for years of infertility. Note: x 
indicate cells not estimable since too few cases.
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Model RR (95% CI)
p-
value
All Children IVF without ICSI, fresh 53 144,207  29.3 reference group
All Children IVF without ICSI, frozen 10 17,121  42.3 Crude 1.44 (0.73-2.85) 0.29
All Children Adj 1.46 (0.74-2.89) 0.27
All Children AdjC 1.45 (0.74-2.87) 0.28
All Children AdjI 1.46 (0.74-2.89) 0.27
All Children AdjG 1.46 (0.74-2.89) 0.27
All Children ICSI, fresh 31 58,262  34.0 Crude 1.16 (0.73-1.85) 0.52
All Children Adj 1.20 (0.75-1.91) 0.45
All Children AdjC 1.15 (0.73-1.83) 0.55
All Children AdjI 1.19 (0.75-1.90) 0.46
All Children AdjG 1.20 (0.75-1.91) 0.45
All Children ICSI, frozen 1 7,022   9.4 Crude 0.32 (0.04-2.34) 0.26
All Children Adj 0.33 (0.05-2.40) 0.27
All Children AdjC 0.32 (0.04-2.33) 0.26
All Children AdjI 0.33 (0.05-2.40) 0.27
All Children AdjG 0.33 (0.05-2.40) 0.27














Model RR (95% CI)
p-
value
All Children ICSI, fresh, surgery 8 3,720 135.7 Crude 4.64 (2.17-9.92) <.01
All Children Adj 4.60 (2.14-9.88) <.01
All Children AdjC 4.57 (2.14-9.77) <.01
All Children AdjI 4.60 (2.14-9.89) <.01
All Children AdjG 4.60 (2.14-9.88) <.01
All Children ICSI, frozen, surgery 0 787   0.0 Crude x x
All Children Adj x x
All Children AdjC x x
All Children AdjI x x
All Children AdjG x x
All Children Pre-Term IVF without ICSI, fresh 17 36,927  38.4 reference group
All Children Pre-Term IVF without ICSI, frozen 3 3,297  67.9 Adj 1.69 (0.49-5.79) 0.40
All Children Pre-Term ICSI, fresh 10 11,508  51.6 Adj 1.47 (0.66-3.26) 0.35
All Children Pre-Term ICSI, frozen 0 1,055   0.0 Adj x x
All Children Pre-Term ICSI, fresh, surgery 5 764 364.5 Adj 9.54 (3.43-26.57) <.01
All Children Pre-Term ICSI, frozen, surgery 0 78   0.0 Adj x x














Model RR (95% CI)
p-
value
All Children Term IVF without ICSI, fresh 36 107,280  26.6 reference group
All Children Term IVF, without ICSI, frozen 7 13,824  36.4 Adj 1.39 (0.62-3.14) 0.42
All Children Term ICSI, fresh 21 46,753  29.0 Adj 1.11 (0.64-1.93) 0.72
All Children Term ICSI, frozen 1 5,967  10.9 Adj 0.42 (0.06-3.09) 0.40
All Children Term ICSI, fresh, surgery 3 2,957  65.0 Adj 2.42 (0.74-7.97) 0.14
All Children Term ICSI, frozen, surgery 0 708   0.0 Adj x x
All Children Boys IVF without ICSI, fresh 42 76,420  48.4 reference group
All Children Boys IVF without ICSI, frozen 6 8,788  52.6 Adj 1.13 (0.48-2.68) 0.77
All Children Boys ICSI, fresh 22 28,635  49.5 Adj 1.11 (0.65-1.90) 0.69
All Children Boys ICSI, frozen 1 3,271  19.8 Adj 0.44 (0.06-3.24) 0.42
All Children Boys ICSI, fresh, surgery 5 1,806 174.0 Adj 3.80 (1.48-9.79) <.01
All Children Boys ICSI, frozen, surgery 0 445   0.0 Adj x x
All Children Girls IVF, without ICSI, fresh 11 67,787  15.6 reference group
All Children Girls IVF without ICSI, frozen 4 8,333  44.9 Adj 2.63 (0.84-8.29) 0.10














Model RR (95% CI) p-
value
All Children Girls ICSI, fresh 9 29,627  26.7 Adj 1.50 (0.61-3.66) 0.37
All Children Girls ICSI, frozen 0 3,751   0.0 Adj x x
All Children Girls ICSI, fresh, surgery 3 1,915 137.7 Adj 7.31 (2.01-26.59) <.01
All Children Girls ICSI, frozen, surgery 0 342   0.0 Adj x x
All Children >1998 IVF without ICSI, fresh 30 52,992  43.0 reference group
All Children >1998 IVF without ICSI, frozen 5 8,131  55.0 Adj 1.32 (0.51-3.42) 0.57
All Children >1998 ICSI, fresh 25 41,682  47.0 Adj 1.12 (0.65-1.90) 0.69
All Children >1998 ICSI, frozen 1 5,637  15.9 Adj 0.38 (0.05-2.80) 0.34
All Children >1998 ICSI, fresh, surgery 7 3,127 174.9 Adj 4.16 (1.81-9.55) <.01
All Children >1998 ICSI, frozen, surgery 0 639   0.0 Adj x x
Singletons IVF without ICSI, fresh 30 89,038  23.9 reference group
Singletons IVF without ICSI, frozen 5 12,309  25.9 Crude 1.09 (0.42-2.82) 0.86
Singletons Adj 1.14 (0.44-2.95) 0.79
Singletons AdjC 1.10 (0.42-2.84) 0.85
Singletons AdjI 1.13 (0.44-2.94) 0.80
Singletons AdjG 1.14 (0.44-2.95) 0.79














Model RR (95% CI) p-
value
Singletons ICSI, fresh 18 39,931  26.0 Crude 1.09 (0.60-2.00) 0.78
Singletons Adj 1.17 (0.63-2.15) 0.62
Singletons AdjC 1.07 (0.59-1.97) 0.82
Singletons AdjI 1.15 (0.63-2.13) 0.65
Singletons AdjG 1.17 (0.63-2.15) 0.62
Singletons ICSI, frozen 0 5,519   0.0 Crude x x
Singletons Adj x x
Singletons AdjC x x
Singletons AdjI x x
Singletons AdjG x x
Singletons ICSI, fresh, surgery 1 2,569  21.9 Crude 0.92 (0.12-6.79) 0.93
Singletons Adj 0.95 (0.13-7.09) 0.96
Singletons AdjC 0.90 (0.12-6.62) 0.91
Singletons AdjI 0.94 (0.13-6.98) 0.95
Singletons AdjG 0.95 (0.13-7.09) 0.96














Model RR (95% CI) p-
value
Singletons ICSI, frozen, surgery 0 566   0.0 Crude x x
Singletons Adj x x
Singletons AdjC x x
Singletons AdjI x x
Singletons AdjG x x
Singletons Pre-Term IVF without ICSI, fresh 6 9,105  35.9 reference group
Singletons Pre-Term IVF without ICSI, frozen 0 944   0.0 Adj x x
Singletons Pre-Term ICSI, fresh 1 3,400  14.0 Adj 0.37 (0.04-3.11) 0.36
Singletons Pre-Term ICSI, frozen 0 443   0.0 Adj x x
Singletons Pre-Term ICSI, fresh, surgery 0 215   0.0 Adj x x
Singletons Pre-Term ICSI, frozen, surgery 0 30   0.0 Adj x x














Singletons Term IVF without ICSI, fresh 24 79,932  19.9 reference group
Singletons Term IVF without ICSI, frozen 5 11,365  26.3 Adj 1.41 (0.53-3.71) 0.49
Singletons Term ICSI, fresh 17 36,531  24.2 Adj 1.35 (0.71-2.57) 0.37
Singletons Term ICSI, frozen 0 5,076   0.0 Adj x x
Singletons Term ICSI, fresh, surgery 1 2,353  21.5 Adj 1.19 (0.16-8.89) 0.87
Singletons Term ICSI, frozen, surgery 0 535   0.0 Adj x x
Singletons Boys IVF without ICSI, fresh 25 47,109  47.8 reference group
Singletons Boys IVF without ICSI, frozen 3 6,365  37.1 Adj 0.84 (0.25-2.80) 0.78
Singletons Boys ICSI, fresh 13 19,618  46.6 Adj 1.05 (0.53-2.11) 0.88
Singletons Boys ICSI, frozen 0 2,583   0.0 Adj x x
Singletons Boys ICSI, fresh, surgery 1 1,275  53.7 Adj 1.16 (0.16-8.72) 0.88
Singletons Boys ICSI, frozen, surgery 0 310   0.0 Adj x x














Model RR (95% CI) p-
value
Singletons Girls IVF without ICSI, fresh 5 41,928   6.0 reference group
Singletons Girls IVF without ICSI, frozen 2 5,944  16.1 Adj 2.46 (0.48-12.71) 0.28
Singletons Girls ICSI, fresh 5 20,313   9.2 Adj 1.67 (0.48-5.82) 0.42
Singletons Girls ICSI, frozen 0 2,936   0.0 Adj x x
Singletons Girls ICSI, fresh, surgery 0 1,294   0.0 Adj x x
Singletons Girls ICSI, frozen, surgery 0 256   0.0 Adj x x
Singletons >1998 IVF without ICSI, fresh 19 36,536  37.5 reference group
Singletons >1998 IVF without ICSI, frozen 3 6,413  37.3 Adj 1.04 (0.31-3.55) 0.95
Singletons >1998 ICSI, fresh 13 29,649  33.4 Adj 0.92 (0.45-1.87) 0.81
Singletons >1998 ICSI, frozen 0 4,446   0.0 Adj x x
Singletons >1998 ICSI, fresh, surgery 1 2,220  33.7 Adj 0.94 (0.12-7.09) 0.95
Singletons >1998 ICSI, frozen, surgery 0 440   0.0 Adj x x
Crude model denotes model adjusting for birth year, age and sex only; Adj model denotes adjusting for birth year, age and sex and additionally adjusting for 
paternal psychiatric history, maternal psychiatric history and paternal and maternal age; AdjC model denotes adjusting for birth year, age and sex, and additionally 
for calendar time;  AdjI model denotes adjusting for birth year, age and sex, paternal psychiatric history, maternal psychiatric history and paternal and maternal age,  
and additionally for years of infertility; AdjG model denotes adjusting for birth year, age and sex and paternal psychiatric history, maternal psychiatric history and 
paternal and maternal age, and additionally adjusting for presence of genetic diseases.Note: x indicate cells not estimable since too few cases.
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Model RR (95% CI)
p-
value
All Children IVF without ICSI, fresh 94 143,924  60.8 reference group
All Children IVF without ICSI, frozen 13 17,095  69.0 Crude 1.14 (0.63-2.04) 0.67
All Children Adj 1.16 (0.64-2.07) 0.63
All Children AdjC 1.14 (0.63-2.04) 0.67
All Children AdjI 1.16 (0.64-2.07) 0.63
All Children AdjG 1.17 (0.65-2.09) 0.60
All Children ICSI, fresh 59 58,177  90.6 Crude 1.49 (1.05-2.11) 0.03
All Children Adj 1.47 (1.03-2.09) 0.03
All Children AdjC 1.49 (1.05-2.11) 0.03
All Children AdjI 1.47 (1.03-2.08) 0.03
All Children AdjG 1.48 (1.04-2.11) 0.03














Model RR (95% CI) p-
value
All Children ICSI, frozen 8 7,005 103.9 Crude 1.71 (0.82-3.58) 0.16
All Children Adj 1.70 (0.81-3.56) 0.16
All Children AdjC 1.71 (0.82-3.58) 0.16
All Children AdjI 1.70 (0.81-3.57) 0.16
All Children AdjG 1.72 (0.82-3.60) 0.15
All Children ICSI, fresh, surgery 6 3,722 144.1 Crude 2.37 (1.03-5.48) 0.04
All Children Adj 2.35 (1.01-5.45) 0.05
All Children AdjC 2.37 (1.02-5.47) 0.04
All Children AdjI 2.35 (1.01-5.46) 0.05
All Children AdjG 2.37 (1.02-5.51) 0.04
All Children ICSI, frozen, surgery 0 787   0.0 Crude x x
All Children Adj x x
All Children AdjC x x
All Children AdjI x x
All Children AdjG x x














Model RR (95% CI)
p-
value
All Children Pre-Term IVF without ICSI, fresh 38 36,788  92.2 reference group
All Children Pre-Term IVF without ICSI, frozen 5 3,285 131.0 Adj 1.44 (0.56-3.66) 0.45
All Children Pre-Term ICSI, fresh 19 11,472 136.1 Adj 1.46 (0.83-2.59) 0.19
All Children Pre-Term ICSI, frozen 4 1,035 363.0 Adj 3.47 (1.22-9.90) 0.02
All Children Pre-Term ICSI, fresh, surgery 4 768 413.9 Adj 4.38 (1.53-12.48) <.01
All Children Pre-Term ICSI, frozen, surgery 0 78   0.0 Adj x x
All Children Term IVF without ICSI, fresh 56 107,136  49.5 reference group
All Children Term IVF without ICSI, frozen 8 13,810  51.3 Adj 1.07 (0.51-2.25) 0.86
All Children Term ICSI, fresh 40 46,706  73.8 Adj 1.51 (0.99-2.31) 0.06
All Children Term ICSI, frozen 4 5,969  55.3 Adj 1.19 (0.43-3.30) 0.74
All Children Term ICSI, fresh, surgery 2 2,954  57.2 Adj 1.21 (0.29-4.99) 0.79
All Children Term ICSI, frozen, surgery 0 708   0.0 Adj x x














Model RR (95% CI) p-
value
All Children Boys IVF without ICSI, fresh 67 76,251  89.0 reference group
All Children Boys IVF without ICSI, frozen 7 8,785  75.9 Adj 0.90 (0.41-1.96) 0.78
All Children Boys ICSI, fresh 41 28,570 128.7 Adj 1.50 (1.00-2.26) 0.05
All Children Boys ICSI, frozen 5 3,262 137.3 Adj 1.61 (0.64-4.06) 0.31
All Children Boys ICSI, fresh, surgery 3 1,807 147.7 Adj 1.73 (0.54-5.57) 0.36
All Children Boys ICSI, frozen, surgery 0 445   0.0 Adj x x
All Children Girls IVF without ICSI, fresh 27 67,673  39.3 reference group
All Children Girls IVF without ICSI, frozen 6 8,310  72.9 Adj 1.75 (0.72-4.25) 0.22
All Children Girls ICSI, fresh 18 29,607  63.0 Adj 1.41 (0.76-2.59) 0.28
All Children Girls ICSI, frozen 3 3,743  83.2 Adj 1.89 (0.57-6.30) 0.30
All Children Girls ICSI, fresh, surgery 3 1,915 163.5 Adj 3.69 (1.11-12.29) 0.03
All Children Girls ICSI, frozen, surgery 0 342   0.0 Adj x x














Model RR (95% CI) p-
value
All Children >1998 IVF without ICSI, fresh 36 52,945  61.2 reference group
All Children >1998 IVF without ICSI, frozen 4 8,127  44.7 Adj 0.74 (0.26-2.10) 0.57
All Children >1998 ICSI, fresh 48 41,626 106.9 Adj 1.78 (1.15-2.75) <.01
All Children >1998 ICSI, frozen 6 5,629  98.9 Adj 1.64 (0.69-3.92) 0.26
All Children >1998 ICSI, fresh, surgery 4 3,135 119.3 Adj 2.08 (0.74-5.89) 0.17
All Children >1998 ICSI, frozen, surgery 0 639   0.0 Adj x x
Singletons IVF without ICSI, fresh 48 88,895  50.6 reference group
Singletons IVF without ICSI, frozen 11 12,271  83.6 Crude 1.65 (0.85-3.21) 0.14
Singletons Adj 1.67 (0.86-3.24) 0.13
Singletons AdjC 1.66 (0.85-3.21) 0.14
Singletons AdjI 1.66 (0.85-3.23) 0.14
Singletons AdjG 1.70 (0.87-3.31) 0.12














Model RR (95% CI) p-
value
Singletons ICSI, fresh 34 39,883  80.0 Crude 1.58 (0.99-2.53) 0.06
Singletons Adj 1.60 (1.00-2.57) 0.05
Singletons AdjC 1.58 (0.98-2.52) 0.06
Singletons AdjI 1.59 (0.99-2.55) 0.06
Singletons AdjG 1.63 (1.01-2.62) 0.04
Singletons ICSI, frozen 7 5,499 118.4 Crude 2.34 (1.03-5.31) 0.04
Singletons ICSI, frozen 7 5,499 118.4 Adj 2.36 (1.04-5.36) 0.04
Singletons AdjC 2.33 (1.03-5.29) 0.04
Singletons AdjI 2.37 (1.04-5.38) 0.04
Singletons AdjG 2.40 (1.06-5.46) 0.04
Singletons ICSI, fresh, surgery 1 2,564  36.1 Crude 0.71 (0.10-5.22) 0.74
Singletons Adj 0.70 (0.10-5.16) 0.73
Singletons AdjC 0.71 (0.10-5.18) 0.73
Singletons AdjI 0.70 (0.10-5.14) 0.73
Singletons AdjG 0.72 (0.10-5.26) 0.74













Model RR (95% CI)
p-
value
Singletons ICSI, frozen, surgery 0 566   0.0 Crude x x
Singletons Adj x x
Singletons AdjC x x
Singletons AdjI x x
Singletons AdjG x x
Singletons Pre-Term IVF without ICSI, fresh 7 9,082  61.5 reference group
Singletons Pre-Term IVF without ICSI, frozen 4 918 417.5 Adj 5.47 (1.58-18.96) <.01
Singletons Pre-Term ICSI, fresh 3 3,392  85.3 Adj 1.18 (0.30-4.65) 0.81
Singletons Pre-Term ICSI, frozen 3 429 737.0 Adj 9.26 (2.35-36.56) <.01
Singletons Pre-Term ICSI, fresh, surgery 0 215   0.0 Adj x x
Singletons Pre-Term ICSI, frozen, surgery 0 30   0.0 Adj x x














Model RR (95% CI) p-
value
Singletons Term IVF without ICSI, fresh 41 79,813  48.3 reference group
Singletons Term IVF without ICSI, frozen 7 11,353  55.4 Adj 1.20 (0.53-2.70) 0.66
Singletons Term ICSI, fresh 31 36,491  75.7 Adj 1.66 (1.01-2.73) 0.05
Singletons Term ICSI, frozen 4 5,070  68.7 Adj 1.52 (0.53-4.33) 0.43
Singletons Term ICSI, fresh, surgery 1 2,348  37.0 Adj 0.81 (0.11-5.96) 0.84
Singletons Term ICSI, frozen, surgery 0 535   0.0 Adj x x
Singletons Boys IVF without ICSI, fresh 34 47,029  74.0 reference group
Singletons Boys IVF without ICSI, frozen 7 6,352 106.2 Adj 1.55 (0.68-3.53) 0.30
Singletons Boys ICSI, fresh 22 19,584 104.8 Adj 1.54 (0.88-2.71) 0.13
Singletons Boys ICSI, frozen 4 2,571 136.6 Adj 2.06 (0.71-5.94) 0.18
Singletons Boys ICSI, fresh, surgery 1 1,270  71.6 Adj 1.02 (0.14-7.57) 0.98
Singletons Boys ICSI, frozen, surgery 0 310   0.0 Adj x x














Model RR (95% CI) p-
value
Singletons Girls IVF without ICSI, fresh 14 41,865  31.2 reference group
Singletons Girls IVF without ICSI, frozen 4 5,919  68.9 Adj 1.93 (0.63-5.90) 0.25
Singletons Girls ICSI, fresh 12 20,299  64.2 Adj 1.72 (0.78-3.80) 0.18
Singletons Girls ICSI, frozen 3 2,928 113.0 Adj 2.96 (0.84-10.46) 0.09
Singletons Girls ICSI, fresh, surgery 0 1,294   0.0 Adj x x
Singletons Girls ICSI, frozen, surgery 0 256   0.0 Adj x x
Singletons >1998 IVF without ICSI, fresh 20 36,516  47.2 reference group
Singletons >1998 IVF without ICSI, frozen 4 6,405  51.9 Adj 1.07 (0.36-3.17) 0.90
Singletons >1998 ICSI, fresh 29 29,601  87.8 Adj 1.94 (1.09-3.45) 0.02
Singletons >1998 ICSI, frozen 6 4,428 117.4 Adj 2.58 (1.03-6.47) 0.04
Singletons >1998 ICSI, fresh, surgery 1 2,214  41.5 Adj 0.94 (0.13-7.06) 0.95
Singletons >1998 ICSI, frozen, surgery 0 440 0 Adj x X
Note: x indicate cells not estimable since too few cases.
Crude model denotes model adjusting for birth year, age and sex only; Adj model denotes adjusting for birth year, age and sex and additionally adjusting for 
paternal psychiatric history, maternal psychiatric history and paternal and maternal age; AdjC model denotes adjusting for birth year, age and sex, and additionally 
for calendar time;  AdjI model denotes adjusting for birth year, age and sex, paternal psychiatric history, maternal psychiatric history and paternal and maternal age,  
and additionally for years of infertility; AdjG model denotes adjusting for birth year, age and sex and paternal psychiatric history, maternal psychiatric history and 
paternal and maternal age, and additionally adjusting for presence of genetic diseases
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RR (95% CI) p-
value
All Children Blastocyst <5 days culture 101 227,184  32.3 reference group
All Children Blastocyst Blastocyst 2 3,934  31.0 Crude 1.24 (0.29-5.31) 0.77
All Children Blastocyst Adj 1.40 (0.32-6.13) 0.66
All Children Blastocyst AdjI 1.39 (0.32-6.08) 0.67
All Children Blastocyst AdjG 1.40 (0.32-6.13) 0.66
All Children Blastocyst Boys <5 days culture 75 117,333  50.2 reference group
All Children Blastocyst Boys Blastocyst 1 2,031  31.5 Adj 0.92 (0.12-7.08) 0.94
All Children Blastocyst Girls <5 days culture 26 109,851  21.4 reference group
All Children Blastocyst Girls Blastocyst 1 1,902  46.3 Adj 2.90 (0.33-25.23) 0.34
All Children Blastocyst PreTerm <5 days culture 35 52,893  47.1 reference group
All Children Blastocyst PreTerm Blastocyst 0 736   0.0 Adj x x
All Children Blastocyst Term <5 days culture 66 174,291  27.8 reference group
All Children Blastocyst Term Blastocyst 2 3,198  37.7 Adj 2.06 (0.46-9.24) 0.35















Model RR (95% CI) p-value
All Children Frozen embryo Fresh 92 206,189  32.5 reference group
All Children Frozen embryo Frozen 11 24,929  30.1 Crude 0.93 (0.49-1.74) 0.81
All Children Frozen embryo  30.1 Adj 0.93 (0.50-1.75) 0.82
All Children Frozen embryo  30.1 AdjI 0.93 (0.50-1.75) 0.83
All Children Frozen embryo  30.1 AdjG 0.93 (0.50-1.75) 0.82
All Children Frozen embryo Boys Fresh 69 106,861  51.0 reference group
All Children Frozen embryo Boys Frozen 7 12,504  40.3 Adj 0.80 (0.37-1.76) 0.59
All Children Frozen embryo Girls Fresh 23 99,328  21.0 reference group
All Children Frozen embryo Girls Frozen 4 12,426  28.1 Adj 1.28 (0.44-3.72) 0.64
All Children Frozen embryo PreTerm Fresh 32 49,199  46.2 reference group
All Children Frozen embryo PreTerm Frozen 3 4,430  44.7 Adj 0.91 (0.28-2.97) 0.87
All Children Frozen embryo Term Fresh 60 156,990  28.2 reference group
All Children Frozen embryo Term Frozen 8 20,499  26.9 Adj 0.97 (0.46-2.03) 0.93















Model RR (95% CI) p-value
All Children ICSI IVF 63 161,328  30.7 reference group
All Children ICSI ICSI 40 69,790  36.4 Crude 1.19 (0.78-1.80) 0.42
All Children ICSI Adj 1.21 (0.80-1.85) 0.37
All Children ICSI AdjI 1.21 (0.80-1.85) 0.37
All Children ICSI AdjG 1.21 (0.80-1.85) 0.37
All Children ICSI Boys IVF 48 85,208  48.8 reference group
All Children ICSI Boys ICSI 28 34,156  52.6 Adj 1.16 (0.71-1.88) 0.55
All Children ICSI Girls IVF 15 76,120  18.9 reference group
All Children ICSI Girls ICSI 12 35,634  28.8 Adj 1.37 (0.64-2.97) 0.42
All Children ICSI PreTerm IVF 20 40,224  40.5 reference group
All Children ICSI PreTerm ICSI 15 13,405  64.6 Adj 1.73 (0.87-3.45) 0.12
All Children ICSI Term IVF 43 121,104  27.8 reference group
All Children ICSI Term ICSI 25 56,385  28.5 Adj 1.04 (0.62-1.73) 0.89















Model RR (95% CI) p-value
All Children Surgically extracted Ejaculated 95 226,611  30.9 reference group
All Children Surgically extracted Surgical 8 4,507 110.1 Crude 3.29 (1.59-6.84) <.01
All Children Surgically extracted Adj 3.29 (1.58-6.87) <.01
All Children Surgically extracted AdjI 3.30 (1.58-6.88) <.01
All Children Surgically extracted AdjG 3.29 (1.58-6.87) <.01
All Children Surgically extracted Boys Ejaculated 71 117,114  48.3 reference group
All Children Surgically extracted Boys Surgical 5 2,251 141.1 Adj 2.78 (1.11-6.99) 0.03
All Children Surgically extracted Girls Ejaculated 24 109,497  20.1 reference group
All Children Surgically extracted Girls Surgical 3 2,256 111.4 Adj 4.72 (1.39-
16.04)
0.01
All Children Surgically extracted PreTerm Ejaculated 30 52,787  42.3 reference group
All Children Surgically extracted PreTerm Surgical 5 842 319.8 Adj 8.06 (2.97-
21.85)
<.01
All Children Surgically extracted Term Ejaculated 65 173,824  27.6 reference group
All Children Surgically extracted Term Surgical 3 3,665  51.6 Adj 1.65 (0.52-5.31) 0.40


















l RR (95% CI)
p-
value
Singletons Blastocyst <5 days culture 52 146,799  23.8 reference group
Singletons Blastocyst Blastocyst 2 3,133  38.6 Crude 1.79 (0.41-7.92) 0.44
Singletons Blastocyst Adj 1.82 (0.40-8.22) 0.44
Singletons Blastocyst AdjI 1.84 (0.40-8.32) 0.43
Singletons Blastocyst AdjG 1.82 (0.40-8.22) 0.44
Singletons Blastocyst Boys <5 days culture 41 75,629  46.0 reference group
Singletons Blastocyst Boys Blastocyst 1 1,632  42.0 Adj 1.04 (0.13-8.17) 0.97
Singletons Blastocyst Girls <5 days culture 11 71,169   6.6 reference group
Singletons Blastocyst Girls Blastocyst 1 1,501  51.1 Adj 6.89 (0.61-77.37) 0.12
Singletons Blastocyst PreTerm <5 days culture 7 13,835  26.9 reference group
Singletons Blastocyst PreTerm Blastocyst 0 304   0.0 Adj x x
Singletons Blastocyst Term <5 days culture 45 132,964  20.9 reference group
Singletons Blastocyst Term Blastocyst 2 2,829  41.2 Adj 2.09 (0.46-9.52) 0.34

















Model RR (95% CI)
p-
value
Singletons Frozen embryo Fresh 49 131,538  25.1 reference group
Singletons Frozen embryo Frozen 5 18,394  17.3 Crude 0.69 (0.27-1.73) 0.43
Singletons Frozen embryo Adj 0.71 (0.28-1.78) 0.46
Singletons Frozen embryo AdjI 0.71 (0.28-1.79) 0.47
Singletons Frozen embryo AdjG 0.71 (0.28-1.78) 0.46
Singletons Frozen embryo Boys Fresh 39 68,002  48.8 reference group
Singletons Frozen embryo Boys Frozen 3 9,259  25.1 Adj 0.54 (0.17-1.76) 0.31
Singletons Frozen embryo Girls Fresh 10 63,535   7.4 reference group
Singletons Frozen embryo Girls Frozen 2 9,135  10.3 Adj 1.30 (0.28-5.93) 0.74
Singletons Frozen embryo PreTerm Fresh 7 12,721  29.3 reference group
Singletons Frozen embryo PreTerm Frozen 0 1,418   0.0 Adj x x
Singletons Frozen embryo Term Fresh 42 118,817  22.0 reference group
Singletons Frozen embryo Term Frozen 5 16,977  17.4 Adj 0.82 (0.32-2.08) 0.68

















Model RR (95% CI)
p-
value
Singletons ICSI IVF 35 101,347  24.6 reference group
Singletons ICSI ICSI 19 48,585  23.1 Crude 0.94 (0.53-1.67) 0.83
Singletons ICSI Adj 1.01 (0.56-1.81) 0.98
Singletons ICSI AdjI 1.00 (0.56-1.79) 1.00
Singletons ICSI AdjG 1.01 (0.56-1.81) 0.98
Singletons ICSI Boys IVF 28 53,475  47.3 reference group
Singletons ICSI Boys ICSI 14 23,786  42.3 Adj 0.97 (0.50-1.88) 0.92
Singletons ICSI Girls IVF 7 47,872   7.7 reference group
Singletons ICSI Girls ICSI 5 24,798   8.0 Adj 1.15 (0.36-3.68) 0.81
Singletons ICSI PreTerm IVF 6 10,050  32.5 reference group
Singletons ICSI PreTerm ICSI 1 4,089  12.0 Adj 0.35 (0.04-2.91) 0.33
Singletons ICSI Term IVF 29 91,297  21.3 reference group
Singletons ICSI Term ICSI 18 44,496  21.7 Adj 1.13 (0.62-2.09) 0.69

















l RR (95% CI)
p-
value
Singletons Surgically extracted Ejaculated 53 146,797  24.3 reference group
Singletons Surgically extracted Surgical 1 3,135  18.3 Crude 0.68 (0.09-4.94) 0.70
Singletons Surgically extracted Surgical 1 3,135  18.3 Adj 0.73 (0.10-5.30) 0.75
Singletons Surgically extracted AdjI 0.72 (0.10-5.25) 0.75
Singletons Surgically extracted AdjG 0.73 (0.10-5.30) 0.75
Singletons Surgically extracted Boys Ejaculated 41 75,676  45.9 reference group
Singletons Surgically extracted Boys Surgical 1 1,585  45.0 Adj 0.96 (0.13-7.02) 0.97
Singletons Surgically extracted Girls Ejaculated 12 71,121   7.9 reference group
Singletons Surgically extracted Girls Surgical 0 1,550   0.0 Adj x x
Singletons Surgically extracted PreTerm Ejaculated 7 13,893  26.8 reference group
Singletons Surgically extracted PreTerm Surgical 0 246   0.0 Adj x x
Singletons Surgically extracted Term Ejaculated 46 132,904  21.5 reference group
Singletons Surgically extracted Term Surgical 1 2,889  17.8 Adj 0.83 (0.11-6.03) 0.85
Note: x indicate cells not estimable since too few cases. Crude model denotes model adjusting for birth year, age and sex only; Adj model denotes adjusting for 
birth year, age and sex and additionally adjusting for paternal psychiatric history, maternal psychiatric history and paternal and maternal age; AdjC model denotes 
adjusting for birth year, age and sex, and additionally for calendar time;  AdjI model denotes adjusting for birth year, age and sex, paternal psychiatric history, 
maternal psychiatric history and paternal and maternal age, and additionally for years of infertility; AdjG model denotes adjusting for birth year, age and sex and 
paternal psychiatric history, maternal psychiatric history and paternal and maternal age, and additionally adjusting for presence of genetic diseases
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Model RR (95% CI)
p-
value
All Children Blastocyst <5 days culture 179 226,774  71.9 reference group
All Children Blastocyst Blastocyst 1 3,936  19.5 Crude 0.27 (0.04-1.94) 0.19
All Children Blastocyst Adj 0.28 (0.04-2.01) 0.20
All Children Blastocyst AdjI 0.27 (0.04-2.00) 0.20
All Children Blastocyst AdjG 0.28 (0.04-2.01) 0.20
All Children Blastocyst Boys <5 days culture 122 117,089 100.0 reference group
All Children Blastocyst Boys Blastocyst 1 2,031  39.6 Adj 0.42 (0.06-3.11) 0.40
All Children Blastocyst Girls <5 days culture 57 109,685  52.0 reference group
All Children Blastocyst Girls Blastocyst 0 1,904   0.0 Adj x x
All Children Blastocyst PreTerm <5 days culture 70 52,691 115.4 reference group
All Children Blastocyst PreTerm Blastocyst 0 736   0.0 Adj x x
All Children Blastocyst Term <5 days culture 109 174,083  56.7 reference group















Model RR (95% CI) p-
value
All Children Frozen embryo Fresh 159 205,824  70.5 reference group
All Children Frozen embryo Frozen 21 24,886  74.2 Crude 1.05 (0.67-1.66) 0.83
All Children Frozen embryo Adj 1.07 (0.68-1.69) 0.77
All Children Frozen embryo AdjI 1.07 (0.68-1.70) 0.77
All Children Frozen embryo AdjG 1.08 (0.68-1.70) 0.75
All Children Frozen embryo Boys Fresh 111 106,629 100.3 reference group
All Children Frozen embryo Boys Frozen 12 12,492  86.9 Adj 0.90 (0.49-1.63) 0.72
All Children Frozen embryo Girls Fresh 48 99,195  48.5 reference group
All Children Frozen embryo Girls Frozen 9 12,394  71.7 Adj 1.45 (0.71-2.97) 0.30
All Children Frozen embryo PreTerm Fresh 61 49,028 107.6 reference group
All Children Frozen embryo PreTerm Frozen 9 4,399 174.7 Adj 1.56 (0.77-3.15) 0.22
All Children Frozen embryo Term Fresh 98 156,795  56.9 reference group
All Children Frozen embryo Term Frozen 12 20,488  49.2 Adj 0.90 (0.49-1.64) 0.73
















Model RR (95% CI)
p-
value
All Children ICSI IVF 107 161,019  61.8 reference group
All Children ICSI ICSI 73 69,691  93.5 Crude 1.51 (1.10-2.09) 0.01
All Children ICSI Adj 1.51 (1.09-2.09) 0.01
All Children ICSI AdjI 1.51 (1.09-2.08) 0.01
All Children ICSI AdjG 1.52 (1.10-2.11) 0.01
All Children ICSI Boys IVF 74 85,036  87.6 reference group
All Children ICSI Boys ICSI 49 34,084 129.4 Adj 1.54 (1.05-2.25) 0.03
All Children ICSI Girls IVF 33 75,982  43.2 reference group
All Children ICSI Girls ICSI 24 35,607  68.8 Adj 1.45 (0.85-2.49) 0.18
All Children ICSI PreTerm IVF 43 40,073  96.0 reference group
All Children ICSI PreTerm ICSI 27 13,354 166.7 Adj 1.73 (1.05-2.86) 0.03
All Children ICSI Term IVF 64 120,946  49.8 reference group
All Children ICSI Term ICSI 46 56,337  70.1 Adj 1.44 (0.97-2.15) 0.07

















Model RR (95% CI)
p-
value
All Children Surgically extracted Ejaculated 174 226,201  70.1 reference group
All Children Surgically extracted Surgical 6 4,508 112.1 Crude 1.56 (0.69-3.54) 0.29
All Children Surgically extracted Adj 1.67 (0.73-3.79) 0.22
All Children Surgically extracted AdjI 1.67 (0.73-3.79) 0.22
All Children Surgically extracted AdjG 1.68 (0.74-3.83) 0.22
All Children Surgically extracted Boys Ejaculated 120 116,869  98.6 reference group
All Children Surgically extracted Boys Surgical 3 2,252 112.9 Adj 1.19 (0.38-3.78) 0.76
All Children Surgically extracted Girls Ejaculated 54 109,333  49.4 reference group
All Children Surgically extracted Girls Surgical 3 2,256 130.2 Adj 2.77 (0.85-9.02) 0.09
All Children Surgically extracted PreTerm Ejaculated 66 52,580 109.4 reference group
All Children Surgically extracted PreTerm Surgical 4 846 356.7 Adj 3.31 (1.18-9.31) 0.02
All Children Surgically extracted Term Ejaculated 108 173,621  56.2 reference group
All Children Surgically extracted Term Surgical 2 3,662  43.5 Adj 0.83 (0.20-3.40) 0.80

















Model RR (95% CI)
p-
value
Singletons Blastocyst <5 days culture 100 146,542  63.7 reference group
Singletons Blastocyst Blastocyst 1 3,135  23.7 Crude 0.39 (0.05-2.85) 0.35
Singletons Blastocyst Adj 0.35 (0.05-2.61) 0.31
Singletons Blastocyst AdjI 0.36 (0.05-2.65) 0.31
Singletons Blastocyst AdjG 0.35 (0.05-2.61) 0.31
Singletons Blastocyst Boys <5 days culture 67 75,485  86.9 reference group
Singletons Blastocyst Boys Blastocyst 1 1,632  43.2 Adj 0.46 (0.06-3.42) 0.45
Singletons Blastocyst Girls <5 days culture 33 71,057  46.4 reference group
Singletons Blastocyst Girls Blastocyst 0 1,503   0.0 Adj x x
Singletons Blastocyst PreTerm <5 days culture 17 13,764 111.3 reference group
Singletons Blastocyst PreTerm Blastocyst 0 304   0.0 Adj x x
Singletons Blastocyst Term <5 days culture 83 132,779  57.1 reference group
Singletons Blastocyst Term Blastocyst 1 2,831  24.4 Adj 0.39 (0.05-2.86) 0.35

















Model RR (95% CI) p-value
Singletons Frozen embryo Fresh 83 131,341  59.1 reference group
Singletons Frozen embryo Frozen 18 18,336  89.1 Crude 1.51 (0.90-2.52) 0.12
Singletons Frozen embryo Adj 1.52 (0.91-2.55) 0.11
Singletons Frozen embryo AdjI 1.52 (0.91-2.55) 0.11
Singletons Frozen embryo AdjG 1.53 (0.92-2.57) 0.10
Singletons Frozen embryo Boys Fresh 57 67,883  82.8 reference group
Singletons Frozen embryo Boys Frozen 11 9,233 108.8 Adj 1.38 (0.72-2.66) 0.33
Singletons Frozen embryo Girls Fresh 26 63,458  40.7 reference group
Singletons Frozen embryo Girls Frozen 7 9,102  78.5 Adj 1.80 (0.78-4.16) 0.17
Singletons Frozen embryo PreTerm Fresh 10 12,690  66.9 reference group
Singletons Frozen embryo PreTerm Frozen 7 1,378 498.0 Adj 6.02 (2.27-15.96) <.01
Singletons Frozen embryo Term Fresh 73 118,652  56.4 reference group
Singletons Frozen embryo Term Frozen 11 16,958  56.1 Adj 1.03 (0.54-1.95) 0.92

















Model RR (95% CI) p-value
Singletons ICSI IVF 59 101,166  54.8 reference group
Singletons ICSI ICSI 42 48,511  80.2 Crude 1.46 (0.96-2.23) 0.08
Singletons ICSI Adj 1.50 (0.98-2.29) 0.06
Singletons ICSI AdjI 1.49 (0.97-2.28) 0.07
Singletons ICSI AdjG 1.52 (0.99-2.33) 0.06
Singletons ICSI Boys IVF 41 53,381  78.2 reference group
Singletons ICSI Boys ICSI 27 23,735 104.3 Adj 1.46 (0.88-2.44) 0.15
Singletons ICSI Girls IVF 18 47,784  35.9 reference group
Singletons ICSI Girls ICSI 15 24,776  64.9 Adj 1.57 (0.78-3.17) 0.21
Singletons ICSI PreTerm IVF 11 10,000  97.4 reference group
Singletons ICSI PreTerm ICSI 6 4,067 136.2 Adj 1.36 (0.49-3.75) 0.55
Singletons ICSI Term IVF 48 91,165  49.3 reference group
Singletons ICSI Term ICSI 36 44,444  71.8 Adj 1.53 (0.97-2.42) 0.07

















Model RR (95% CI)
p-
value
Singletons Surgically extracted Ejaculated 100 146,548  63.5 reference group
Singletons Surgically extracted Surgical 1 3,129  27.6 Crude 0.42 (0.06-3.06) 0.40
Singletons Surgically extracted Adj 0.45 (0.06-3.22) 0.42
Singletons Surgically extracted AdjI 0.45 (0.06-3.22) 0.42
Singletons Surgically extracted AdjG 0.45 (0.06-3.27) 0.43
Singletons Surgically extracted Boys Ejaculated 67 75,537  86.5 reference group
Singletons Surgically extracted Boys Surgical 1 1,580  54.5 Adj 0.64 (0.09-4.65) 0.66
Singletons Surgically extracted Girls Ejaculated 33 71,011  46.4 reference group
Singletons Surgically extracted Girls Surgical 0 1,550   0.0 Adj x x
Singletons Surgically extracted PreTerm Ejaculated 17 13,822 110.5 reference group
Singletons Surgically extracted PreTerm Surgical 0 246   0.0 Adj x x
Singletons Surgically extracted Term Ejaculated 83 132,726  57.0 reference group
Singletons Surgically extracted Term Surgical 1 2,884  28.4 Adj 0.53 (0.07-3.85) 0.53
Crude model denotes model adjusting for birth year, age and sex only; Adj model denotes adjusting for birth year, age and sex and additionally adjusting for 
paternal psychiatric history, maternal psychiatric history and paternal and maternal age; AdjC model denotes adjusting for birth year, age and sex, and additionally 
for calendar time;  AdjI model denotes adjusting for birth year, age and sex, paternal psychiatric history, maternal psychiatric history and paternal and maternal age,  
and additionally for years of infertility; AdjG model denotes adjusting for birth year, age and sex and paternal psychiatric history, maternal psychiatric history 
and paternal and maternal age, and additionally adjusting for presence of genetic diseases. Note: x indicate cells not estimable since too few cases.
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eTable 9 Hormones. Comparing children born following hormone treatment as only fertility treatment vs children spontaneous conceived without 
use of hormones.














All Children No Hormones 6,933 34,155,462 15.6 reference group
All Children Hormone treated 26 70,333 14.1 Crude 0.90 (0.61-1.33) 0.61
All Children Adj 0.91 (0.62-1.34) 0.64
Singletons No Hormones 6,713 33,372,926  15.0 reference group
Singletons Hormone treated 24 62,389  14.2 Crude 0.95 (0.63-1.42) 0.79
Singletons Adj 0.96 (0.64-1.43) 0.84
Mental Retardation
All Children No Hormones 15,784 34,108,394 39.8 reference group
All Children Hormone treated 43 70,277 34.4 Crude 0.86 (0.64-1.16) 0.34
All Children Adj 0.89 (0.66-1.21) 0.46
Singletons No Hormones 15,241 33,327,569  38.5 reference group
Singletons Hormone treated 38 62,342  33.4 Crude 0.87 (0.63-1.19) 0.39
Singletons Adj 0.90 (0.65-1.24) 0.52
Crude model denotes model adjusting for birth year, age and sex only; Adj model denotes adjusting for birth year, age and sex and additionally adjusting for 
paternal psychiatric history, maternal psychiatric history and paternal and maternal age. Note: x indicate cells not estimable since too few cases.
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All Children IVF without ICSI, fresh 1.01 (0.77 - 1.32)   0.96 1.01 (0.83 - 1.24)   0.91
All Children IVF without ICSI, fresh >1998## 1.14 (0.79 - 1.63)   0.49 0.92 (0.66 - 1.28)   0.64
All Children IVF without ICSI, fresh Boys 1.07 (0.79 - 1.45)   0.66 1.14 (0.90 - 1.45)   0.28
All Children IVF without ICSI, fresh Girls 0.85 (0.47 - 1.54)   0.60 0.75 (0.51 - 1.09)   0.13
All Children IVF without ICSI, fresh Pre-Term 0.82 (0.51 - 1.33)   0.42 0.69 (0.50 - 0.95)   0.02
All Children IVF without ICSI, fresh Term 0.95 (0.68 -  1.32)   0.75 0.86 (0.66 - 1.12)   0.25
All Children IVF without ICSI, frozen 1.43 (0.77- 2.66)   0.26 1.12 (0.65- 1.93)   0.68
All Children IVF without ICSI, frozen >1998## 1.25 (0.52- 3.00)   0.62 0.67 (0.25- 1.79)   0.42
All Children IVF without ICSI, frozen Boys 1.19 (0.54- 2.66)   0.67 1.00 (0.48- 2.10)   1.00
All Children IVF without ICSI, frozen Girls 2.17 (0.81- 5.80)   0.12 1.26 (0.56- 2.80)   0.58
All Children IVF without ICSI, frozen Pre-Term 1.45 (0.47- 4.51)   0.52 0.96 (0.40- 2.30)   0.92
All Children IVF without ICSI, frozen Term 1.30 (0.62- 2.73)   0.49 0.91 (0.46- 1.83)   0.80
Continues on next page
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eTable 10 (cont.)













All Children ICSI, fresh 1.23 (0.86- 1.75)   0.25 1.45 (1.12- 1.87)   <.01
All Children ICSI, fresh >1998## 1.27 (0.85- 1.88)   0.24 1.57 (1.18- 2.09)   <.01
All Children ICSI, fresh Boys 1.21 (0.79- 1.84)   0.38 1.70 (1.25- 2.31)   <.01
All Children ICSI, fresh Girls 1.30 (0.67- 2.50)   0.44 1.04 (0.66- 1.66)   0.86
All Children ICSI, fresh Pre-Term 1.28 (0.68- 2.38)   0.45 1.01 (0.64- 1.59)   0.96
All Children ICSI, fresh Term 1.07 (0.70- 1.65)   0.75 1.31 (0.96- 1.78)   0.09
All Children ICSI, frozen 0.32 (0.04- 2.24)   0.25 1.65 (0.82- 3.30)   0.16
All Children ICSI, frozen >1998## 0.37 (0.05- 2.65)   0.32 1.48 (0.66- 3.29)   0.34
All Children ICSI, frozen Boys 0.45 (0.06- 3.17)   0.42 1.81 (0.75- 4.36)   0.18
All Children ICSI, frozen Girls x x 1.39 (0.45- 4.30)   0.57
All Children ICSI, frozen Pre-Term x x 2.39 (0.89- 6.37)   0.08
All Children ICSI, frozen Term 0.39 (0.05- 2.75)   0.34 1.03 (0.39- 2.76)   0.95

















All Children ICSI, fresh, surgery 4.56 (2.28- 9.13)   <.01 2.18 (0.98- 4.86)   0.06
All Children ICSI, fresh, surgery >1998## 4.47 (2.13- 9.40)   <.01 1.67 (0.63- 4.45)   0.31
All Children ICSI, fresh, surgery Boys 3.92 (1.63- 9.44)   <.01 1.85 (0.59- 5.73)   0.29
All Children ICSI, fresh, surgery Girls 6.18 (1.99-19.18)   <.01 2.59 (0.83- 8.02)   0.10
All Children ICSI, fresh, surgery Pre-Term 8.08 (3.35-19.49)   <.01 2.80 (1.05- 7.48)   0.04
All Children ICSI, fresh, surgery Term 2.26 (0.73- 7.01)   0.16 1.00 (0.25- 4.01)   1.00
All Children ICSI, frozen, surgery Not estimable - Too few cases

















Singletons IVF without ICSI, fresh 0.89 ( 0.62 -  1.27)   0.52 0.83 ( 0.63 -  1.11)   0.21
Singletons IVF without ICSI, fresh >1998## 1.02 ( 0.65 -  1.61)   0.92 0.74 ( 0.48 -  1.15)   0.18
Singletons IVF without ICSI, fresh Boys 1.00 ( 0.67 -  1.48)   0.98 0.94 ( 0.67 -  1.31)   0.70
Singletons IVF without ICSI, fresh Girls 0.61 ( 0.25 -  1.46)   0.27 0.62 ( 0.37 -  1.05)   0.08
Singletons IVF without ICSI, fresh Pre-Term 1.01 ( 0.45 -  2.26)   0.98 0.47 ( 0.23 -  0.99)   0.05
Singletons IVF without ICSI, fresh Term 0.83 ( 0.56 -  1.25)   0.38 0.84 ( 0.62 -  1.14)   0.27
Singletons IVF without ICSI, frozen 0.96 (0.40- 2.31)   0.93 1.32 (0.73- 2.38)   0.36
Singletons IVF without ICSI, frozen >1998## 0.92 (0.30- 2.88)   0.89 0.84 (0.31- 2.24)   0.72
Singletons IVF without ICSI, frozen Boys 0.80 (0.26- 2.48)   0.70 1.39 (0.66- 2.92)   0.38
Singletons IVF without ICSI, frozen Girls 1.48 (0.37- 5.93)   0.58 1.17 (0.44- 3.11)   0.76
Singletons IVF without ICSI, frozen Pre-Term x x 2.46 (0.92- 6.58)   0.07
Singletons IVF without ICSI, frozen Term 1.11 (0.46- 2.67)   0.81 0.97 (0.46- 2.03)   0.93

















Singletons ICSI, fresh 1.03 (0.65- 1.64)   0.90 1.23 (0.87- 1.72)   0.24
Singletons ICSI, fresh >1998## 0.93 (0.54- 1.60)   0.79 1.35 (0.93- 1.94)   0.11
Singletons ICSI, fresh Boys 1.04 (0.60- 1.79)   0.90 1.35 (0.88- 2.05)   0.17
Singletons ICSI, fresh Girls 1.04 (0.43- 2.50)   0.94 1.02 (0.58- 1.80)   0.95
Singletons ICSI, fresh Pre-Term 0.38 (0.05- 2.73)   0.34 0.50 (0.16- 1.56)   0.23
Singletons ICSI, fresh Term 1.11 (0.69- 1.79)   0.66 1.30 (0.92- 1.85)   0.14
Singletons ICSI, frozen x x 1.84 (0.88- 3.86)   0.11
Singletons ICSI, frozen >1998## x x 1.88 (0.84- 4.19)   0.12
Singletons ICSI, frozen Boys x x 1.85 (0.69- 4.93)   0.22
Singletons ICSI, frozen Girls x x 1.78 (0.57- 5.51)   0.32
Singletons ICSI, frozen Pre-Term x x 4.00 (1.29-12.43)   0.02
Singletons ICSI, frozen Term x x 1.22 (0.46- 3.25)   0.69

















Singletons ICSI, fresh, surgery 0.81 (0.11- 5.75)   0.83 0.53 (0.07- 3.75)   0.52
Singletons ICSI, fresh, surgery >1998## 0.88 (0.12- 6.27)   0.90 0.59 (0.08- 4.20)   0.60
Singletons ICSI, fresh, surgery Boys 1.09 (0.15- 7.78)   0.93 0.88 (0.12- 6.22)   0.89
Singletons ICSI, fresh, surgery Girls x x x x
Singletons ICSI, fresh, surgery Pre-Term x x x x
Singletons ICSI, fresh, surgery Term 0.92 (0.13- 6.54)   0.93 0.62 (0.09- 4.39)   0.63
Singletons ICSI, frozen, surgery Not estimable - Too few cases
Note: x indicate cells not estimable since too few cases.
# Adj model denotes adjusting for birth year, age and sex and additionally adjusting for paternal psychiatric history, maternal psychiatric history and 
paternal and maternal age;
## >1998 Only include children born between 1st January 1999 and 31st December 2007
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Adj Rate## per 
100,000
Model### RR (95% CI) p-value
Autistic Disorder
Any IVF Singletons 54 149,932 24.9 reference group
Multiples 49 81,186 46.0 Crude 1.66 (1.13-2.44) 0.010
46.0 Adj 1.88 (1.28-2.77) 0.001
Spontaneous Singletons 6,683 33,285,383 13.8 reference group
Multiples 173 709,295 15.9 Crude 1.22 (1.05-1.42) 0.010
15.9 Adj 1.15 (0.99-1.34) 0.068
Relative risk ratio for any IVF vs Spontaneous Adj 1.63 (1.08-2.47) 0.021









Adj Rate## per 
100,000
Model### RR (95% CI) p-value
Intellectual Disability
Any IVF Singletons 101 149,677 60.0 reference group
Multiples 79 81,033 91.4 Crude 1.36 (1.01-1.83) 0.041
Adj 1.49 (1.11-2.00) 0.008
Spontaneous Singletons 15,178 33,240,234 36.4 reference group
Multiples 469 707,727 51.1 Crude 1.46 (1.33-1.60) <0.001
51.1 Adj 1.42 (1.29-1.56) <0.001
Relative risk ratio for any IVF vs Spontaneous Adj 1.05 (0.77-1.43) 0.747
RR: Relative risk
# Multiple include twins and any higher order birth
## Rate adjusted for sex, age and birth year,
### Crude: Model adjusting for birth year, age and sex only, Adj: Model adjusting for birth year, age and sex, and additionally adjusting for paternal 
psychiatric history, maternal psychiatric history and paternal and maternal age 
228 (229)
eTable 12 All children. Distribution of confounders and children characteristics for spontaneuos conceived with and without hormone treatment. Hormone 
treatment being the only treatment for fertility.





with hormone treatment as the 
only fertility treatment
Number of Children (% boys) 2,499,096 (51.4) 11,070 (50.7)
Father Psych. History, N (%) 36,255 ( 1.5) 39 ( 1.4)
Mother Psych. History, N (%) 46,186 ( 1.8) 51 ( 1.8)
Pre-term (before week 37), N (%)  142,402 ( 5.7) 435 (15.7)
Multiple Birth, N (%) 53,434 (2.14) 606 (21.8)
Birth year, Median (Min-Max) 1994 (1982-07) 2004 (1990-07)


























Years of involuntary infertility, Median (10th-90th 
percentiles)
0 (0-0) 2 (0-7)
229 (229)
